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Fluorescence correlation spectroscopy (FCS) and its modality fluorescence cross-
correlation spectroscopy (FCCS) as well as imaging total internal reflection fluorescence 
correlation spectroscopy (ITIR-FCS) are single molecule sensitive optical tools to study 
mobility, concentrations and/or interactions. These methods are gaining popularity in the 
past few years due to their non-invasive nature for in vivo biological systems. The aim of 
this thesis is to apply and develop single-wavelength-FCCS (SW-FCCS), a variant of 
FCCS, to quantitate the protein-protein interactions in vivo, and to apply ITIR-FCS to 
quantitatively study the mobility modes of membrane molecules. The thesis is organized 
into the following chapters: 
Chapter 1 gives an introduction of the epidermal growth factor receptor (EGFR). The 
introduction starts from a history of EGFR study, and focuses on the function and clinical 
importance of EGFR, its structure, the cycling within the cells, important signalling 
pathways triggered by EGFR, EGFR in the nucleus, and special topics such as 
dimerization of EGFR as well as its relationship with membrane domains and the 
cytoskeleton. 
Chapter 2 introduces the principles of FCS, FCCS and ITIR-FCS, followed by 
instrumental setup of SW-FCCS and ITIR-FCS, respectively. It further introduces the 
FCS diffusion law applied using our ITIR-FCS setup.  
Chapter 3 presents materials and methods besides FCS used in this thesis. 
Chapter 4 discusses the pre-formed dimers of EGFR measured by SW-FCCS in living 
cells. This chapter firstly confirms the data consistency with the previous results, and 
then presents the discoveries about the dimer% changes upon EGF stimulation. 
Chapter 5 reports the measurement of an activation and time dependent interaction 
between a cytosolic and a membrane bound protein by SW-FCCS in live cells. This 
chapter demonstrates the activation of the receptor through detecting the phosphorylation 
dependent binding of a phosphotyrosine binding (PTB) domain.  
Chapter 6 describes the application of ITIR-FCS in studying  the diffusion of EGFR. The 
first part discusses the calibration of important parameters which should be determined 
ix 
 
before the method is applied in our setting. Then the results from confocal FCS and ITIR-
FCS are compared to confirm the consistency of the data. The last part of this chapter 
introduces the information of EGFR and PTB which can be extracted from ITIR-FCS 
measurements. 
Chapter 7 focus on the factors affecting the diffusion mode of EGFR. The combination of 
diffusion coefficient analysis and FCS diffusion law studies provides insights about the 
influence of lipid rafts, cytoskeleton, and receptor activation on the mobility of EGFR.  
Chapter 8 concludes and presents an outlook for future FCS and FCCS developments for 
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Chapter 1. Introduction 
1.1 Epidermal Growth Factor Receptor (EGFR) 
The history of studying EGFR can be traced back to the early 1960s when Cohen and 
colleagues firstly noted that some component in the extract of the mouse submaxillary 
salivary glands caused newborn mice to open their eyes earlier (Levi-Montalcini and 
Cohen 1960). Shortly after that, they isolated a 53-amino-acid polypeptide, now known 
as epidermal growth factor (EGF) (Cohen 1962). In 1975, the same group characterized 
its cell membrane receptor, namely epidermal growth factor receptor (EGFR) (Carpenter, 
Lembach et al. 1975). Later, Ullrich and colleagues successfully cloned EGFR from 
cDNA, which leads to the discovery of the receptor Tyrosine kinase (RTK) super-family 
(Ullrich, Coussens et al. 1984). Since then, EGFR has become one of the most intensely 
studied members in this super-family.  
EGFR belongs to the ErbB family, whose name is derived from Erythroblastic Leukemia 
Viral Oncogene Homolog (v-erbB). In human, this family contains 4 proteins, EGFR 
(ErbB1, Her1), ErbB2 (Her2, Neu), ErbB3 (Her3), and ErbB4 (Her4). The tyrosine 
kinase (TK) domains have the highest sequence identities (82% identity for ErbB2, 59% 
ErbB3, and 81% for ErbB4) (Mitsudomi and Yatabe 2010) and the C-terminal domains 
have the lowest (12-30% identity) among the family members (Jorissen, Walker et al. 
2003). This thesis will focus on human EGFR, but a brief introduction about other 
members will be mentioned at the end of this chapter.  
The EGFR gene is located at chromosome 7p12-13 of Homo sapiens (human), and has 11 
transcripts. The complete protein has 1210 AA (amino acid) residues and then is 
processed into a mature form with 1186 AA residues with a molecular weight of about 
170 kDa (Humphrey, Wong et al. 1988; Resat, Ewald et al. 2003). N-linked glycosylation 
is required for EGFR's membrane translocation and subsequent acquisition of functions 
(Jorissen, Walker et al. 2003). In the following parts of this chapter, the functions and 
clinical importance of EGFR will be introduced in section 1.1.1, followed by the structure 
in section 1.1.2, and the cycling of EGFR within the cells will be summarized in section 
1.1.3. Next, the signalling pathways triggered by EGFR, EGFR in the nucleus, 
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dimerization of EGFR and EGFR's relationship with membrane domains and 
cytoskeleton will be in section 1.1.4 - 1.1.8, respectively.  
 
1.1.1 The importance and clinical trials 
There are 7 ligands known to bind to EGFR, including EGF, transforming growth factor-
α (TGF- α), amphiregulin (AR), epigen (EPN), betacellulin(BTC), heparin-binding EGF 
(HBEGF) and epiregulin (EPR) (Mitsudomi and Yatabe 2010). EGFR transfers the 
signals from extracellular space into the cells and initiates a large set of important 
pathway cascades, such as MAPK (mitogen-activated protein kinase) pathway, PI-3K 
(phosphatidylinositol-2 kinase) pathway, and STAT (signal trandsucer and activator of 
transcription) pathway (Lurje and Lenz 2009; Huang, Chen et al. 2011; Rosenzweig 
2012), and leads to different cell fates. The combination of different ligands, 
phosphorylation sites and heterodimer-formation during activation (see section 1.1.6.) 
expand the possibilities of signalling pathways stimulated by this single molecule, 
resulting in a bow-tie structure of the network.  
In normal cells, EGFR signalling is tightly regulated, as its activity is essential for normal 
development and survival. Insufficient EGFR signalling results in death of vertebrates in 
the perinatal period (Lill and Sever 2012), whereas overexpression and mutation of 
EGFR is often found in many cancers (Seshacharyulu, Ponnusamy et al. 2012), such as 
non-small-cell lung cancer (NSCLC), colorectal cancer (CRC), squamous cell carcinoma 
of the head and neck (SCCHN), ovarian, breast, kidney, pancreatic and prostate cancer 
(Yarden and Sliwkowski 2001; Baselga 2002; Hynes and Lane 2005; Press and Lenz 
2007; Burgess 2008; Ciardiello and Tortora 2008; Seshacharyulu, Ponnusamy et al. 
2012). Abnormal expression is reported to be associated with disease progression, 
radiochemotherapy resistance, and poor survival. Studies find that 44% of the patients 
with gastric cancers were EGFR-positive and the EGFR expression significantly 
associated with poor prognosis and disease recurrence (Galizia, Lieto et al. 2007). In 
patients with adenocarcinoma, cytoplasmic EGFR overexpression was shown to be 
related with shorter overall survival than those without EGFR overexpression (P = 0.02) 
(Ueda, Ogata et al. 2004). In addition, EGFR signalling is also related to 
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neurodegenerative diseases such as Parkinson's disease (Iwakura, Piao et al. 2005) and 
Alzheimer's Disease (Wang, Chiang et al. 2012).  
The mis-regulation of EGFR includes over-expression and constitutive-activation-
mutation (Ciardiello and Tortora 2008). The mutations disrupt the auto-inhibition 
mechanism of EGFR kinase domain and impair the down-regulation of the receptor 
(Sharma and Settleman 2009). The high probability of TK-domain mutation associated 
with the malignancies suggests that it is closely related to its kinase function. 
Approximately 90% of mutations affect the TK domain-coding region (exon 18-24), and 
increased gene copy number, which is much rarer (Ciardiello and Tortora 2008; 
Mitsudomi and Yatabe 2010). To be more specific, exon 19 deletion accounts for 45% 
and point mutations of L858R in exon 21 accounts for another 40% (Kuan, Wikstrand et 
al. 2001) of mutations. Somatic mutations targeting exons 18-21 were found in ~20% of 
non-small cell lung carcinomas. 
Mutations display different drug responses: mutation such as T790M, accounting for 
about 50% EGFR mutation cases, was found associated with a resistance to TK inhibitors 
(TKI) such as gefitinib and erlotinib (Kobayashi, Boggon et al. 2005; Pao, Miller et al. 
2005; Shih, Gow et al. 2005). On the other hand, a consistent improvement in 
progression-free survival was demonstrated in non-small-cell cancer patients with EGFR 
gene mutations, but no overall survival was found (Maemondo, Inoue et al. 2010).  
Several approaches have been developed to depress the EGFR mis-regulation: 1) 
competitors of the ligands or monoclonal antibodies, such as cetuximab, occupy the spot 
and block the activation induced by the ligands-receptor binding. Besides, cetuximab can 
induce EGFR internalization and down-regulation to overcome the overexpression. 2) TK 
inhibitors (TKI), such as competitors of ATP (erlotinib, efitinib, and Gifitinib, for 
example), target to the ATP-binding pockets within the EGFR tyrosine kinase (TK) 
domain and block the phosphorylation and the following signalling. 3) chemopreventive 
agents, including Genistain, Curcumin, and Caspacin, aim at down-regulating EGFR at 
the gene level (Ciardiello and Tortora 2008; Seshacharyulu, Ponnusamy et al. 2012). 
Several drugs were reported to successfully interfere with EGFR mediated effects in solid 
tumors and were approved by the FDA for the treatment of certain cancers. For instance, 
cetuximab and panitumumab are for treatment of metastatic colorectal cancer. Erlotinib is 
approved for advanced/metastatic lung cancer, and erlotinib in combination with 
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gemcitabine is approved for advanced/metastatic pancreatic cancer. Positive news 
include: a meta-analysis showed anti-EGFR therapies using gefitinib (a TKI), cetuximab, 
panitumumab, zalutumumab (all three are monoclonal antibodies) applied in addition to 
standard therapy confered a statistically significant improvement in overall survival, 
progression free survival and overall responses rate in recurrent/metastatic head and neck 
cancer (Petrelli and Barni 2012); clinical studies with cetuximab have revealed its 
effectiveness in combination with platinum-based chemotherapy in patients with 
recurrent/metastatic squamous-cell carcinoma of the head and neck (Vermorken, Mesia et 
al. 2008); erlotinib was found being able to prolong survival in patients with non-small-
cell lung cancer after the failure of their first-line or second-line chemotherapy 
(Shepherd, Rodrigues Pereira et al. 2005).  
However, even the very promising therapeutic agents are not effective against many 
receptor-positive tumors in all the patients. Besides, the results are found to conflict with 
each other in some cases, probably related to race, age, gender, and habits (Lund, Trivers 
et al. 2009; Meguid, Hooker et al. 2010). For example, investigation of responsiveness to 
erlotinib found that the presence of EGFR and its gene amplification and mutations 
indicated no survival benefit among patients with non-small-cell lung cancer, making a 
question mark on its anti-EGFR function. The combination of cetuximab or panitumumab 
(both monoclonal antibodies of EGFR, FDA approved for the treatment of metastatic 
colorectal cancer) with oxaliplatin-based chemotherapy showed no survival benefit in 
KRAS wild type metastatic colorectal cancer patients (Zhou, Huang et al. 2012). The 
challenges lie in understanding the complexity of the network. For example, it remains 
elusive how EGFR interacts with downstream molecules and impact various pathways, 
the understanding of which will help overcome the acquired resistance to anti-EGFR 
drugs, such as new mutation to avoid binding to the drugs and cross talk bypassing the 
EGFR signalling (Rosenzweig 2012).   
As the importance of EGFR in disease progression and the difficulties for people to 
overcome have been presented above, it is thus imperative to understand the receptor in 




1.1.2 The structure of EGFR 
EGFR comprises of five domains: an extracellular region (ECD, residues 1-619), a 
transmembrane (TM) domain (620-642), an intracellular juxtamembrane (JM) region 
(643-684), a tyrosine kinase (TK) domain (685-952), and a C-terminal tail (983-1186) 
(Burgess 2008; Ferguson 2008; Boran 2012). The crystal structure of full-length EGFR 
hasn't been solved due to solubility problems. However in 2002, the complex of EGFR 
extracellular domains and the ligands, was determined (Garrett, McKern et al. 2002; 
Ogiso, Ishitani et al. 2002).  It was found that the complex exists in a 2:2 stoichiometry, 
and the ligand is clamped by domain L1 and L2 of the extracellular region (see next 
paragraph) (Figure 1.1). While the crystal structures of the EGFR kinase domain have 
been determined in two forms: form A is unphosphorylated but adopts an active 
conformation, while form B is in an inactive confirmation that resembles that of Src 
(sarcoma) family kinases and CDKs (cyclin-dependent kinases) (Zhang, Gureasko et al. 





Figure 1. 1 The Crystal Structure of the 2:2 EGF-EGFR complexes. 
(A) ribbon diagram of the extracellular domains of EGFR with EGF. Two EGF molecules are 
painted with pal green and pink. Domains I, II, III, IV in the two receptors in the dimer are 
colored yellow, orange, red, and gray vs cyan, dark blue, pal blue, and gray, respectively. The 
disulfide bonds are shown in yellow. Most of domain IV is disordered. (B) The top view of (A). (C) 
The surface model of (A).Source: Ogiso H research article (Ogiso, Ishitani et al. 2002). 
 
The extracellular region (ectodomains) is conformational changeable and subdivided into 
four domains: I (L1), II (S1, CR1), III (L2), IV (S2, CR2) (Bajaj, Waterfield et al. 1987; 
Ward, Hoyne et al. 1995). Among them, domain L1 and L2 consist of β-helix folds, and 
shares 37% amino acid identity. CR1 and CR2, as indicated by the names, are rich in 
cysteine. CR1 domain forms disulfide bonds with CR1 domain of the other receptor in an 
activated dimer. The crystal structure revealed two distinct conformations of EGFR 
ectodomains: in the inactive conformation, CR1 and CR2 interact with each other and 
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prevent interaction with their ligand; while in the active conformation, CR1 and CR2 are 
moved away from each other, thereby enabling the exposure of the ligand-binding pocket 
of domain L1 and L2. The dimerization arm in domain CR1 is known to facilitate the 
formation of dimers, which leads to the kinase domain of one receptor to cross-
phosphorylate specific residues in the partner's C-terminal tail (Seshacharyulu, 
Ponnusamy et al. 2012).  
The transmembrane region is a single membrane spanning α-helix domain, which 
continues into the juxtamembrane domain, JM domain (Jorissen, Walker et al. 2003; Jura, 
Endres et al. 2009). 
The JM domain can be divided into 2 regions, JMA (645-663) and JMB (664-682). 
However, the structure of the JM region is not fully known yet. The comparison with 
other RTKs suggests the regions may contribute to the autoinhibition of the kinase 
(Ferguson 2008; Red Brewer, Choi et al. 2009; Sengupta, Bosis et al. 2009) and 
dimerization-induced kinase activation (Schindler, Sicheri et al. 1999; Boran 2012).  
The tyrosine kinase domain, TK domain, contains two lobes, the smaller N-lobe and the 
larger C-lobe. During activation, the catalytic domain of EGFR forms an asymmetric 
dimer in which the C-lobe of one of the dimers (D1) actives the other (D2) as an 
allosteric activator by interacting with its N-lobe, similar to cyclins ("D1") to cyclin-
dependent kinases ("D2") (Zhang, Gureasko et al. 2006; Ferguson 2008). However, the 
discovery of preformed dimers and oligomers before activation suggests a more subtle 
conformational regulation during the process (more details will be introduced and 
discussed in section 1.1.6.). 
The crystal structure of the C-terminal 190 amino acids has also not been fully solved yet. 
Results of circular dichroism studies suggest there are a considerable amount of 
secondary structure (Lee, Hazlett et al. 2006). The C-terminal tail does not only serve as 
docking sites for signalling molecules containing SH2 (Src Homology 2) or PTB 
(phosphotyrosine binding) domains to trigger the transmission of the signal from outside 
to inside of the cells (Jorissen, Walker et al. 2003; Zhang, Gureasko et al. 2006), but also 
provides regulation for receptor autophosphorylation and/or transformation of receptor 




1.1.3 The cycle of EGFR in a cell 
Before being located on the plasma membrane, the nascent 130 kDa EGFR polypeptide is 
firstly modified by adding 8 or 9 N-linked oligosaccharide chains to become a 160 kDa 
protein in the ER (endoplasmic reticulum) during translation. Next, this immature form is 
exported to the Golgi complex, where it acquires the final glycosylation and then is 
delivered to the plasma membrane as a 170 kDa mature protein (Johns, Mellman et al. 
2005). 
After being transported to the membrane, EGFR is constitutively internalized at a rate 
comparable to the basal membrane recycling rate at steady-state. Then EGFR is recycled 
at a rate several times higher than the internalization rate (Sorkin and Goh 2009). So the 
bulk of EGFR proteins are located in the membrane.  
In resting cells, EGFR forms a mixture of monomer and dimers (Gadella and Jovin 1995; 
Moriki, Maruyama et al. 2001; Clayton, Walker et al. 2005; Saffarian, Li et al. 2007; Yu, 
Hale et al. 2009; Hofman, Bader et al. 2010). Ligand-binding and other stimulation such 
as the changes of membrane structure activates the receptor and shift the equilibrium. The 
TK domain is then phosphorylated and triggers recruitment of effector proteins via Src 
homology 2 (SH2) and phosphotyrosine binding (PTB) domains.  
After activation by its ligands, EGFR is internalized and degraded quickly, which is 
referred to as EGF-induced down-regulation of EGFR, the major negative feedback 
regulatory mechanism to control its signalling (Wells, Welsh et al. 1990). The accelerated 
internalization process is known to be mediated mainly by clathrin, caveolin or other 
clathrin-independent carriers such as through tubular structures in micropinosomes 
(Zwang and Yarden 2009). EGFR undertakes rapid endocytosis through clathrin-coated 
pits (CCPs) on the membrane after receptor activation. The tensile force generated by 
actin polymerization helps CCPs pinch off from the membrane to form endocytic 
vesicles, which then fuse with early endosomes and release the receptor complex into 
these vesicles (Seshacharyulu, Ponnusamy et al. 2012). Components engaged in CCP 
formation include the AP-2 adaptor complex, which recognizes motifs in the receptor C-
tail after its activation (Goh, Huang et al. 2010). The clathrin-mediated endocytosis 
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(CME) is observed mainly in middle to low EGFR expression situation, when the EGF-
EGFR complex concentration can be minimized efficiently (Sigismund, Woelk et al. 
2005; Sorkin and Goh 2009). Whereas under overexpression conditions and/or high 
ligand concentrations, clathrin-independent endotycosis via caveolae determines the 
overall rate of internalization. Ubiquitylated EGFRs are sorted into these flask-shaped 
invaginations coated by oligomerized caveolin, which eventually fuse with early 
endosomes (Sigismund, Woelk et al. 2005). A third endocytic mechanism is led by the 
formation of circular dorsal ruffles (CDRs), which are ring-like membrane protrusions 
composed of actin-rich structures. This clathrin- and caveolin-independent mechanism is 
capable of promoting the endocytosis in elongated tubular structures and uptake of a 
large fraction of ligand-engaged EGFRs (Orth, Krueger et al. 2006).  
Accumulated in the endosomes through tubular and vesicular networks at the periphery 
of the cell soon after endocysosis, the receptors undergo ubiquitylation possibly by Cbl 
(Casitas B-lineage Lymphoma), an E3 ubiquitin-protein ligase, and might have different 
fates: sorting into the multivesicular bodies (MVBs) initiated by the interaction with the 
HRS/STAM complex to undertake proteolysis; inserting into signalling endosomes; or 
recycling back to the membrane from the tubular extensions (Citri and Yarden 2006; 
Sorkin and Goh 2009; Zwang and Yarden 2009). New evidence suggests that the 
internalized EGFR in the early endosomes may be transported to the nuclei for other 
functions through recognition of its C-terminal nuclear localization signal (NLS) by 
importing either in early endosomes or in the ER as intact full-length receptors (Wang, 





Figure 1. 2 The endocytosis pathways. 
Source: Lill research article (Lill and Sever 2012)  
 
1.1.4 Interaction of EGFR upon activation (signalling pathway map) 
The importance of EGFR in diseases is revealed by the important pathways initiated by 
the activation of EGFR, such as mitogen-activated protein kinase (MAPK), 
phosphatidylinositol 3-kinase (PI3K)/AKT, signal transducers and activators of 





Figure 1. 3 The summary of 3 major pathways triggered by EGFR activation  
 
1.1.4.1 MAPK/ERK Pathway 
As a major downstream signalling cascade, the MAPK pathway starts from GRB2/Sos 
complex adaptor proteins binding to EGFR’s docking sites upon the receptor activation 
directly or indirectly through Shc. This interaction leads to a three-dimensional 
conformational change of Sos, which results in recruitment of Ras-GDP and subsequent 
Ras-GTP. The activated form in turn causes the phosphorylation of RAF1, MAPK1 and 
MAPK2, which regulates specific intranuclear transcription factors such as C-myc and 
CREB (cAMP response element-binding protein), and regulates the transcription of C-
Fos gene, and thus induce cell migration and proliferation (Murphy and Blenis 2006; 




1.1.4.2 PI3K/Akt Pathway 
The activation of PI3K/Akt pathway is mediated by the heterodimer between EGFR and 
ErbB3, due to the lack of PI3K docking site on EGFR but highly prevalent on ErbB3. 
PI3Ks are composed of two subunits, a separate regulatory subunit (p85) and a catalytic 
subunit (p110). The regulatory subunit p85 interacts via adaptor proteins such as GAB1, 
IRS-1 and IRS-2 (Fujioka, Kim et al. 2001; Onishi-Haraikawa, Funaki et al. 2001). The 
activated catalytic subunit converts phosphatidylinositol 4,5-biphosphate (PIP2) to 
phosphatidylinositol 3,4,5-triphosphate (PIP3), which in turn phosphorylates and 
activates Akt, and then regulates cell growth, provides apoptosis resistance to 
chemotherapy and tumor invasion and migration (Vivanco and Sawyers 2002). Another 
well characterized target of PI3K lipid products is protein kinase B(PKB), which is 
activated by PI3K lipid products and phosphorylation by 3’-phosphoinositide-dependent 
kinase-1 (PDK1) through recruitment to cell membranes (Vanhaesebroeck and Alessi 
2000)]. PTEN (Phosphatase and tensin homolog) reverses the activity of PI3K and acts as 
a regulator of this pathway (Engelman 2007).  
 
1.1.4.3 STAT Pathway 
EGFR regulates STAT pathways through a Janus kinase (JAK)-dependent or direct 
binding mechanism (Kloth, Laughlin et al. 2003; Andl, Mizushima et al. 2004). JAK is 
not required for activation when STATs bind directly to EGFR, but provides maximal 
activation. STAT proteins dimerize upon interacting with phosphotyrosine residues via 
their SH2 domains and translocate to the nucleus and function as a transcription factor, 
inducing the expression of specific target genes, such as CyclinD1, CyclinD3, c-Mac, 
p21wafl and p27 (Quesnelle, Boehm et al. 2007), which are involved in cell proliferation, 




1.1.4.4 Other Pathways 
As the centre of the bow-tie shape signalling pathway map, EGFR also regulates many 
other pathways through direct or indirect interactions. Tyrosine phosphorylation of EGFR 
leads to the recruitment of phospholipase Cɣ (PLC-ɣ), which then catalyses the 
hydrolysis of PIP2. The hydrolysis generates second messengers IP3 (Inositol 
Trisphosphate) and DAG (1,2-Diacylglycerol).  IP3 can release stored Ca2+ ions from the 
endoplasmic reticulum (ER), while DAG activates PKC (Protein Kinase-C), which leads 
to phosphorylation of various substrate proteins in regulating extracellular matrix re-
modelling, and then the activation of IKKs (I-ĸB-Kinases), and consequently the 
transcription factor NF-ĸB (Nuclear Factor-ĸB) (Wang, Wu et al. 2006; Litherland, Elias 
et al. 2010). Several groups' reports suggest a role of EGFR in regulating Rho and Rac is 
initiated by the interaction between EGFR and Vav-2, a guanine nucleotide exchange 
factor, via its SH2 domain. The activation of Rac and Rho directs cytoskeletal 
rearrangements, and therefore the cells' mitogenesis and migration (Blagoev, 
Kratchmarova et al. 2003). EGFR regulates some pathways in a cross-connected manner. 
For example, Src, a family of non-RTKs that plays a fundamental role in cell 
proliferation, migration, adhesion and tumor angiogenesis, is known to be cross-
connected with the PI3K and STAT pathways. However, Src was shown to interact with 
EGFR, even though its TK activity is independent of RTK signalling (Leu and Maa 
2003). 
However, EGFR-proximal signalling events changes with time and location after its 
activation, it was found that its function and related pathways may be very different in the 
nucleus from the plasma membrane.  
 
1.1.5 EGFR in the nucleus 
EGFR has been detected in the nuclei of many highly proliferative tissues and cell lines, 
such as regenerating liver, human placenta, A431 cell line (Marti, Burwen et al. 1991; 
Lin, Makino et al. 2001). Abnormal nuclear phosphorylated EGFR is strongly associated 
with poor prognosis in some cancers such as esophageal squamous cell carcinoma 
(Hoshino, Fukui et al. 2007).  
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EGFR is found involved in different pathways in different locations. For example, Grb2 
was primarily found interacting with membrane surface EGFR, whereas Eps8 was found 
associated only with intracellular EGFR (Burke, Schooler et al. 2001). The nuclear EGFR 
participates in both transcriptional regulation and signalling transduction, which are 
responsible for inflammation/genome instability/tumor progression and DNA 
repair/chemo-&radio-resistance, respectively (summarized in ref (Wang and Hung 
2009)). However, EGFR was reported to lack a putative DNA binding domain, so it is 
presumed to function by interacting with DNA binding transcription factors such as 
STAT3 and E2F1, and the bindings were found  to be associated with overexpression of 
Cyclin-D1 (a regulator of cyclin-dependent kinase), iNOS (inducible nitric oxide 
synthase), and B-Myb (Myb-related protein B) (Lo, Hsu et al. 2005; Hanada, Lo et al. 
2006; Seshacharyulu, Ponnusamy et al. 2012).  
 
1.1.6 Dimerization of EGFR 
In the traditional model of EGFR activation, the receptors exist as monomers during the 
resting state. When EGF binds to receptors, 2 receptors are able to form a 2:2 back-to-
back dimer with ligands embedded in each of their ligand-binding pocket formed by 
domain L1 and L2 (Ferguson 2008).  This leads to the allosteric activation of each of the 
asymmetric dimer partner's C-tail (Zhang, Gureasko et al. 2006), which serves as the 
docking sites for the receptors' downstream proteins or domains including SH2 and PTB 
(Ferguson 2008). Besides, in the 2-receptor-2-ligand stoichiometry, binding of the first 
ligand shows negative cooperativity, leading to reduced affinity for binding of the second 
ligand and the existence of "high-affinity" and "low-affinity" classes (Alvarado, Klein et 
al. 2010).  
However, it has long been found that dimerization of EGFR is necessary but not 
sufficient for the kinase activation (Jorissen, Walker et al. 2003). Evidence from as early 
as 1995 presented by different groups showed EGFR forms dimers without ligand. The 
pre-formed dimer percentage, dimer%, is different by groups using different methods 
(Gadella and Jovin 1995; Moriki, Maruyama et al. 2001; Clayton, Walker et al. 2005; 
Saffarian, Li et al. 2007; Yu, Hale et al. 2009; Hofman, Bader et al. 2010). For example, 
Gadella and colleagues, by using donor photobleaching fluorescence resonance energy 
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transfer (pbFRET), showed that EGFR forms dimers in the absence of ligand (Gadella 
and Jovin 1995). The Hofman group showed that 40% of EGFR molecules exhibit 
preformed dimers from their homo-FRET experiments (Bader, Hofman et al. 2009; 
Hofman, Bader et al. 2010). Linda Pike’s group concluded that ~50% molecules are non-
monomer, either dimer or oligomer through investigation by Live Cell Fluorescence 
Intensity Distribution Analysis (live cell FIDA) (Saffarian, Li et al. 2007). Ichiro 
Maruyama’s group reported ~80% of the surface receptors as dimer by chemical cross-
linking (Moriki, Maruyama et al. 2001). And the Clayton/Burgess groups used image 
correlation spectroscopy (ICS) to calculate that the average molecule number for each 
cluster without ligands were 2.2 and the number increased to 3.7 with EGF treatment 
(Clayton, Walker et al. 2005). Some other groups claimed that the inactivated EGFR 
could also form oligomers (Saffarian, Li et al. 2007; Kozer, Kelly et al. 2011; Boggara, 
Athmakuri et al. 2013). EGFR showed a higher level of aggregation after stimulation in 
different studies (Kawashima, Yoon et al. 2009; Yu, Hale et al. 2009). 
It is not surprising that the resulting dimer% are so different. The different methods used 
for studying the dimer% are considered one of the reasons of why they are so different 
since each method is sensitive to somewhat different parameters and thus contain 
idiosyncratic errors. Besides the methods, experimental conditions including temperature 
and cell line were shown to affect the dimer% (Gadella and Jovin 1995; Yu, Hale et al. 
2009).  Gadella and colleagues in 1995 determined the dimerization as at least 36% at 
20°C by donor photobleaching fluorescence resonance energy transfer (pbFRET) and 
fluorescence lifetime imaging microscopy (FLIM) and the dimerization increased as 
temperature increased (Gadella and Jovin 1995). In 2009, C Yu and colleagues found that 
different cell lines responded differently by analyzing TIRF intensity images (Yu, Hale et 
al. 2009). 
Despite the importance of the mechanism of how EGFR exists and activates, the methods 
to study such interactions at the single molecule level in living cells are limited. No 
information on the nature of the EGFR clusters was provided. Thus, it is not clear where 
the large clusters of EGFR selectively located in the membrane. Hence, while previous 
studies have shed some light on the study of EGFR dimer formation, it is not clear how 
the non-activated and activated receptors move in their physiological environment.  Thus, 
the location of the clusters as well as the form-changes during the activation process are 
not confirmed. In addition, considerations such as the conformational coupling of the 
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extra- and intracellular domains make the study of intact receptor  necessary, rather than 
investigating its domains separately.  
 
1.1.7 EGFR and lipid raft 
1.1.7.1 Plasma membrane organization 
The membrane system plays a significant role in almost all the processes in a cell. It 
consists of plasma membrane, endoplasmic reticulum (ER), mitochondria and nuclear 
membrane. Among them, the plasma membrane is a selectively permeable membrane 
that serves as a wall as well as a gatekeeper for a cell. This means, the cell membrane 
does not only protect the cells from the outer environment, but also plays important roles 
in signal transduction between the environment and the cells. The signal transductions are 
initiated by the binding between growth factor receptors such as EGFR and ligands, and 
lipid rafts which appear to act as signalling platforms (Simons and van Meer 1988; Hur, 
Park et al. 2004; Eum, Andras et al. 2009; Staubach and Hanisch 2011). 
Research on membrane structure is always a complicated and interesting topic because it 
is closely related to the functions of membranes. Plasma membranes are composed of a 
lipid bilayer, which contains hundreds of different lipid species, carbohydrates and 
proteins. The membrane organization is cell specific. In 1972, S.J. Singer and G.L. 
Nicolson proposed the fluid mosaic model, which described membranes as a two-
dimensional liquid in which its compositions diffuse randomly and easily in a certain 
level (Singer and Nicolson 1972). This landmark model of membrane structure is widely 
accepted even though it is probably inaccurate. Other scientists began to present 
experimental evidence suggesting the existence of “clusters of lipids” almost immediately 
(Lee, Birdsall et al. 1974). In 1982, Karnovsky et al. formalized the hypothesis of lipid 
domains, which are called ‘lipid rafts’ nowadays, by presenting their observations of 
heterogeneity in lifetime decay of 1,6-diphenyl-1,3,5-hexatriene (Karnovsky, Kleinfeld et 
al. 1982). The early studies which established the lipid raft hypothesis found that 
glycoshpingolipid clusters formed detergent-resistant membranes (DRM), meaning they 
were not soluble in Triton X-100, a commonly used nonionic surfactant, at 4°C, and were 
rich in cholesterol and GPI-anchored proteins (Brown 1994). The hypothesis was then 
17 
 
supported by the observation that the detergent-resistant clusters formed spontaneously in 
artificial membranes (Dietrich, Bagatolli et al. 2001).  
Although artificial vesicles are able to mimic the membrane composition to a certain 
level, these simplified systems couldn't incorporate the complexity of all the membrane 
composites, such as complicated microdomains, cytoskeletal interactions and trafficking 
events, which causes inconsistent results between artificial membrane and in vivo studies, 
e.g. the introduction of cholesterol in DOPC vesicles led to an increase in the affinity 
between EGFR and its ligand (den Hartigh, van Bergen en Henegouwen et al. 1993) but 
in living cells, depletion of cholesterol enhanced the binding of EGFR to EGF, whereas 
cholesterol loading lowers the binding (Pike and Casey 2002; Roepstorff, Thomsen et al. 
2002). Hence, the study of molecules of interest under physiological conditions in live 
cells is required to understand the underlying mechanisms.  
 
1.1.7.2 The definition of lipid rafts  
In the past 30 years of development, different groups have described lipid rafts in slightly 
different ways. One widely accepted definition of lipid rafts is “small (10-200nm), 
heterogeneous, highly dynamic, sterol and sphingolipid-enriched domains that 
compartmentalize cellular process. Small rafts can sometimes be stabilized to form larger 
platforms through protein–protein and protein–lipid interactions.” (Pike 2006). The 
characteristics that distinguish lipid rafts and normal plasma membranes are the twice 
higher concentration of cholesterol in raft versus non-raft regions and the elevated 
sphingolipid concentrations. The former is called the liquid-ordered (lo) phase, while the 
latter is the liquid-disordered (ld) phase. Particularly, comparing with two other important 
membranes, ER and mitochondria membrane, the plasma membrane has a higher level of 
cholesterol (Pike 2009), indicating the important role lipid rafts play in signal-
transduction on the plasma membrane. There are groups found that ~90% of cholesterol 
resides in the plasma membrane (Crane and Tamm 2004) and the concentration is focally 
increased in lipid rafts, which regulate the membrane fluidity and permeability, and act as 
platforms for various proteins (Lambert, Vind-Kezunovic et al. 2006). On the contrary, 
some groups concluded that cholesterol is not enriched in sphingolipid domains in the 
plasma membranes of fibroblasts (Frisz, Klitzing et al. 2013). Nevertheless, evidence 
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from both sides shows the abundance of cholesterol affects the membrane proteins' 
function.  
Furthermore, a more complex level of organization than the raft/non-raft binary model in 
cell membranes was considered recently (Triffo, Huang et al. 2012). It was found that at 
least 2 types of distinct, non-overlapping domains co-exist in the cell membrane, and the 
differential sorting may be mediated by interactions between the positively charged 
residues of the molecule and negatively charged lipid head groups. The findings add one 
more layer on the organizational complexity of raft structure in living cells.  
One important but controversial component of rafts is proteins. The localization of 
proteins and lipid rafts and how the localization influences proteins' functions play an 
important role in rafts-related studies. Lipid rafts form transient confinement zones in 
which membrane proteins including EGFR were found to dwell for seconds. In order to 
understand the specific signalling process on the plasma membrane, such as EGFR 
activation, in detail, it is necessary to review this field in terms of cholesterol, lipids and 
proteins in rafts. 
 
1.1.7.3 The composition of raft: cholesterol, lipids and raft-localized proteins 
Cholesterol is considered the "glue" which holds specific lipids and proteins to form the 
rafts because it can tightly intercalate with saturated hydrocarbon chains in raft-related 
lipids such as sphingolipids (Simons and Toomre 2000). Therefore, one of the most 
important experimental methods for studying rafts is interrupting rafts by changing the 
amount of cholesterol in cells, which includes increasing its amount by adding in extra 
cholesterol and extracting it by drug treatments.  
Recent lipidomics studies have shown a good picture of the lipid composition. Direct 
comparisons of rafts prepared by both detergent-free and detergent-containing protocols 
and different detergent protocols showed significant differences in lipid composition, 
such as sphingomyelin, phosphatidylcholine, phosphatidylserine and ethanolamine 
plasmalogens (Pike, Han et al. 2002; Schuck, Honsho et al. 2003; Pike, Han et al. 2005).  
Ethanolamine plasmalogens levels, especially those containing arachidonic acid, are also 
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elevated in rafts. Since plasmalogens can serve as antioxidants, their function may be 
detoxifying the molecules, which internalize via lipid rafts (Pike, Han et al. 2002; Pike, 
Han et al. 2005). Furthermore, proven by different methods, rafts prefer a liquid-ordered 
structure, in which acyl chains are tightly packed (Brown and London 1998; Fridriksson, 
Shipkova et al. 1999; Ge, Field et al. 1999; Brown and London 2000).     
After Brown and Rose reported that proteins with a glycosylphosphatidyl inositol (GPI) 
anchor were associated with vesicles that were enriched in glycosphingolipids, indicating 
the specific residence of GPI-anchored proteins in lipid rafts (Brown and Rose 1992), 
more and more groups reported their discoveries on protein-families that resided in 
specific lipid rafts, such as G proteins, non-receptor tyrosine kinases, protein 
phosphatases, cytoskeletal and adhesion proteins (Pike 2009).  
Broad-based proteomic methods are widely used to identify the protein composition of 
lipid rafts because it is very hard to predict whether the proteins target lipid rafts purely 
because of their sequence, as little progress has been made on raft-specific modifications. 
The known targeting ways include protein modifications through myristoylation or by 
GPI anchors, and covalent attachment like palmitoylation (Brown 1994; Simons and 
Toomre 2000).  
However, the commonly used co-isolation methods used in the proteomic studies brings 
in a few problems: for one thing, contaminations from the preparation process such as 
mixture of ER and mitochondrial membranes could provide different answers to the same 
questions (Pike 2009); in addition, membrane proteins are known to be difficult to isolate 
by common proteomics extraction methods and could react differently to different 
detergents (Schuck, Honsho et al. 2003); furthermore, proteomics analysis may not be 
able to reflect low abundant proteins. Thus, normal proteomics methods provide broad 
but limited information and may present false positive or false negative results. 
Therefore, caution must be exercised when assessing the proteomics results, suggesting 
the necessity of living cell studies to validate the localization of any specific protein of 
great interests, in this thesis, EGFR. In the next section, studies related to the interactions 




1.1.7.4 EGFR localization, diffusion and activation on the membrane 
The debate on EGFR localization is a challenging topic and opposing evidence is coming 
in thick and fast. As discussed in the previous sections, EGFR is an essential 
representative of membrane receptors in terms of its important functions in pathways 
related to cell survival, proliferation, differentiation, migration and adhesion (Nicholson, 
Gee et al. 2001; Yarden 2001; Ciardiello and Tortora 2008). Lipid rafts highly possibly 
regulate EGFR in triggering the pathways, so it is of great importance to explore the 
details how lipid rafts influence the localization, diffusion and activation of EGFR. This 
raises a series of questions: firstly, whether EGFR is located in lipid rafts, if so, what kind 
of rafts EGFR resides in; secondly, how the diffusion of EGFR is influenced by its 
localization; thirdly, how the activation of EGFR influences its localization and diffusion, 
and how the localization inhibit or facilitate the activation. In the next section, findings 
pertaining to answer these questions will be reviewed. 
The first membrane extraction evidence that EGFR is a raft-located protein was from 
Mineo and colleagues in 1996, when they found that in normal Rat-1 cells EGFR 
concentrated in caveolae-like piece of membrane by examining the Triton X-100 
insoluble complex (Mineo, James et al. 1996). However, controversial results appeared 
soon. Ringerike and colleagues reported that most EGFR is located in non-caveolae rafts 
by immunogold electron microscopy in 2002 (Ringerike, Blystad et al. 2002).  Other 
groups such as Pike and colleagues also reported that EGFR was actually soluble in 
Triton X-100 but was found enriched in rafts prepared by a detergent-free protocol or 
special detergents such as Brij 98 (Pike, Han et al. 2005).  
The contradicting results show, for one thing, the traditional preparation methods are not 
very stable, and for another, there should be different kinds of rafts coexisting. Therefore, 
due to the development of microscopy techniques, studies of EGFR began to be 
conducted in living cells. For example, Orr and colleagues used single particle tracking 
(SPT) to discover that the diffusion of EGFR was interrupted by dwellings within 
nanodomains, that is, rafts (Orr, Hu et al. 2005).  
Localization of EGFR is important because it exerts a special effect on the functions of 
EGFR such as binding with ligands and subsequent activation. Interestingly, again, 
opposing effects were observed in different settings of experiments. In artificial 
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membranes, the binding of EGF-EGFR was observed to be enhanced by adding 
cholesterol (den Hartigh, van Bergen en Henegouwen et al. 1993); while in biological 
membranes, the depletion of cholesterol was shown to increase the EGF-EGFR binding 
(Pike and Casey 2002; Roepstorff, Thomsen et al. 2002; Hofman, Ruonala et al. 2008). 
Even in cell experiments, some studies showed that localization of EGFR in lipid rafts 
inhibits the ligand-binding and thus the signalling pathways (Chen and Resh 2002; 
Roepstorff, Thomsen et al. 2002; Lim and Yin 2005) while other groups presented results 
that lipid rafts promote EGFR signalling (Zhuang, Lin et al. 2002; Peres, Yart et al. 
2003). Between these two opinions, the idea that localization in rafts inhibits the 
signalling of EGFR seems to receive more support. In the results of Orr and colleagues, 
the interrupted diffusion of EGFR was dramatically altered by cholesterol depletion. In 
particular, the time EGFR spent in nanodomains was increased significantly by 
cholesterol extraction (Orr, Hu et al. 2005). Their results are in good agreement with the 
hypothesis of Lambert and colleagues that cholesterol depletion caused EGFR release by 
breaking rafts into small confined areas and EGFR tend to be activated spontaneously 
due to the elevated density and/or separation from some inhibitors located previously in 
the same rafts. This hypothesis was based on their observation that clusters containing 
high amount of phosphorylated EGFR was induced by cholesterol depletion (Lambert, 
Vind-Kezunovic et al. 2006). 
It was reported that the mobility of EGFR was greatly reduced after cholesterol depletion, 
measured by fluorescence recovery after photobleaching (FRAP) (Lambert, Vind-
Kezunovic et al. 2006). Although different diffusion-study techniques may present 
different absolute values, the relative change and trends are usually the same. So their 
study shed light on our diffusion research. Another hypothesis of the inhibitory function 
of lipid rafts was proposed by Lim and colleagues: the signalling could be reduced by 
prolonging the diffusion of ligands to their receptors (Lim and Yin 2005). This 
hypothesis is also reasonable in that their quantification model is consistent with many 
other groups' experimental results. 
Some groups provided observations based on the determination of the cholesterol level, 
which help to understand more precisely the effect of cholesterol depletion on membrane 
disruption. Fluorescence Intensity Distribution Analysis (FIDA) implied that when the 
cholesterol level was reduced by about 40%, the net effect was to increase clustering of 
the receptor (Saffarian, Li et al. 2007). Diffusion law studies reveal that when only 8% of 
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the total cholesterol was converted to cholestenone, rafts were abolished partially and 
when the converted cholesterol was increased to 20%, the rafts were completely 
abolished (Lenne, Wawrezinieck et al. 2006).  
The different results in studying this debated topic may result from the different methods, 
experimenting conditions, and cell types. For example, the membrane extraction methods 
have the limitation that they are not real-time observation. For one thing, the extraction 
itself may manipulate the membrane. For another, different types of detergents may cause 
very different results and bring in possible artifacts that are difficult to detect.  The 
experimental conditions also influence much of the results, as, e.g., under different 
temperatures the cell may respond differently to the same treatment, and the expression 
level of target proteins could also lead to different results. Similarly, some functions of 
different cell types largely depend on its initial resources. So the results must be viewed 
with special caution and caution should be exercised when comparing different results 
from various research groups. 
 
1.1.8 EGFR and the cytoskeleton 
1.1.8.1 Cytoskeleton 
Besides rafts, another major constraint of molecule diffusion on the membrane is caused 
by the restriction of the cytoskeleton, a meshwork composed of actin filaments and 
associated proteins. The cytoskeleton carries out three major functions: cell contents 
organization by intracellular transportation, cell connections to the external environment, 
and cell shape maintenance and movement (Fletcher and Mullins 2010). The cytoskeleton 
was found in both eukaryotic and prokaryotic cells, but with different building blocks. 
In eukaryotic cells, the cytoskeletal filaments are composed of microfilaments, 
intermediate filaments and microtubules. Microfilaments are composite of linear 
polymers of actin (so it is sometimes called actin filaments) and form double helix 
structure with a diameter of ~6 nm (You, Cowin et al. 2001). They act as tracks for 
myosin to perform its motor work, and also play key roles in changes of cell shapes, 
organelle transport, regulation of ion transport and receptor-mediated responses of 
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external signals (dos Remedios, Chhabra et al. 2003). Actin filament can grow 5-10 times 
faster at the plus end than the minus end so that the cell shape is changed. The dynamic 
structure is controlled by Rho family proteins, such as Rho for the formation of actin 
stress fibers and focal adhesions, Rac for membrane ruffling and Cdc42 for filopodia 
formation (Mounier and Arrigo 2002). Intermediate filaments  are anti-parallel helices 
structure with 10 nm in diameter on average (Fuchs and Cleveland 1998). Intermediate 
filaments are the most flexible in the three types of cytoskeletal polymers. They can 
crosslink to each other, actin filaments and microtubules by plectins to form various 
structures (Fletcher and Mullins 2010). The features that distinguish them from 
microfilaments and tubulin microtubules include their diverse primary structure, nonpolar 
architecture, broad distribution in cytoplasm as well as nucleus, and nucleotide-
independent dynamics (Omary, Coulombe et al. 2004). The best understood function of 
intermediate filaments is maintaining cell integrity (Fuchs and Cleveland 1998). Besides 
this, they serve as the structural components of the nuclear lamina and sarcomeres and 
the phosphorylation of them triggers nuclear-envelope breakdown at the start of mitosis 
(Tsai, Wang et al. 2006). Intermediate filaments show different individuality for specific 
functions in various cells, such as those made of neurofilament proteins in neural cells 
and keratins in epithelial cells (Fuchs and Cleveland 1998). α- and β-tubulin form the ~25 
nm-diameter-microtubules (Fuchs and Cleveland 1998), which are hollow cylinders with 
approximately 15 nm-diameter lumen and can be as long as ~18 µm (Chernobelskaya, 
Grigoriev et al. 2001). Usually the microtubule cylinders are formed by 13 protofilaments 
in vivo, and possibly in the range of 9-18 under experimental conditions. The 
microtubule-organizing centres are usually made up by γ-tubulin, which is believed to 
provide a template for the 13-protofilament microtubule lattice (Amos 2004).  
Microtubules play key roles in intracellular transport of organelles such as mitochondira 
or vesicles and formation of mitotic spindles in cell division (Nogales 2000).  
Homologues of all the major proteins of the eukaryotic cytoskeleton and stable 
filamentous structures have been found in prokaryotes (Shih and Rothfield 2006). The 
proteins share similar functions and structures with eukaryotic cytoskeleton proteins but 
their evolutionary relationship is very distant. The actin-like proteins in prokaryotes 
include MreB and ParM (van den Ent, Amos et al. 2001; van den Ent, Moller-Jensen et 
al. 2002), which share the characteristics of the actin superfamily, such as actin fold and 
actin ATPase domain (Bork, Sander et al. 1992). Besides, two types of tubulin homolog 
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have been identified in prokaryotes, namely FtsZ and BtubA/B (Nogales, Downing et al. 
1998; Schlieper, Oliva et al. 2005). FtsZ assembles into a Z-ring for the division 
apparatus and is essential in the synthesis of new cell wall by recruiting required proteins 
(Romberg and Levin 2003; Shih and Rothfield 2006). Different from the universal 
presence of FtsZ, BtubA and ButbB were identified only in the genus Prosthecobacter in 
the division Verrucomicrobia.  
 
1.1.8.2 The effect of cytoskeleton on EGFR diffusion 
On the membrane, the components of the cytoskeleton form fences and pickets in the size 
of fifty to a few hundred nanometers that restrict molecular diffusion and partitioning of 
membrane molecules. Cytoskeleton accounts for the hop diffusion of molecules in the 
plasma membrane, such as TfR (Transferrin receptor) in COS-7 fibroblasts (Fujiwara, 
Ritchie et al. 2002). Hop diffusion, as suggested by the name, occurs due to the 
confinement within the actin-based fences and pickets and infrequent intercompartmental 
hops/transitions (Ritchie, Shan et al. 2005).  
Many other molecules were reported to experience cytoskeleton constraints. For example, 
trapping of saturated sphingolipids sphingomyelin (SM) was found abolished to a certain 
extent while the trapping of gangliosides GM1 was even enhanced after the cells were 
treated with 30-min Latrunculin B, a powerful disruptor of microfilament (Mueller, 
Ringemann et al. 2011).  
The relationship of EGFR and the cytoskeleton on the plasma membrane (cortical actin 
cytoskeleton) was observed in different cells and conditions. On the one hand, EGFR was 
shown to be constrained by the cytoskeleton in some cases; on the other, the signalling 
triggered by EGFR stimulated the cytoskeleton remodellling (Di Fiore and Scita 2002). 
Although EGFR have been reported to interact directly with actin microfilaments in 
biochemical experiments for a long time, and the interaction regions were found to be 
residues 984-996 (den Hartigh, van Bergen en Henegouwen et al. 1992; Gronowski and 
Bertics 1993), the observation of the interaction in living cells was only found in the 
presence of EGF (Song, Xuan et al. 2008). Reports showed that treatment of Latrunculin 
A, another microfilament disruptor, had no effect on the first-order rate of diffusion of 
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EGFR in Mgat5 cells. But the mobile fraction of EGFR was significantly increased when 
the galectin lattice was present (Lajoie, Partridge et al. 2007). PLD activity studies in 
BHK cells showed that Latrunculin A did not have a significant effect on EGFR 
nanoclustering (Ariotti, Liang et al. 2010). However, some other groups reported 
Latrunculin A led to an increase in the diffusion coefficient of EGFR, indicating the 
extended boundaries caused by the depolymerization of F-actin. Nevertheless, the same 
report also mentioned that this depolymerization didn't significantly change the time 
EGFR spend in the domains (Orr, Hu et al. 2005). Hence, the effect of cytoskeleton on 
EGFR diffusion is still open to further investigation and experimental conditions must be 
well controlled.  
 
1.2 Other members of ErbB family  
Besides EGFR, the ErbB family has three other members, ErbB2, ErbB3 and ErbB4. 
Heterodimers among the family members are responsible to trigger different pathways 
upon activation. Therefore, it is important to review some basic information of the other 
members in this family to better understand the function of EGFR. 
 
1.2.1 ErbB2 
The crystal structure of the ectodomain of ErbB2 revealed that the structure has a 
conformation similar to that of the ligand-bound EGFR, explaining the inability to 
receive the message directly from the ligands (Garrett, McKern et al. 2003). ErbB2 is 
able to form dimers with all the members. ErbB2-containing heterodimers are 
characterized by a higher affinity than other combination and a slower endocytosis due to 
a faster recycling back to the membrane (Citri and Yarden 2006). Hence, it is involved in 
regulating cell growth, survival and differentiation by activating pathways such as 
PI3K/Akt and Ras/Raf/MEK/MAPK (Yarden and Sliwkowski 2001).  
The amplification of HER2 gene and overexpression of ErbB2 protein can be found in 
many cases of different cancers, such as 30% of breast cancers, and is associated with 
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poorer prognosis and high recurrence rate (Ross, Slodkowska et al. 2009). Currently, 
trastuzumab, a monoclonal antibody, is an approved adjuvant treatment specifically 
targeting on patients with ErbB2-positive early stage breast cancer (Arteaga, Sliwkowski 
et al. 2012). The mechanisms, though are not fully understood, include the antibody-
dependent cell-mediated cytotoxicity, preventing the formation of constitutively active 
form of ErbB2, inhibition of the receptor dimerization, and inhibition of the interaction 
with downstream pathway components. A statistically significant advantage in overall 
survival was recorded in early years, but the results were not evident at the most recent 
analysis (Piccart-Gebhart, Procter et al. 2005; Gianni, Dafni et al. 2011). Another 
antibody, pertuzumab, has very recently been approved to be used in combination with 
trastuzumab and decetaxel or T-DM1 (Aurisicchio, Marra et al. 2012).  Lapatinib is the 
only drug approved specifically for patients with ErbB2-positive advanced-stage breast 
cancer. It reversibly inhibits the intracellular TK activity of both EGFR and ErbB2. 
Preclinical research showed its inhibition of growth of ErbB2-positive breast cancer cells 
that were resistant to trastuzumab (Xia, Gerard et al. 2005). And early clinical trials 
combining lapatinib and other drugs showed better efficacy and tolerance (Cameron, 
Casey et al. 2008; Blackwell, Burstein et al. 2010). However, inherent and acquired 




In contrast to ErbB2, ErbB3 has the ligand-binding domain but lacks an active kinase 
domain. Specifically, the ligands of ErbB3 include heregulins (neuregulins, NRG1 and 
NRG2). It functions by forming active heterodimers, especially with ErbB2, and 
providing the binding sites for p85, a PI3-kinase subunit (Mitsudomi and Yatabe 2010). 
The ErbB2/ErbB3 dimer is considered the most active dimer in this family and is crucial 
for ErbB2-mediated signalling (Holbro, Beerli et al. 2003).  
Overexpression of ErbB3 is reported in cancers such as breast cancer and lung 
adenocarcinomas more than a decade ago (Lemoine, Barnes et al. 1992; Yi, Harclerode et 
al. 1997). Due to people's low interest in its weak TK activity as well as the lack of 
detectable mutations, its importance has been only explored in the past few years, after it 
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was pointed out that ErbB3 plays a key role in establishment of resistance to therapies 
(Aurisicchio, Marra et al. 2012). Reports showed ErbB3 was unregulated in response to 
EGFR/ErbB2-targeted TKI treatments, suggesting the activation of ErbB3 to bypass the 
suppression of EGFR/ErbB2 activity (Sergina, Rausch et al. 2007). Efforts towards anti-
ErbB3 therapies have generated a wealth of antibodies mainly in two types, monospecific 
anti-ErbB3 antibodies (such as MM-121, AMG 888 and GE-huMab-HER3) and 
bispecific antibodies, which are able to specifically target two receptors (such as 
MEHD7945A against ErbB3 and EGFR, and MM141 against ErbB3 and IGF1R) 
(Schoeberl, Pace et al. 2009; Schaefer, Haber et al. 2011; Aurisicchio, Marra et al. 2012). 
Although very promising in preclinical trials, these agents required further confirmation 
and trials to understand their efficacy.  
 
1.2.3 ErbB4 
ErbB4 shares some ligands with EGFR such as BTC, HBEGF and EPR, shares NRG1 
and NRG 2 with ErbB3 and has its specific ligands like NRG3 and NRG4 (Mitsudomi 
and Yatabe 2010). However, ErbB4 is complicated in that it has more isoforms through 
mRNA splicing (Citri and Yarden 2006). The four functionally distinct isoforms differ in 
the intracellular cytoplasmic domain (CYT-1 and CYT-2) or in the juxtamembrane 
region (JM-a and JM-b). The difference between CYT-1 and CYT-2 is that CYT-1 
isoform contains a 16-AA length sequence transcribed from excon 26, while CYT-2 lacks 
this sequence. The sequence enables the CYT-1, but not CYT-2, isoform to be capable of 
coupling to PI3K via a YTPM sequence (Elenius, Choi et al. 1999). The intracellular 
domain (ICD) of CYT-1 isoform has been reported to promote mammary epithelial cell 
differentiation, while the ICD of CYT-2 has been demonstrated to support proliferation 
(Muraoka-Cook, Sandahl et al. 2009). The difference between the extracellular 
juxtamembrane isoforms is the splicing of the 23-AA long excon 16 for JM-a and 13-AA 
long excon 15 for JM-b. The splicing renders the JM-a isoform, but not JM-b, to be 
cleavable by TNF-α-converting enzyme (TACE) (Rio, Buxbaum et al. 2000), a part of 
regulated intramembrane proteolysis (Heldin and Ericsson 2001).  
The role of ErbB4 as tumor-driving is controversial. ErbB4 is known to overexpress in 
cancers including breast cancer (Knowlden, Gee et al. 1998) or mutate in tumors such as 
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in melanoma (Prickett, Agrawal et al. 2009), and experimental down-regulation of ErbB4 
in tumor cells was found suppressing the cell growth (Starr, Greif et al. 2006; Hollmen, 
Maatta et al. 2009). However, another study suggested that ErbB4 may be involved in 
cell growth inhibition rather than proliferation (Feng, Sartor et al. 2007).  
ErbB4-specific antibodies were tested for clinical use. MAb-3 has been demonstrated to 
suppress the growth of lung and prostate cancer cells (Starr, Greif et al. 2006; Vexler, 
Lidawi et al. 2008). Another antibody mAb-1479, which specifically targets the JM-a 
isoform, was reported to inhibit the growth of breast cancer cells (Hollmen, Maatta et al. 
2009). However, given the difficulties in drawing conclusions about the function of ErbB 
right now, the development of ErbB4-target therapies requires more complicated 
consideration. One of the major challenges lies in the identification of subsets of patients 





Chapter 2. FCS theory 
2.1 Fluorescence Correlation Spectroscopy (FCS) 
Just like an organism, even one single cell itself is a complicated and fascinating system, 
in which all types of biomolecules function and collaborate with each other, forming an 
extraordinarily complex network based on their interactions. Traditionally, the 
interactions among biomolecules, especially proteins, were mainly studied either in vitro 
and/or in a qualitative manner, which can hardly fulfil the developing requirements of 
understanding more details under physiological conditions in living organisms. 
Fortunately, the discovery of the green fluorescent protein (GFP) provides the possibility 
of monitoring protein behaviour in situ. Genetic GFP tagging makes the proteins of 
interest visible by the help of fluorescence imaging tools, the development of which has 
improved in the past few decades. Ordinary optical microscopes, including confocal-
microscopes, cannot provide accurate information on concentrations, nor can they 
measure molecular dynamics. Important physico-chemical information is missing, such 
as local concentrations, molecular motilities and interactions. However, these can be 
easily accessed by fluorescence correlation spectroscopy (FCS). In addition, images may 
easily cause pseudo-positive or unclear results in exploring protein-protein interactions 
(Saka and Rizzoli 2012) because the optical  resolution limit (~200 nm) is much larger 
than the size of proteins and one cannot reliably determine whether two proteins are in 
actual contact or just happen to be in proximity (Huang, Babcock et al. 2010). In other 
words, co-localization may not equal to interaction. This problem was addressed from 
different angles. The direct solution is improving the resolution by 'superresolution' 
techniques. For example, Stimulated Emission Depletion Microscopy (STED) can reach 
down to 20 nm (Donnert, Keller et al. 2006). Yet, this is still larger than normal protein 
complexes. Another direction is the detection of intrinsic physical parameters that change 
during an interaction such as fluorescence quenching or Förster (Fluorescence) resonance 
energy transfer (FRET). Another approach uses temporal information about the 
concomitant movement of two separate molecules such as fluorescence cross-correlation 
spectroscopy (FCCS). In the following sections, I will introduce FCS before addressing 
the function of FCCS in the later part. 
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FCS was firstly introduced by Madge, Elson and Webb in 1972 (Magde, Elson et al. 
1972). FCS is a technique in which the fluorescence fluctuations, which are caused by 
tagged molecules passing through an illuminated observation volume (fL size), are 
analyzed to access the physical parameters that generate the fluctuations, such as local 
concentration and diffusion coefficient. The characteristic rate constants can be obtained 
by further analysis. The fluctuations are recorded as a function of time and then are 
autocorrelated to give an autocorrelation curve, which is a measure of the average 
duration of a fluctuation. The autocorrelation curve decays with time. The shape and 
magnitude of the decay are used to analyze the physical parameters of the molecular 
processes producing the fluctuations. The theory of the autocorrelation function will be 
outlined in section 2.3.  
FCS has many advantages. The optimal concentration for FCS detection (~nM range) 
falls into the physiological concentration of many proteins. Hence, it is ideal to study the 
proteins with low to middle expression level, which avoids the introduction of artifacts 
caused by too much overexpression, such as protein aggregation or saturation of targeting 
machinery. The high temporal resolution of FCS allows the differentiation of various 
diffusion processes such as Brownian diffusion (Mets and Rigler 1994), anomalous 
diffusion (Weiss, Hashimoto et al. 2003; Malchus and Weiss 2010) and flow (Magde, 
Webb et al. 1978; Gosch, Blom et al. 2000). FCS is able to quantitate the kinetic rate 
constants for a biomolecular reaction (Kinjo and Rigler 1995; Schwille, Oehlenschlager 
et al. 1996; Octobre, Lemercier et al. 2005). Besides, ns to µs scale processes such as 
rotational diffusion (Ehrenberg and Rigler 1974; Aragón and Pecora 1975; Loman, 
Gregor et al. 2010) and  triplet state dynamics (Widengren, Rigler et al. 1994; 
Widengren, Mets et al. 1995) can be monitored by FCS. The recent clinical application of 
FCS on quantitatively determining different type of von Willedbrand disease (vWD) 
sheds light on future directions of broader usages of this elegant technique (Torres, 




2.2. Derivatives of FCS 
Currently, FCS is based on confocal setups (Rigler, Mets et al. 1993) and provides 
temporal information for the particles of interests by the help of a sensitive detector such 
as an Avalanche Photo Diode (APD).   
Another powerful derivative of FCS is FCCS. FCCS analyses the fluorescence signal 
from two or more particle species that are each tagged with a fluorophore of a distinct 
emission spectrum. The signals from the distinct fluorophores are recorded in separate 
wavelength-dependent detection channels, and the signals are cross-correlated to retrieve 
information about the interaction between the different fluorophore species. Because 
FCCS relies on the cross-correlation of different signals, it reports directly on molecular 
interactions and is not dependent on changes in diffusion coefficients or mass as is the 
case in FCS (Meseth, Wohland et al. 1999). Besides, FCCS avoids the orientation and 
distance dependence of other techniques such as FRET (Lee, Lee et al. 2010) and 
Biomoleculer Fluorescence Complementation (BiFC) (Kerppola 2006). Therefore, 
compared with FCS, FCCS is particularly useful in quantitating molecular interactions 
that happen between molecules with similar molecular weights (Hwang and Wohland 
2004) and is complementary to imaging techniques, providing essentially the same spatial 
resolution but adding information on molecular interactions (Bacia and Schwille 2007).  
FCCS was first demonstrated by J. Rička and T. Binkert in 1989 using scattered light 
from nonfluorescent latex particles in the blue channel and fluorescence from labeled 
latex particles in the green channel (Rička and Binkert 1989). This technique found 
widespread application when Schwille and colleagues successfully measured DNA-DNA 
re-naturation through detecting and cross-correlating the fluorescently tagged DNA in 
1997 using a dual-colour (DC)-FCCS setup (Schwille, Meyer-Almes et al. 1997), in 
which the different dyes are excited with separate lasers. Since then the application of 
FCCS varies from the quantitation of biomolecular interactions, protein oligomerizations, 
to enzyme activity (Liu, Sudhaharan et al. 2007; Tudor, Feige et al. 2007; Lee, Lee et al. 
2010; Worch, Bokel et al. 2010; Ma, Ahmed et al. 2011; Weidemann, Worch et al. 2011).  
DC-FCCS, while a very powerful technique, suffers also from problems. Initially the 
alignment of two lasers to precisely the same spot was difficult, crosstalk between the 
two detection channels and moving structures, e.g. the plasma membrane of living cells, 
32 
 
gave rise to a false positive cross-correlation background. Therefore new FCCS 
modalities were suggested. Single wavelength FCCS (SW-FCCS) has the advantages of 
easier calibration, simpler set-up, and elimination of non-ideal overlap of excitation 
volumes by exciting several fluorophores simultaneously using one single laser line 
(Hwang and Wohland 2004; Hwang and Wohland 2005; Liu, Sudhaharan et al. 2007; 
Ma, Ahmed et al. 2011). Similarly, two-photon excitation FCCS (TP-FCCS) uses a single 
laser line for the two-photon excitation of two separate fluorophores (Swift, Burger et al. 
2007). Although the count per particle per second (cps) achieved by TP-FCCS is 
generally lower than that of DC-FCCS due to photobleaching (Dittrich and Schwille 
2001) and saturation (Berland and Shen 2003), TP-FCCS provides potentially a wider 
selection of fluorophore pairs compared to SW-FCCS (Hwang and Wohland 2007). 
Another derivative, pulsed interleaved excitation FCCS (PIE-FCCS) uses two lasers that 
are pulsed alternatively to overcome the spectral crosstalk among fluorophores. The laser 
pulses are alternated in the range of nanoseconds such that the emission and excitation 
cycles of one type of fluorophore are completed before the next fluorophore is excited 
(Thews, Gerken et al. 2005). PIE-FCCS thus generates crosstalk free cross-correlations. 
In addition, it can determine contributions from FRET, which can be used to correct 
FCCS data (Lamb, Muller et al. 2005; Müller, Zaychikov et al. 2005). Cell and 
membrane movement can be corrected by using scanning FCCS (Betaneli, Petrov et al. 
2012), as only the signal from around the maximum in each scan line is correlated. 
 
2.3.  Principle of confocal FCS and SW-FCCS 
2.3.1. Theory of FCS 
The principle of FCS is based on the recording of fluorescent fluctuations when 
fluorescent molecules diffuse in and out of an observation volume. In a confocal 
microscope FCS setup, the observation volume is created by a focused laser beam in 
conjunction with a pinhole. The diffraction limited focused beam has a volume on the 
order of femtolitres (fL). The fluorescent intensity trace and its fluctuations contain 
physical information about the molecules of interest. However, to extract the physical 
parameters, the intensity trace needs to be transformed into a decay curve through the 
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process of autocorrelation. The autocorrelation function (ACF) used in this process is 
defined as (Magde, Elson et al. 1972) 
2
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where τ is the lag time, and '< >' denotes the average fluorescence intensity, which is 
generated from  
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F(t) is the detected fluorescence intensity, and '< >' stands for average. 
F(t) can be written as 〈𝐹(𝑡)〉 + 𝛿𝐹(𝑡), where 𝛿𝐹(𝑡) is the fluctuation of 𝐹(𝑡), which on 
average is 0. Eq (2.1) can be derived as 
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suggesting in this form that the  ACF decays to 1 at infinite τ (𝐺∞=1).  
G(τ) has different forms for different molecular processes. For example, for a molecular 
species diffusing freely in three dimensions, the theoretical correlation function is given 
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where N is the average number of particles in the observation volume. 𝜏𝐷is the average 










where 𝜔0 is the radial distance at which the maximum intensity has dropped by 1/e
2. And 
the maximum intensity is in the center of the observation volume.  
The structure factor K is equal to the ratio of height of the focal volume over its waist 
(𝐾 = 𝜔𝑧/𝜔0).  





which means N is determined by the amplitude of the ACF curve.   
𝐺∞ , as mentioned above, is normally 1. But it is kept as a fitting parameter since 
τ=infinity is never reached and thus there will be some deviations from the theoretical 
value.  
When the single molecular species binds to some other molecules, there will be two 
particles, whose diffusion times are 𝜏𝐷1 and 𝜏𝐷2:  
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where the 𝐹2 is the fraction of the second component (with 𝜏𝐷2) of the total number of 
particles. 
If the triplet state is also taken into account, the correlation function is expressed as: 
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where 𝐹𝑡𝑟𝑖𝑝  is the fraction of the particles in the triplet state, and 𝜏𝑡𝑟𝑖𝑝  stands for the 
relaxation time of the triplet state.  
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In a 2D or planar free diffusion system with one type of molecules, the structure 
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(2.9) 
Similarly, if 2 different types of molecules and 1 triplet state is considered, the model is 
expressed as:  
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(2.10) 
 
2.3.2. Theory of FCCS 
As mentioned in Chapter 1, FCCS has advantages in determining molecular interactions, 
especially between two molecules with similar relative molecular weights. For FCS, at 
least a difference of a factor of 1.6 in 𝜏𝐷is required, corresponding to at least 4-8 times 
change in mass before and after binding, to be able to reliably detect two different 
species. However, FCCS does not depend on the changes in mass. The labels used in this 
thesis are enhanced green fluorescent proteins (EGFP) and monomeric red fluorescent 
proteins (mRFP), so the two channels are named 'green channel' and 'red channel'. 
Besides the autocorrelation analysis for each channel, cross-correlation is carried out 
between the two channels. The normalized cross-correlation function (CCF) is (Schwille, 
Meyer-Almes et al. 1997):  
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The model used for CCF fitting usually doesn't account for triplet states. The triplet states 
of the two interacting molecules are independent of each other, so they do not cross-
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The aim of FCCS measurements is to quantitate binding. The next part will introduce 
how the relative amplitude of CCF to ACF suggests the strength of binding.  
𝑉𝑒𝑓𝑓, the effective observation volume, is obtained from  
3/2 2
0eff zV π ω ω=  (2.13) 
which is by a factor of 23/2 larger than the confocal volume (Ruttinger, Buschmann et al. 
2008).  
Assuming a 1:1 binding stoichiometry, the detected fluorescence intensity is a function of 
the following parameters: 𝜂 , the count rate per molecule per second (cps); 𝐶𝑖 , the 
concentrations of the particles involved; 𝑞𝑖, the correction factors accounting for changes 
in fluorescence yields upon binding via processes such as quenching or fluorescence 
energy transfer; 𝛽𝑖, the uncorrelated background count rate, which is caused by possibly 
the autofluorescence and weak light in the dark room; 𝑁𝐴, the Avogadro’s number and 
𝑉𝑒𝑓𝑓  (Schwille, Meyer-Almes et al. 1997; Hwang and Wohland 2004; Shi, Foo et al. 
2009): 
[ ( ) ]g g g g gg A eff g g r r g g r r grF N V C C q q Cη η η η β= + + + +  (2.14) 
[ ( ) ]r r r r rr A eff g g r r g g r r grF N V C C q q Cη η η η β= + + + +  (2.15) 
Insertion of Eq (2.14) and Eq (2.15) into Eq (2.11), one can solve for the amplitudes of 
the ACFs and CCF, 𝐺𝑖(0) (𝑖 represents green, 𝑔, or red, 𝑟 or cross-correlation, 𝑔𝑟),  can 
then be expressed as 
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(2.18) 
where ‘ 𝑖 ’ represents green or red labeled particles. 𝐶𝑔𝑟  is the concentration of the 
complex particles; 𝜂𝑔
𝑔 and 𝜂𝑟
𝑔 are the cps of the green and red labelled particles in the 
green channel respectively; 𝜂𝑔𝑟  and 𝜂𝑟𝑟 are the cps of green and red labelled particles in 
the red channel respectively. In other words, 𝜂𝑟
𝑔 and 𝜂𝑔𝑟  are the bleedingthrough from red 
light into green channel and from green light into red channel, respectively.  
The value of 𝐺𝑔(0), 𝐺𝑟(0), 𝐺𝑔𝑟(0) can be obtained from the fitting of the experimental 
ACF and CCF curves. The cps can be calculated by dividing the average intensity by N. 
The uncorrelated background count rate is obtained by recording the intensity of un-
transfected cells with the same laser power as the experimental group. And the correction 
factors can be obtained by a separated experiment with tandem FPs (Foo, Naredi-Rainer 
et al. 2012). Therefore, there are 3 unknown parameters (𝐶𝑔 , 𝐶𝑟  and 𝐶𝑔𝑟 ) for the 3 
equations (2.16, 2.17, 2.18), so the three parameters can be obtained by solving the 
equations.   
The FPs expression level varies in the cell system, so the binding percentage/complex 
percentage (cplx%) is expressed as a function of complex concentration (𝐶𝑔𝑟) and the 












+                             
(2.19) 
The final result equals to whichever is larger, because the number of complexes is limited 
by the number of lower concentrated molecules (Shi, Foo et al. 2009). Only those cells 
were selected which had expression levels that differed not more than by a factor of 2 
from each other. The solved cplx% is normalized by the cplx% calculated from a 
negative control, in which two unbound molecules tagged with the same type of FPs 
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(EGFP and mRFP in this experiment) were measured to set the lower limit, and a positive 
control, in which a tandem construct with both EGFP and mRFP were measured to set the 
upper limit. The upper limit must be considered because even the positive control cannot 
return a cplx% of 100% due to the reasons mentioned in a previous study from our lab, 
such as different fraction of nonfluorescent proteins for EGFP and mRFP, as well as the 
differences in observation volumes (Foo, Naredi-Rainer et al. 2012). 
For calculation of the dimer percentage in the EGFR-EGFP/mRFP-EGFR group, things 
are slightly different because the contribution of both heterodimer and homodimer needs 
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(2.22) 
The dimer percentage of co-transfected dual-color EGFR is defined as: 
 
(2.23) 
This equation takes the three kinds of dimers, 2g, 2r, gr, into consideration. The fitting of 
the ACF and CCF curves are performed by a custom-written program in Igor Pro 6.0 
(WaveMetrics, Lake Oswego, OR, USA). The binding quantification, complex 
percentage, and dimer percentage were calculated by a custom-written program in 
Mathematica (Wolfram Research, Champaign, IL, USA). 
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2.3.3. Calibration for FCCS 
To determine the effective observation volume (𝑉𝑒𝑓𝑓), a calibration process is performed 
as follows: SW-FCCS measurements are performed on a 1 nM Rhodamine 6G (R6G) 
solution (diffusion coefficient is known). After pinhole adjustment, the structure 
parameter K is calculated through fitting and𝜔0 is then determined by Eq (2.6) and Eq 
(2.13).  
The determination of the diffusion coefficients of target protein was performed as 
follows: 𝜏𝐷 × 𝐷 is constant (Eq 2.6), which means 𝜏𝐷−𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑓𝑙𝑢𝑜𝑟𝑜𝑝ℎ𝑜𝑟𝑒 ×
𝐷𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑓𝑙𝑢𝑜𝑟𝑜𝑝ℎ𝑜𝑟𝑒 = 𝜏𝐷−𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑓𝑙𝑢𝑜𝑟𝑜𝑝ℎ𝑜𝑟𝑒 × 𝐷𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑓𝑙𝑢𝑜𝑟𝑜𝑝ℎ𝑜𝑟𝑒 . Using a 
standard fluorophore with a known value for D, here Rhodamine 6G (R6G) with D = 426 
µm2/s (Petrasek and Schwille 2008) and the 𝜏𝐷  of both R6G and target protein from 
fitting, we can calculate the D of the target protein by 
D target protein=(τD-standard fluorophore × D standard fluorephore )/ τD-target protein (2.24) 
 
2.3.4 Instrumentation of SW-FCCS 
The instrumentation of SW-FCCS is shown in Figure 2.1. In brief, FCCS measurements 
were achieved by a modified commercial Olympus FV 300 confocal microscope: The 
single excitation laser, emitted by an argon ion 514-nm laser (Melles Griot, Albuquerque, 
NM), was reflected by a 458/514 dichroic mirror and focused to the sample where it 
formed a confocal volume through a water-immersion objective (60×, NA 1.2; Olympus). 
The laser power of 20 µW was used for both calibration and the CHO cells FCCS 
measurements, respectively. Emission spectra passed through a 150-µm pinhole and were 
split to two different directions by the help of a home-built slider to achieve both 
confocal-image taking and FCCS measurements and arrived to two sets of detectors: two 
FV300 photomultipliers for imaging and two avalanche photodiodes (SPCM-AQR-14-
FC; Pacer, Berkshire, UK) for FCCS. In the FCCS mode, after the slider the fluorescence 
are split by a 560DCLP dichroic mirror (Omega Optical, Brattleboro, VT) to pass two 
band-pass filters, 545AF35 and 615DF45 (Omega Optical), for green and red channels, 
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respectively. The autocorrelation and cross-correlation curves were derived online by a 
hardware correlator (Flex02-01D; Correlator.com, Bridgewater, NJ). 
 
Figure 2. 1 Set up of our Single-Wavelength Fluorescence Cross Correlation Spectroscopy (SW-
FCCS) system  
The laser beam excites the sample through an objective and the emission spectra are collected by 
the same objective, pass through a pinhole and split into two beams by a dichroic mirror. The 
reflected light (green light) goes into the right detector (avalanche photodiode in this case) while 
the passing light goes into the left detector. The fluctuation of the emission light caused by the in 
and out of fluorophores is transferred into auto-correlation curves by a hardware correlator and 
their cross correlation curves are generated online as well. 
 
2.4. Imaging Total Internal Reflection-FCS (ITIR-FCS) 
2.4.1 Total Internal Reflection (TIR) illumination 




When a light beam travels from a higher refractive index material to a lower index 
material, it undergoes both refraction and reflection. The refraction angle is given by 
Snell's Law:  
1 1 2 2sin sinn nθ θ=  (2.25) 
n1 and n2 are the refractive indices (RI) of the two material respectively (assuming n1 > 
n2), while θ1 and θ2 are the angles between the light and the normal of the interface.  
Total internal reflection is an optical phenomenon observed when the incident light beam 
strikes at the material interface at an angle greater than some "critical angle" given by Eq 
(2.26).  
1
2 1sin ( / )c n nθ
−=  (2.26) 
where θc is the critical angle. In this case, the beam totally internally reflects rather than 
refracts through the interface but generates a thin layer of electromagnetic field named 
"evanescent field" since the electric and magnetic field should be continuous at the 
interface. The evanescent field has the same frequency as the incident light and 
exponentially decays in intensity with distance from the interface. The penetration depth 
d of the evanescent field is given by (Axelrod, Burghardt et al. 1984) 
2 2 2 1/2
2 1( sin )4





The parameter λ is the wavelength of the incident light. A penetration depth of <100 nm 
is easily achievable in experiments (Toomre and Manstein 2001; Axelrod 2008). 
Total internal reflection fluorescent microscopy takes advantage of the TIR illumination 
and has been widely used to selectively excite fluorophores in aqueous environments (eg. 
cells expressing the molecules of interest) very close to the solid surface (eg. glass where 
the cells were seeded). Hence it largely decreases the background by removing 
contributions from parts of the sample that are away from the surface. It is particularly 
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useful to study phenomena on the cell membrane. The direct visualization allows us to 
better understand membrane dynamics such as cytoskeletal associations and membrane 
molecules diffusion (Petersen, Hoddelius et al. 1993; Watanabe and Mitchison 2002; 
Yildiz, Tomishige et al. 2004; Reck-Peterson, Yildiz et al. 2006; Joo, Balci et al. 2008; 
Sungkaworn, Lenbury et al. 2011). The uniqueness of TIR microscopy enables new 
applications in biophysical studies by simultaneously combining with other techniques, 
such as FCS. The combination, namely "ITIR-FCS" in this thesis, can be used to examine 
the kinetics of proteins to cellular or artificial membranes (Kannan, Guo et al. 2007; Guo, 
Har et al. 2008; Sankaran, Manna et al. 2009; Sankaran, Shi et al. 2010; Bag, Sankaran et 
al. 2012). 
 
2.4.2 ITIR-FCS  
As introduced in the previous sections, FCS is very powerful in measuring dynamics with 
high time resolution. However, the conventional confocal FCS setups using either 
photomultiplier tubes (PMTs) or avalanche photodiodes (APDs) as detectors allow only 
one spot to be detected each time. The single-spot measurement may distort the 
observation because the system undergoes local changes during the long measuring time. 
Hence, different modalities were developed to meet the need of having spatial and 
temporal information simultaneously. Image correlation spectroscopy (ICS) is able to 
obtain the spatial and temporal correlation, but its temporal resolution is still limited by 
the maximum scanning speed of the confocal laser scanning system. Early trials also 
include using a 2x2 CMOS detector array (Gosch, Serov et al. 2004) and APD arrays 
(Gosch, Blom et al. 2005) to record signals from up to 4 different spots.  
ICS provides quantitative information of spatial distribution of molecules on a surface 
such as number and size of aggregates, and further modifications were made to extend its 
applications (Hebert, Costantino et al. 2005; Gielen, Smisdom et al. 2009). The 
autocorrelation of ICS differs from FCS in terms of the correlation function. ICS spatially 
correlates the images (Petersen, Hoddelius et al. 1993) rather than temporally correlating 
the signal traces as done in FCS. Image cross-correlation spectroscopy (ICCS) was used 
to analyze pairs of images of two possibly interacting molecules with binding fractions 
higher than 20% (Kolin and Wiseman 2007). Space-time image correlation spectroscopy 
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(STICS) can be used to measure flows so that a more complete transport map can be 
obtained (Hebert, Costantino et al. 2005; Rossow, Mantulin et al. 2009). To overcome 
significant photobleaching or the "blinking" problem, k-Space image correlation 
spectroscpy (kICS) was invented. With kICS, each image is 2D Fourier transformed 
(Kolin, Ronis et al. 2006). Later, a new implementation of kICS was introduced to give a 
PSF-independent correlation function (Durisic, Bachir et al. 2007; Kolin and Wiseman 
2007). Another alternative, Raster ICS (RICS) was developed to probe fast dynamics as 
the previous mentioned modifications are still rather restricted by the imaging rate of the 
microscope (Digman, Sengupta et al. 2005; Brown, Dalal et al. 2008; Hong, Wang et al. 
2010; Rossow, Sasaki et al. 2010).  
However, ICS still didn't measure all pixels in a plane simultaneously because the images 
were obtained by a scanning laser beam, which dwells at each pixel for a certain time. 
But this issue can be overcome by applying cameras which can directly record the signal 
from a surface simultaneously, such as charge coupled detector (CCD) and 
complementary metal oxide semiconductor (CMOS) cameras.  A CCD camera is formed 
by two elements, a photoactive region and a transmission region. On the photoactive 
region, an electric charge is accumulated proportional to the light intensity in each of the 
pixel units (one pixel unit is a capacitor). Then each pixel transfers its contents to the 
neighboring pixel, while the last pixel nearest to the charge amplifier dumps its charge 
into it. Then the charge amplifier converts the charge into a voltage. By repeating this 
process, the contents from the entire photoactive region are converted into a sequence of 
voltages, which will be sampled, digitized and stored in memory (Boyle and Smith 1971).  
Later, electron multiplying CCD (EMCCD) cameras were invented. Compared with a 
CCD, an EMCCD camera has an extra step after the readout that can amplify the signals 
by impact ionization of electronic charge. The advantage of EMCCDs is the relative 
reduction of the read-out noise because of the signal amplifying process. Besides, the 
single-molecule sensitive device differentiates photons from noise by cooling down 
camera to -80°C so that the thermal noise is largely reduced. A CMOS camera, in 
general, is less sensitive than a CCD camera.  But it offers faster frame rate and a larger 
size of the image. The difference lies in that the electronic signal collected in CMOS are 
converted to a voltage and amplified individually in each pixel, leading to not only a 
faster readout (higher frame rates) but also an inherent variability in the resulting signal. 
The relatively worse Signal-to-Noise ratio was improved by the introduction of scientific 
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CMOS (sCMOS). But still, sCMOS is good at offering smaller pixel sizes and higher 
frame rates while EMCCD provides higher sensitivity.  
The development of electron multiplying charge-coupled device (EMCCD) cameras with 
down to 0.5 ms time resolution and a 24 µm×24 µm pixel-size (which becomes 240 
nm×240 nm with the magnification of the 100× objective) show very good potential in 
combining TIR illumination to FCS measurements.  Although the time resolution is not 
as good as using a PMT or APD, the camera is still fast enough to capture the diffusion 
behavior of molecules on the membrane. Using EMCCD camera as the detector for FCS 
measurements, ITIR-FCS, was successfully performed in our lab, including but not 
limited by the references listed here (Kannan, Har et al. 2006; Kannan, Guo et al. 2007; 
Sankaran, Manna et al. 2009; Bag, Sankaran et al. 2012; Sankaran, Bag et al. 2013; 
Singh, Krieger et al. 2013).  
As the name suggests, ITIR-FCS provides the correlation for every pixel in an image 
rather than a single spot. Specifically, a stack of frames with certain number of pixels 
(w×l) can be recorded at sequential time points and saved as a .tiff file; each pixel of each 
image frame has an intensity value, which forms an intensity trace along the recorded 
time period (equal to acquisition time for each frame, Δτ, times the number of frames 
recorded, Nf), just like the trace in confocal FCS mentioned previously in this chapter 
(Figure 2.1); the autocorrelation is performed at each pixel, so the output is w×l number 
of autocorrelation curves.  
 
2.4.2.1 Correlation of ITIR-FCS 
Once an image stack is recorded one can calculate autocorrelations for each pixel or 
cross- correlation between any chosen pixels (Sankaran, Shi et al. 2010).  
In calculating the correlations a range of semi-logarithmic lag-times are used with less 
number of computations as it is based on the multi-tau algorithm (Schaetzel and Peters 
1991). The correlation is conducted by a (p,q) correlator, in which p means that there are 
p lag-time correlations performed in the first set of correlations while q denotes the 
number of groups of channels with different bin times. The first set of the correlations are 
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done for the time points with linearly increasing lag-times 𝜏 = 𝑚 × ∆𝜏, where m ranges 
from 0 to p-1, and intervals are Δτ, the acquisition time of each frame. The next set of p/2 
correlations possesses time points with linearly spaced lag-times at intervals of 2Δτ 
beginning with (p-1+2) Δτ. The signals in frames in between are integrated into the next 
nearest correlated time points, check points. Then the third set of p/2 correlations possess 
linearly spaced lag-times at intervals of 4Δτ beginning with (2p-1+4) Δτ. The correlation 
process is repeated for intervals of 8Δτ, 16Δτ, until 2(q-1)Δτ. The total number of lag-
times for a correlation is only [p+(p/2)×(q-1)]. In other words, for a (p,q) correlator, the 















In this architecture, correlation from a stack of 2048 frames based on a (16,8) correlator 
can be achieved by just [16+16/2×(8-1) =] 72 correlation channels. That is, in a time-
series data with 2048 frames, the 'check-points' are:  
Frame 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 
Frame 17, 19, 21, 23, 25, 27, 29, 31,  
Frame 35, 39, 43, 47, 51, 55, 59, 63,  
Frame 71, 79, 87, 95, 103, 111, 119, 127,  
Frame 143, 159, 175, 191, 207, 223, 239, 255,  
Frame 287, 319, 351, 383, 415, 447, 479, 511,  
Frame 575, 639, 703, 767, 831, 895, 959, 1023,  
Frame 1151, 1279, 1407, 1535, 1663, 1791, 1919, 2047. 
As it is advised to perform the correlation with higher number of frames in order to 
increase the precision of the calculated correlation. In my experiment, a (16,8) correlator 




2.4.2.2 Estimation of PSF (point spread function) by ITIR-FCS 
In ITIR-FCS, each pixel of the EMCCD camera works as an individual pinhole. 
However, compared with confocal FCS, ITIR-FCS has its own specific characteristics 
because: 1) the illumination laser is constant in power in the pixel plane rather than 
having a Gaussian distribution as in confocal-illumination. 2) The pixel is square shape 
rather than round. So the effective area (𝐴𝑒𝑓𝑓) of the observation area is a convolution 
between the pixel area (a×a) and the point spread function (PSF) of the microscope: 
2
eff PSFA a= ×  (2.29) 
The one-dimensional PSF can be approximated as a Gaussian function with center 𝑥0 and 























where λ𝑒𝑚 is the wavelength of emission laser and NA is the numerical aperture of the 
microscope. Gaussian approximation of the microscope PSF in our setting is determined 
to be about 0.4 by three different methods as introduced in Ref (Bag, Sankaran et al. 
2012).  
 
2.4.2.3 Bleach correction 
Photobleaching is the irreversible loss in fluorescence intensity caused by photochemical 
destruction of the fluorophore. Due to the limitation of fluorophores' replenishment 
source in the membrane, this is a general problem in 2D FCS measurements (Ries, 
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Chiantia et al. 2009). So it is important to be able to extract correct information from the 
measurements.  
The problem that photobleaching brings to us is that the shape of the correlation curve is 
strongly altered and dominated by bleaching rather than the fluctuation of the intensity if 
the intensity decay rate is not large compared with the measurement time. When the 
correlation curve is dominated by bleaching, the diffusion coefficient fitted is around 2 
orders of magnitude lower than the expected value of molecules diffusing on the 
membrane. To extract unbiased information about diffusion without influence of 
photobleaching, two methods can be used to correct the effect of bleaching, exponential 
correction and a sliding window correction.  
Exponential correction assumes that the decay of the fluorescence intensity can be 
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(2.32) 
Then the raw intensity data at any instant for the particular pixel are normalized by the 
value of F0 fitted from Eq (2.32) to that of the fitted value at the same instant, and the 
corrected data are used for the further correlation and fitting. After correction, as the 
average of the intensity is kept the same level as in the beginning, the number of particles 
represents the number before bleaching. Typically 2 exponentials are sufficient, and if 
only one single exponential is needed, A2 can be set to 0. 
The sliding window correction is done by dividing the intensity stream into short and 
equal time slices (3 s was chosen in this thesis to make 1024 the number of frames for the 
auto-correlation process. According to a previous study in our lab (Sankaran, Bag et al. 
2013), at least 1000× acquisition time are needed for proper estimation of parameters), 
calculating the ACFs for each time slice and averaging them. During the shorter time 
periods the intensity decay is relatively weak so that the corresponding ACFs calculated 
are not biased by the photobleaching. Then the series of ACFs are averaged to improve 
the signal-to-noise ratio (Delon, Usson et al. 2004).  
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Both correction processes can be performed using our custom-written ImFCS program 
(http://staff.science.nus.edu.sg/~chmwt/ImFCS.html). 
 
2.4.2.4 Data fitting in ITIR-FCS 
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where N is the number of particle in this pixel, D is the diffusion coefficient, 𝑎 is the side 
length of the pixel, 𝑤0  is the Gaussian approximation mentioned above, G∞ is the 
convergence of G(𝜏) at long correlation times. Convolution of the area with the PSF is 
used as the real observation area, effective area (𝐴𝑒𝑓𝑓), which can be used to compute the 
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(2.34) 
The value of D is directly determined by the fitting.  
 
2.4.3 Instrumentation of ITIR-FCS 
The instrumentation of ITIR-FCCS is shown in Figure 2.2. In brief, a commercial 
Olympus IX-71 epi-fluorescence microscope was modified to achieve ITIR-FCS 
measurements in a TIR mode: The single excitation laser beam, emitted by an air-cooled 
argon ion 514-nm laser (Spectra-Physics Lasers, Mountain View, CA, USA), was 
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introduced into the microscope through a single-mode fiber and two tilting angle mirrors, 
reflected by a dichroic mirror, and focused on to the back focal plane of the high NA oil 
immersion objective (PlanApo 100×/1.45, Olympus, SG). TIR illumination was achieved 
by adjusting the combination of the two tilting mirrors. Emission spectra passed through 
the same dichroic mirror, filtered by a 524 nm long-pass filter lens and imaged on the 
CCD chip of the EMCCD camera. The signal was recorded by Andor Solis For Imaging 
(version 4.18.30004.0) and the series of frames were saved as .tiff file for further 
analysis. The pixel size on the sample plane was 240 nm×240 nm. The EM gain used for 
image recording was 300 for all measurements. And the time resolution used was kept 2 
ms. The size of the region of interest (ROI) was changed according to the shape of the 
cells. 
To the best of our knowledge, there is no commercial software that can be used to treat 
the image stacks including loading, correlating and fitting. Hence, an open-source 
program, ImFCS, was written in C++ and linked to the software IgorPro by Jagadish 
Sankaran in our lab, allowing users to load the intensity records, correlate the 
autocorrelations and temporal and spatial cross-correlations, fit the data with a predefined 
model and display the results in terms of images and histograms of relevant parameters 






Figure 2. 2 Set up of our ITIR-FCS system. 
The laser beam exciting the sample passes through a dichroic mirror and the TIR illumination is 
achieved by adjusting the tilting angle mirrors (not shown in this figure). The emission spectra are 
collected by the same objective, reflected by the same dichroic mirror and goes into the EMCCD 
camera. The intensity trace set is recorded by Andor and saved as a .tiff file. The file is transferred 
into auto-correlation curves and analyzed by a home-made program. 
 
2.5. FCS diffusion law 
As mentioned in Chapter 1, the diffusion of the membrane molecules is confined by 
different structures in the cell membrane and form different diffusion modes. The cell 
membrane is made up of numerous lipid species and proteins. Rather than simply 
forming a homogenous system (Singer and Nicolson 1972), the lipids and proteins seem 
to be arranged into domains below the optical resolution limit (Pike 2009). Besides, the 




However, the size of the FCS detection volume is limited by diffraction and is not able to 
analyze the confinement directly. In 2005, Wawrezinieck et al., demonstrated the 
limitation of studying the shape of the ACFs in determination of the molecules' diffusion 
modes, and introduced a new method called FCS diffusion law, which is an efficient way 
of studying the confinements (Wawrezinieck, Rigneault et al. 2005).   
 
2.5.1 Theory 
The diffusion law is obtained by plotting several apparent diffusion times against the 
corresponding observation areas. Then the intercept on the y-axis is obtained through 
linear fitting of the points. Hence, the information below the diffraction limit can be 
extracted. The transit time upon extrapolation is an indication of confinement (Figure 
2.3). For free diffusion, the intercept is expected to be zero. A positive intercept is an 
indication of hindered diffusion in lipid rafts, while a negative intercept is indicative of 
diffusion restricted by meshwork.  
 
Figure 2. 3 Diffusion law plot 
 
The reason of the apparent positive intercept is as follows: the molecules diffuse more 
slowly in rafts than in the bulk membrane, so when the observation area is comparable to 
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the rafts, the measured diffusion time is relatively short. When the observed diffusion 
area of the bulk membrane is much larger than the rafts, the diffusion time is 
correspondingly longer but increases not as much as the area, as it averages over raft and 
non-raft regions. The fitting of this non-linearity results to a positive intercept.  
The apparent negative intercept is caused by that the molecules exhibit free diffusion 
within the mesh but cannot cross the borders freely. As a result, when the observation 
area is comparable to the mesh size, the measured diffusion time is short, but when the 
observation area is getting bigger than the mesh, the diffusion time increases faster than 
the increase of the observation area. In this case, the fitting of the plotting leads to a 
negative intercept. 
 
2.5.2 Diffusion law in confocal and TIRF FCS setup 
Conventionally, FCS diffusion law is performed in confocal systems by gradually 
changing the size of the focal volume. The change can be done by varying the extension 
of the laser beam falling onto the microscope objective back-aperture. The size of the 
confocal volume can be obtained from a calibration dye, such as R6G, as mentioned 
previously in the Chapter.  The diffusion law plots the diffusion time 𝜏𝐷 of the membrane 
molecule as a function of the square of the waist 𝑤2.  
The FCS-diffusion law has been successfully demonstrated in confocal FCS 
modifications such as z-scan and super-resolution microscopes (Humpolickova, Gielen et 
al. 2006; Eggeling, Ringemann et al. 2009; Mueller, Ringemann et al. 2011).  It also can 
be easily performed in ITIR-FCS setup as the changes of detection areas can be achieved 
by pixel binning post-acquisition. Binning is the process of adding up the intensity values 




   
        where ⌊𝑥⌋ is the largest integer smaller or equal to x.  
The digital binning provides the possibility of obtaining the diffusion times for different 
area sizes (𝐴𝑒𝑓𝑓  above) simultaneously. And the FCS diffusion law is obtained by 
plotting 𝐴𝑒𝑓𝑓/D vs 𝐴𝑒𝑓𝑓 . The standard error of the mean for each binning is used to  




2.6 Objectives and significance of the study 
The objective of this thesis is to develop and apply SW-FCCS to quantitate protein-
protein interaction in a dynamic process and ITIR-FCS to study the mobility and 
distribution of membrane molecules. The basic principles and setup of FCS and FCCS 
were introduced in this chapter. Compared with conventional biochemical methods, 
FCS/FCCS have several advantages in that the interactions are observed in living 
conditions with very high sensitivity, and the results can be analyzed quantitatively.  
In biochemical experiments in vitro, information about pathways are lost in the average 
(Ridgeway, Millar et al. 2012), and the full complexity is often ignored, leaving the 
biological mechanisms barely clearly understood. Quantitating interactions and 
distributions of proteins helps return the elementary processes back to their original 
context. The quantitation provides numerical information for computational simulations 
and improves the precision of the simulations. Besides, it offers the possibilities of drug 
screening, targeted therapies, and system response predictions (Bacia, Kim et al. 2006; 
Resat, Costa et al. 2011).  Further, if we could understand the differences between normal 
and diseased responses of these pathways clearly, the information will put us into a much 
better position when choosing appropriate and even personalized combination of 
treatments to deal with different persons' diseases (Burgess 2008). 
Therefore, the modern biological research needs to move one step ahead from merely 
identification, and instead investigate the precise physicochemical characterization of the 
processes on the level of individual proteins and other biomolecules, the smallest 




Chapter 3. Materials and methods 
3.1 Construction of PTB-EGFP 
The sequences and maps of plasmids containing EGFR, PTB and PMT are listed in the 
Appendix at the end of this Chapter. The construction of the following plasmids has been 
described in a previous publication (Liu, Sudhaharan et al. 2007) from our lab: 
pNUT/mRFP-EGFR, pEGFP-N1/EGFR-GFP, pEGFP-N1/PMT-mRFP, pECFP-
N1/PMT-GFP, and pNUT/mRFP-EGFR-GFP. EGFR in the plasmids is initially from 
pNUT/EGFR plasmid which encodes human egfr cDNA (Moriki, Maruyama et al. 2001; 
Liu, Sudhaharan et al. 2007). pcDNA3.1/PTB-mRFP is constructed by the following 
process: pcDNA3.1/PTB-citrine, a gift from Dr. Philippe I. H. Bastiaens (Offterdinger, 
Georget et al. 2004), which encodes the phosphotyrosine-binding domain from human 
shc cDNA, is digested by BamH I and Xba I; the GFP fragment was amplified by 
polymerase chain reaction (PCR) with the following oligonucleotide primers encoding 
BamH I and Xba I sites (underlined), respectively: 5'-
CGCGGATCCATGGTGAGCAAGGGCGA and 5'-
TTATGATCTAGAGTCGCGGCCGC (Sigma-Proligo, Sg Pty Ltd). The resulting PCR 
fragment was digested with BamH I and Xba I, ligased into pcDNA3.1 mentioned above 
and transformed into DH-5α competent cells to extract the plasmids. 
 
3.2 Cell sample preparation 
All experiments are performed on CHO-K1 (Chinese hamster ovary) cells. Most 
measurements are conducted on the membrane and some are performed in the cytoplasm. 
CHO cells were obtained from ATCC (Manassas, VA, US) cultivated in F12-K medium 
(Ham’s F12 medium with Kaighn’s modification. Invitrogen) adding 1% PS, penicillin G 
and streptomycin (PAA, Austria), and 10% FBS, fetal bovine serum (Invitrogen, CA, 
US), and kept at 37°C in 5% (v/v) CO2 humidified atmosphere.  
Electroporation was used for transfection of CHO cells, during which, ~90% confluent 
cells in a 75 cm2 flask were washed once with 1×PBS, ( phosphate buffered saline, 
Invitrogen, CA, US), trypsinized with 0.25% trypsin-0.03% EDTA solution (BSF, the 
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Biopolis Shared Facilities, SG) for 5 min at 37°C, and then re-suspended in culture 
medium. Cells (~1×106) were precipitated by centrifugation and re-suspended in small 
amount of culture medium and transferred half into one electroporation cuvette (2-mm 
wide, Bio-Rad, Hercules, CA, US) for one transfection. For the co-expression of two 
different constructs, the molar ratio of the two plasmids was kept at 1:1 calculated from 
their mass and size. After mixing the DNA, ~20 mg in total, with cells, the cuvette was 
chilled on ice for 5 min. GenePulser Xcell (Bio-Rad) was used by following the 
manufacturer’s preprogrammed protocol for CHO cells. After pulse, cells were left for 10 
min at room temperature, and ~50,000 cells/well were seeded in a six-well chamber 
containing prewashed cover-glasses (30 mm in diameter; Lakeside, Monee, IL, US). 
Transfected cells grew in the culture medium for 24–36 hrs before measurement.  
Before FCCS measurements, cells were starved for 4-8 hrs by F12-K medium without 
PS/FBS to avoid receptor activation by the growth factors present in FBS, and then 
washed thoroughly with 1×PBS to avoid influence of media on fluorescence and covered 
with 1ml 1×PBS in the mini chamber during measurements. 
To measure the cells in 37°C condition, an LCI incubator system (LCI Live Cell 
Instrument, Korea) for various types of chambers was used to fit in varies 
microscope stages, be able to maintain humidity and control temperatures as well as 
adjust CO2%. The system includes: 
1.       A movable heating stage with special covers 
2.       Automatic CO2 gas mixing and supply system 
3.       Software to control the gas supply process and humidity as well as temperatures. 
 
3.3 Drug treatments 
EGF (Merck, Germany) stock was neutralized by HEPES (50mM, pH7.2, BSF, SG) 
before addition to the cells. EGF was added drop-wise into the plate containing the cells. 
The final concentration for stimulation experiments was kept at 100 ng/ml.  
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To avoid influence of fast EGFR internalization after EGF stimulation during SW-FCCS 
observation, cells were incubated with endocytosis inhibitors 30 minutes before adding 
EGF.  The final concentration of the inhibitors was NaN3 (Sigma-Aldrich, St Louis, MO, 
US), 10 mM; NaF (Sigma), 2 mM; 2-deoxy-D-glucose (Sigma), 5 mM, respectively 
(Keilin 1936; Horton, Meldrum et al. 1973; Shenolikar and Nairn 1991; Liu, Sudhaharan 
et al. 2007). 
AG1478 (Calbiochem, Germany), a specific inhibitor of EGFR tyrosine kinase, was 
dissolved into DMSO at a concentration of 10mM and frozen in -20°C, avoiding light as 
a stock. The stock was diluted into a final concentration of 100 nM when treating the 
cells (Offterdinger, Georget et al. 2004). 
Methyl-β-cyclodextrin (mβCD, Sigma) is known to form soluble inclusion complexes 
with cholesterol and deplete cholesterol from cells in culture dishes (Ilangumaran and 
Hoessli 1998).  mβCD was dissolved in PBS buffer as stock solution and kept in 4 °C 
fridge for less than 30 days. Cells were treated with 5 mM, 3 mM 1.5 mM and 0.5 mM 
mβCD, respectively, for 30 min in 37 °C, 5% CO2 incubator.  
Latrunculin A (LatA, Calbiochem) is secreted by sponges and known to inhibit the 
addition of G-actin to the end of the filament so that destroy the cytoskeleton structure 
(Coue, Brenner et al. 1987). LatA was dissolved in DMSO as 10 mM stock, aliquoted 
and stored in -20 °C, avoid light. Before use, the stock was diluted by PBS and the final 
concentration for cell treatment was 3 µM.   
 
3.4 lipid-mimetic dialkylindocarbocyanine (DiI) analogues  
The Dil analogues used to understand the fluidity of the CHO cell membrane are Dil-C12 
(1,1'-didodecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate, molecular weight 
765.6) and Dil-C18 (1,1'-dioctadecyl-3,3,3',3'- tetramethylindocarbocyanine perchlorate, 
molecular weight 933.9). The two Dils, as shown in figure 3.1, have the same head 
group, the size of which is normal to the plane of the lipid bilayer (Axelrod 1979), but 
different alcyl tail length, which affects their propensities to partition into membrane rafts 




Figure 3. 1 Structure of DiI-C12 and Dil-C18.  
 
The lipid analogues were dissolved in DMSO to prepare the stocks solutions with a 
concentration of around 1mM and the stocks were kept in 4°C fridge for no more than 2 
weeks avoiding light. The concentration was determined using UV spectrophotometer. 
Before staining, the stock solution was vibrated vigorously and diluted to 0.1 µM with 
1xPBS. The working solution was also vigorously vibrated before adding to the cells. 
The cells were rinsed 3 times with 1×PBS before the working solution was added, then 
incubated in 37 °C, 5% incubator for 10 mins. After incubation, the cells on the cover-




3.5 Cholesterol concentration determination 
Concentration of cholesterol was determined by the Amplex® Red Cholesterol Assay Kit 
(Invitrogen) following the manual (Grimm, Grimm et al. 2005; Blattmann, Schuberth et 
al. 2013). Briefly, the reagent stock solutions, including 1× buffer (also used as negative 
control), cholesterol oxidase, cholesterol esterase, and resorufin (positive control) were 
prepared and stored at -20 °C, protected from light accordingly. In experiment, the cells 
were seeded in 6-well chamber (to mimic exactly the FCS experiments) and the reactions 
were conducted in the wells. The intensity of resulting  solutions was determined by our 
confocal microscopy one by one.  
 
Appendix 
Sequences of studied proteins and maps of plasmids: 
1. EGFR  
1.1 Sequence of EGFR  
(stop codon not included) 
ATGCGACCCTCCGGGACGGCCGGGGCAGCGCTCCTGGCGCTGCTGGCTGCGC
TCTGCCCGGCGAGTCGGGCTCTC(single point mutant for construction, it should be 













































































1.2 Map of vectors containing EGFR sequence and the vector in re-
constructed plasmids 

















2 PMT (Plasma membrane targeting sequence, negative controls) 
2.1 The sequence of PMT 
ATGGGCTGCTTCTTCAGCAAGCGGCGGAAGAGCAAGCGGCGGAAGGCCGAC
AAGGAGAGC 
2.2 The map of the vectors 






2.2.2 Map of PMT-mRFP plasmid 
 
 
3 PTB  
3.1. The PTB sequence 




























Chapter 4. Quantitative study of dimerization of EGFR 
 
The debates about the pre-formed dimers of EGFR has been raised decades ago, yet the 
dimerization is still not clear nowadays. New evidence emerges with the development of 
techniques such as FCCS. This chapter will introduce the dimerization measured by 
FCCS in live cells, which provides novel insight into this issue. In this chapter, I will 
confirm the data consistency with our previous results (Liu, Sudhaharan et al. 2007) 
before the topic is investigated. Then I will introduce the dimerization of EGFR in resting 
cells, followed by the discovery about the effect of EGF on the dimerization.  
 
4.1 Result 
4.1.1. Dimer% value consistency 
Quantitative dimerization measurements of EGFR were performed by co-expressing 
mRFP-EGFR and EGFR-EGFP in CHO cells as described in the previous chapter. In 
brief, the cells were transfected using an electroporator, the transfected cells were placed 
on round-shape cover slips for the convenience of measurement, and allowed 24 hours to 
attach firmly. Then the cells were serum-starved for 4-8 hours, and internalization 
inhibitors were applied 0.5-1 hr before measurements.  To set the stage for the 
measurements of dimerization, we used PMT-mRFP-and-PMT-EGFP co-expression in 
CHO cells as the negative control, and mRFP-EGFR-EGFP as the positive control. FCCS 
measurements were performed by focusing on the top membrane above the nucleus of a 
single cell, and if a series of measurements were performed on the same cells, the 
measuring position was kept as much as possible to be the same position as the first 
measurement. We used the following conditions for our measurements:  cells were 
chosen that have spindle-like shapes, are stably attached to the cover slip surface, have 
count rate lower than 200 kHz, and exhibit a green/red intensity ratio between 0.5 and 2 
at the beginning of the measurements. We used these conditions because: the spindle-like 
shape and firm attachment indicate that the cells are healthy; the lower intensity is used to 
avoid measurements of overexpressing samples; the ratio between the numbers of red and 
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green particles had to lie within a factor 0.5-2 to avoid artifacts in FCCS measurements 
due to cross-talk.  
When the fluorescent receptors pass through the focal volume, they are excited and the 
photons they emitted are recorded as the intensity trace shown in Figure 4.1.A. The single 
traces were autocorrelated to give rise to the autocorrelation function for the green and 
the red channel, which gives information on the surface concentration of red and green 
particles in the sample. The red and green channel intensity traces were then cross-
correlated to obtain the cross-correlation function to determine which fraction of the red 
and green particles interacted. Figure 4.1.B shows a typical set of correlation curves for 
the EGFR measurements on the membrane. The ACF and CCF curves were fit by a 2-
dimension-2-particle-1-triplet (2D2p1t) model as they clearly indicated the presence of 
two components. The ACF and CCF amplitudes obtained from these fits were substituted 
into Eqs (2.20-2.23) which were then solved to yield the actual concentrations of the 
monomeric and dimeric proteins consistent with the model of a dimer/monomer 
equilibrium. It should be noted that it is possible that higher order oligomers exist. These 
would distort the ACFs and cause inaccurate amplitudes and would lead to inaccurate 
values for the dimer fraction. The  level of inaccuracy would depend on the brightness 





Figure 4. 1 EGFR dimerization monitored by SW-FCCS from CHO cells expressing mRFP-
EGFR/EGFR-EGFP.  
(A) Illustration of a typical intensity trace recorded from both green and red channel. (B) Typical 
auto- and cross-correlation curves translated from the same set of data as in (A) which shows the 
presence of dimer without ligand's existence. The concentration of EGFR suggested in this figure 
is around 30,000, the sum of ~18, 000 EGFR-EGFP  ~12,000 mRFP-EGFR, and the dimer% is 
77%. 
(data from 20090207N1_07-before) 
 
The fitting model used contains several parameters: number of particles in the 
observation volume, the relaxation time and fraction of the triplet state, diffusion time of 
the two components, and their fractions. After fitting with the model, the ACF curves 
gave us constant ranges for the parameters: the lifetime of triplet state was no larger than 
10 µs, the fast diffusion time which (fast component) is between 0.5-2 ms, and the slow 
diffusion time (slow component) is between 60-90 ms. The fast component with a 𝜏𝐷 of 
~0.5-2 ms range was very likely caused by the intracellular pool (Lenne, Wawrezinieck et 
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al. 2006), while the slow component corresponded to the membrane-diffusing EGFR 
which exhibited a 𝜏𝐷 of ~60-90 ms, a value quite typical for large membrane  receptors.  
The values of positive (mRFP-EGFR-EGFP) and negative (PMT-EGFP+PMT-mRFP) 
controls define the dynamic range achievable by SW-FCCS in the experimental 
measurements (Fig 4.2). The dimer% from negative controls was 7 % ± 1 %, setting a 
lowest level for the experiments. It should be noted that over one-fourth of the negative 
controls don’t give any solution for the interaction percentage and thus this estimate is a 
conservative upper value. The dimer% from PMT-EGFP+PMT-mRFP co-expressing 
cells demonstrated that the complementation of the fluorescent proteins did not drive the 
interaction of the chimeric proteins. Similarly, the dimer% from positive control, 51 % ± 
3 %, was used to set the highest level for the experiments. There are several reasons why 
the positive control does not exhibit 100 % cross-correlation (Foo, Naredi-Rainer et al. 
2012). Firstly, the detection volumes will not be exactly equal due to the different 
emission wavelength detected for the two proteins. Secondly, not all fluorescent proteins 
are in a fluorescent state but can be in dark states, which has been shown in particular for 
the red fluorescent proteins (Hillesheim, Chen et al. 2006; Foo, Naredi-Rainer et al. 
2012). The dark states are related to non-matured or photobleached proteins as well as 
potential long-lived photophysical dark states. And thirdly, FRET between the labels 
should be taken into consideration. 
 
Figure 4. 2. EGFR-EGFP/mRFP-EGFR form dimers in the absence of stimulation.  
The normalized value of dimer percentage is 65 ± 4 % (Average ± SE). Graph A, B and C present 
the various levels of dimer percentage detected. (A) is one of the lowest dimer% found. (B) 
represent the most cases. (C) shows the highest dimer% in the experiments. 
 
The relative amplitudes of cross-correlation curves of FPs-fused EGFR expressed on the 
CHO cell surface were compared with the controls. The presence of EGFR pre-formed 
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dimers was evidenced from a calculated dimer% of mRFP-EGFR+EGFR-EGFP group in 
between the negative and positive controls. The dimer% represents the percentage of the 
receptor molecules found in homo- (red+red or green+green) or heterodimers 
(red+green). The average dimer% calculated from a mixture expression of N'-mRFP-
EGFR and EGFR-EGFP was 33 % ± 2 % (Table 4.1). When the absolute values were 
normalized to the dimer% of the positive control, 51%, the average became 65 % ± 4 %, 
which is consistent with the normalized value of previous work in our group conducted 
by Liu Ping of 68 ± 8 % (Liu, Sudhaharan et al. 2007). It should be noted that we 
changed the fitting procedure to narrow the fitting range to between 0.05 ms and 3 s to 
get better parameter estimates. This reduced the 'overfitting' of the controls, and lowered 
overall both, the negative and positive controls, but not the percentage of interaction 
measured.  
The cells expressed different amounts of EGFR. From the number of particles in the focal 
volume, which were in the range of ~1-50 molecules, assuming the surface area of a 
CHO cell is in the range of ~450-600 µm2 (Subramanian, Boder et al. 2007; Miyagi and 
Maruyama 2010), we can calculated that the expression level of EGFR was smaller than 
1×105 receptors per cells, within the range for EGFR expression observed in normal cells 
(Carpenter and Cohen 1979; Zhang, Gureasko et al. 2006; Endres, Engel et al. 2011). All 
of them expressed significantly less receptor than the A431 epithelial carcinoma cell 
lines, which is known to over-express EGFR to above 2×106 receptors per cells (Haigler, 












Work by Liu Ping (Liu, Sudhaharan et al. 2007) 
mRFP-EGFR+EGFR-EGFP by 
Liu Ping  
50±5 68±8 18 
mRFP-EGFR-EGFP by Liu Ping  73±4 100±6 14 
PMT-EGFP/PMT-mRFP by Liu 
Ping  
19±2 26±3 24 
This work 
mRFP-EGFR+EGFR-EGFP of 
sequential recording in cells 
33±2 65±4 71 
mRFP-EGFR-EGFP (positive) 51±3 100±6 15 
PMT-EGFP/PMT-mRFP 
(negative) 
7±1 11±1 41 
 
4.1.2. Determination of receptor dimer fractions  
We have examined the possible artificial factors introduced during the experimental 
process that could affect the dimer% in the inactive state, such as different expression 
levels and the relative expression level of the two FP labelled EGFR. As shown in Figure 
4.3, we found that when the relative ratio of the concentration of EGFR-EGFP to that of 
mRFP-EGFR is in the range of 0.3-3, the distribution of the absolute value of dimer% 
does not show any particular pattern. So the value of dimer% was not affected no matter 
whether EGFR-EGFP or mRFP-EGFR was expressed more. Figure 4.3.B shows the 
distribution of dimer% in the range of N=~1 to 50, which corresponds to the presence of  
~5 to 120 particles per µm2 or ~3k to 72k receptors/cell (the sum of both mRFP-EGFR 
and EGFR-EGFP) on the membrane (Hsieh, Yang et al. 2008), a low to middle 




Figure 4. 3 The distribution of dimer%.  
The dimer% distribution was not affected in the condition (A): the relative ratio of the two FP 
chimer between 0.3 and 3, and condition (B): the amount of EGFR expression in a relatively low 
to medium value range. The concentration of EGFR is the sum of both mRFP-EGFR and EGFR-
EGFP 
 
4.1.3. EGF induced an increase in the dimer% and induced strong EGFR 
clustering in some cells 
To independently access the dimerization kinetics upon the activation of the receptors in 
cells,  single cells before EGF stimulation as well as 2-3 time points after stimulation (in 
the 3-time-point scenario, the time points are 3 min, 10 min and 20 min, while in 2-time-
points scenario, the time points are 10 min and 20 min) were tracked. The first time point 
recorded after stimulation usually started at 2 min after adding EGF, and before every 
measurement, the focus is re-adjusted to avoid severe membrane movement. The 3 min 
mentioned here actually means a time range between 2 to 4 min after drug treatments. 
The missing 3-min-points were due to the preparation work for the following 
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experiments. Internalization inhibitors were applied to keep the receptors longer on the 
membrane so that the dynamic process could be captured. In total, 43 cells were 
recorded. Among the 43 cells, the dimer% after EGF stimulation of 4 cells could not be 
solved as these concentrations were far beyond reasonable range, so they were excluded 
from the calculation. The problem that some measurements do not give realistic solutions 
comes from the fact that the receptors formed large clusters and the dimer% gave 
unrealistic solutions.  
To evaluate the dimer% changes, cells in which EGFR aggregation was observed (6 in 
total) which have a very high dimer% (usually >70 %, absolute value) as well as a change 
in ACF shape (Figure 4.4.A), possibly due to cell movement, were excluded. The 





Figure 4. 4.a Auto- and cross-correlation curves measured from one CHO cell expressing mRFP-
EGFR/EGFR-EGFP before and after EGF stimulation with different responses. 
 (A) CCF suggests aggregation; (B) Intensity trace of ACFs in figure (A); (C) and (D) show type a 
response, EGFR clustering on the membrane; (E) and (F) show type b response, EGFR 
aggregation under the membrane. (To be continued in the next page.)The time after stimulation 




Figure 4.4.b. Continue of Figure 4.4.a. 
(G) and (H) show type c response, elevated dimer% on the membrane; (I) and (J) show type d 
response, both ACFs and CCF suggest no response. 
(data from 20091002, p3c7; 20090807_p201; 20090207 N3_02; 20120630, p303) 
 
There are several kinds of responses to EGF stimulation. Besides EGFR clustering on the 
membrane as observed in our previous work (Liu, Sudhaharan et al. 2007) (type a in 
Figure 4.4.a), there are some other types, as shown in Figure 4.4.a and 4.4.b, such as 
aggregation in vehicles (type b, in which the clear left-shift  of ACF cannot be corrected 
by moving the focus upper and lower, suggesting the change was not caused by 
membrane movement), elevated dimerization (type c), and lack of response (type d). The 
type a and b in Figure 4.4.a both can be considered as very strong aggregation induced by 
EGF, indicating the dynamic localization of the EGFR clusters.  
On average, the increased level of EGFR oligomerization/clustering was evidenced from 
the gradually increasing value of the dimer%. The dimer% comparison table (table 4.2) 
suggests the response of the receptor to ligands started from at latest 3 min after 
stimulation for some of the cells, as shown by the elevated dimer%. Then the dimer% 
peaked at around 10 min and kept high until at least 20 min (table 4.2). The high value of 
normalized dimer% indicate the possibility of higher order oligomerization. The results 
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were in good accordance with those obtained by Ichinose et al, who observed that the 
high affinity between EGF and EGFR can last from 10 min to 30 min (Ichinose, Murata 
et al. 2004).  
The observation of a gradually increasing dimer% added a layer of complexity to the 
mechanism of activation and signalling from EGFR. The situation suggests that although 
the activation of EGFR doesn't simply result from dimerization, there is a higher 
population in dimer-state after adding EGF. The increased level of dimer% may be 
related to the active state of the receptor (Lemmon 2009).   
To figure out the possible factors that may be related to the increased ratios, we firstly 
plotted the ratio of dimer%_after_stimulation over dimer%_before_stimulation, 
"increased ratio" in this thesis, against the number of the receptors in the focal volume at 
the beginning of the series of the measurements (Figure 4.5.A). We found that the 
increased ratio is not related to the receptor density. Then we tried to plot the increased 
ratio versus the dimer%_before stimulation (Figure 4.5.B). In general, the lower the inital 
dimer%, the higher the increased ratios. In this plot, we found that if the initial dimer% 
was smaller than 20 % (absolute value), dimer% was easily elevated upon stimulation, 
and the average increased ratio was (average ±SD, same as the following increased 
ratios): 2.7±0.8 at 3 min, 3.6± 2.0 at 10 min, and 3.8±2.5 at 20 min, which were much 
higher than the average over all presented in table 4.2. On the contrary, when the initial 
dimer% was larger than 20 %, the  elevation level of dimer% in different cells became 
different. In some time points, decreased dimer% was observed (Figure 4.5.C). Hence, 
there is a positive relationship between the initial dimer% value and activation. Besides, 
it should be noticed that the values calculated here are always assuming only 
dimerization happens, so any other oligomers would distort this picture. However, the 
dimer percentage is, even in the worst case, i.e. higher oligomers dominate, an indicator 
of interactions. 
It seems the dimerization state of the cells was re-organized after stimulation. For 
example, a rather low initial dimer% may elevate strongly to a high level dimer% but a 
high-level dimer% may decrease somehow to a lower dimer% after stimulation (which 
may suggest that the receptors are pre-activated in some cases). If the group of cells is 
considered as a whole, the distributions of dimer% shifted to higher and higher values 
after stimulation. In Figure 4.4.D, the dimer% value are plotted from the smallest value to 
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the largest value for each time point, and joined with lines. The similar shapes of the line-
plots for the different time points suggest that the distributions of dimer% values were 
kept constant but with elevated average value. 
The changes of diffusion time 𝜏𝐷 does not depend on the initial dimer%, if there is any. 
On average, the receptors diffused more slowly after stimulation as the increased 
diffusion time shown in table 4.2 (One exception was observed: D of EGFR-EGFP after 
20 min EGF stimulation was increased, but the result was not confirmed by the mRFP-
EGFR), which may be due to larger oligomer formation because larger clusters diffuse 
slowly, or the translocation of EGFR from some faster diffusion environments to some 
more viscous environments, such as in different types of rafts.  The slightly but constant 
larger diffusion time for mRFP-EGFR compared with EGFR-EGFP is caused by the 
slightly larger focal volume formed in the red channel (Foo, Naredi-Rainer et al. 2012). 
Table 4. 2 dimer% before and after stimulation 
 Before EGF*  EGF3min EGF 10min EGF 20min 
Normalized to positive 
control (%) (±SE) 
64±8 82±9 102±7 97±9 
Increased ratio (±SE, 
Normalized to before-
activation value) 
1.0 1.9±0.2 2.3±0.3 2.2±0.4 
τD-red (ms) (±SE) 66.7±5.1 82.2±9.6 86.5±9.7 88.7±11.7 
τD-green  (ms) (±SE) 62.6±4.7 76.9±8.2 80.8±13.9 54.9±7.1 
D-red (µm2/s) (±SE) 0.31±0.03 0.24±0.02 0.28±0.05 0.27±0.02 
D-green (µm2/s) (±SE) 0.32±0.03 0.27±0.03 0.28±0.02 0.33±0.03 
Number of cells measured 33 20 30 30 






Figure 4. 5 Kinetics of EGFR dimerization.  
(A) dimer% increased ratio vs EGFR density: the dimer% in each time point after stimulation are 
divided by the initial dimer% before stimulation. The calculated ratio serves as the y-axis while 
the initial dimer% serves as the x-axis. (B) dimer% increased ratio after EGF stimulation vs 
dimer% before stimulation: the red line suggest no change between before and after stimulation. 
(C) dimer% in different time points observed cell by cell: Each number on the x-axis stands for 
one and the cells are queered by their dimer% before stimulation, from small to large. For 
example, dim% of cell number 1 before stimulation is smaller than dim% of cell number 2 before 
stimulation. The red line linked the points represents an  initial value as reference. (D) the 
dimer% for cells measured in each time point are plotted from the smallest value to the largest 
value. Because a few of the measured initial values are larger than the average of +ctrl, to avoid 
confusion, the values presented here are un-normalized (absolute values). 
 
4.1.4. The fraction of slow component is related to the receptors' response to 
EGF stimulation 
The fraction of slow component of a membrane-diffusing molecule can indicate how fast 
the molecules are exchanged between the membrane and cytoplasm. The fraction of slow 
component in EGFR's ACFs ranges from 52 % to 61 % in normal cells, but among the 
recorded cells, there was a group of cells with abnormally high apparent dimer% (164 % 
on average, normalized value) and abnormally low slow-component% (usually below 
40%). The value of 164% is a clear indication of aggregation or oligomerization beyond 
dimer. Moreover, EGFR in these cells aggregated even more seriously upon stimulation 
almost immediately. Such low fraction were not caused by measurements conducted 
slightly 'off' the membrane due to cell movements, because the apparent 'off-membrane' 
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measurement was not able to be adjusted back to normal by moving the focus above and 
below, suggesting this situation is more probably caused by some abnormal behaviour of 
EGFR in those cells rather than due to an incorrectly focused microscope. The 
accumulation could be caused by pre-activation for example, which can then explain their 
fast aggregation upon stimulation for the protein to start its endocytosis, providing some 
insights into the cells undergoing EGFR endocytosis. 
 









PMT-EGFP 70±2 41 
11±1 
PMT-mRFP 56±2 41 
EGFP in mRFP-EGFR-EGFP 61±2 28 
100±6 
mRFP in mRFP-EGFR-EGFP 57±2 28 
EGFR-EGFP (Group Normal) 52±2 33 
64±8 









4.1.5. Influence of dimer formation on molecular brightness 
The parameter cps (count per particle per second, also called 'brightness' in this thesis) is 
a quantity that is determined by the fluorophore's absorption coefficient, the molecular 
quantum yield of the fluorophore, the power of the excitation source and the properties of 
the instrument. Theoretically, cps should have a two-peak distribution when the dimers 
form and the first peak should be at the level of a single GFP brightness level ("monomer 
82 
 
peak" in this thesis) while the second peak be at the 2-times brightness level ("dimer 
peak" in this thesis), as presented in tandem EGFP (Foo, Naredi-Rainer et al. 2012). 
Hence, the cps distributions were plotted to show the existence of dimer state (See Figure 
4.6). 
In my experiments, under 20µW 514 nm illumination, the brightness (η) of the constructs 
is presented in table 4.4. For simplification, we used unique values of 𝜂𝑚𝑅𝐹𝑃−𝐸𝐺𝐹𝑅 =1700Hz, 𝜂𝐸𝐺𝐹𝑅−𝐸𝐺𝐹𝑃 = 1600Hz, 𝜂𝑃𝑀𝑇−𝑚𝑅𝐹𝑃 = 2100Hz, 𝜂𝑃𝑀𝑇−𝑚𝑅𝐹𝑃 = 2700Hz. 
Table 4. 4 The brightness of the constructs used 
Constructs mRFP-EGFR* EGFR-EGFP PMT-mRFP PMT-EGFP 
Brightness 
(±SD) 
1636±628 1695±455 2118±689 2662±397 
*: include the values from PTB-EGFR interaction from Chapter 5. 
 
The comparison of EGFP results should be more reliable than mRFP due to a better 
photonstability of the fluorescent proteins. In both PMT-EGFP/PMT-mRFP and mRFP-
EGFR/EGFR-EGFP co-expressing cells, the distributions of the cps in red channel are 
wider than in the green channel (Figure 4.6.A and 4.6.B), suggesting that mRFP is less 
photostable than EGFP (Hillesheim, Chen et al. 2006; Hendrix, Flors et al. 2008).  
Although PMT should exist as monomer while EGFR forms dimers on the membrane, 
comparison of cps of the two different proteins cannot confirm the results, because as 
shown in Figure 4.6.A and 4.6.B, PMT-EGFP and EGFR-EGFP excited by the same laser 
power give different cps (2662 vs 1695, See table 4.4). Since the laser intensity decays as 
the distance away from the center of the effective volume increases, the lower cps of 
EGFR-EGFP indicates the possibility that the receptor is so bulky that it affects the 
proximity of EGFP to the membrane. In this case the cps comparison between PMT-
EGFP and EGFR-EGFP was not able to determine the dimer formation, although the 
same EGFP were tagged. However, results from EGFR-EGFP itself during the activation 
process could still provide us some insights of the activation process.  
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The "dimer peak" is much smaller than the "monomer peak" or even not really 
observable, as clearly suggested in the histogram of EGFR-EGFP in Figure 4.6.B. This 
result could be addressed by the fact that the dimer formation could happen in all 
difference scenarios. For example, the combination could be Red-Red, Red-Green, 
Green-Green. According to the previous calculation that 2/3 of the particles were dimers, 
the dimers formed by two same FPs would be maximum 1/6 of the total number of 
particles. When the problem of non-fluorescent proteins is taken into account, then the 
ratio could be even lower.  
Regarding the activation process, the results could also be presented in 2 scenarios. The 
widely distributed cps histogram in figure 4.6.C suggests there is a range of sizes of 
EGFR clusters in cells undergoing early stage of EGFR internalization process (Abulrob, 
Lu et al. 2010). The uncertainty suggests that EGFR does not form stable oligomers in 
this process. This instability also coincides with the different sizes and mobility of peaks 
observed in earlier work (Liu, Sudhaharan et al. 2007). As shown in figure 4.6.D, in 
which the relative cps ratio was derived from cps of EGFR-EGFP in the activated state 
divided by that of EGFR-EGFP in the inactivated states, there was a new peak with an 
average of 1.7 emerging after 20min stimulation, suggesting a clear higher portion of 
EGFR formed non-monomeric structures. If there was relatively moderate 
photobleaching in such a relatively long illumination time, the peak is in line with the 
results of Clayton et al., (Clayton, Walker et al. 2005), who presented that the receptors 
form tetramers after stimulation. The average and distribution of cps before and after 
EGF were not changed, suggesting there was no significant state-change for certain 





Figure 4. 6 Comparison of cps distributions in different proteins and different conditions.  
In all figures, red marks/bars represent red FP tagged proteins and green marks represent green 
FP tagged proteins: (A) PMT-mRFP and PMT-EGFP; (B) mRFP-EGFR and EGFR-EGFP 
without stimulation; (C) mRFP-EGFR and EGFR-EGFP in the EGFR-clustered cells after 
stimulation, an increased and more dispersed distribution is observed; (D) EGFR-EGFP after 
EGF stimulation for 3 min, 10 min and 20 min. 
 
4.2 Discussion 
The observations of pre-formed dimers of EGFR without ligand stimulation started two 
decades ago (Gadella and Jovin 1995; Moriki, Maruyama et al. 2001; Clayton, Walker et 
al. 2005; Saffarian, Li et al. 2007; Yu, Hale et al. 2009; Hofman, Bader et al. 2010). 
Many advanced optical techniques have been applied to gain more information about the 
percentage of dimers. The use of microscopy technology provided results from some 
aspects but did not permit an analysis of the diffusion status of the clustered EGFRs. For 
instance, the distribution of EGFR in different states (monomer, dimer, oligomer) and 
how the distribution is changed by EGFR activation are still not clear.  
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Here we first analyzed the dimerization status of EGFR in the cells expressing both 
chimeric molecules, mRFP-EGFR and EGFR-EGFP. Using SW-FCCS analysis we 
demonstrated the presence of dimer in the low to middle expression level in CHO cells. 
The dimer% was elevated by EGF stimulation, and aggregation was found in some cells. 
More than 10 min was required before maximal dimer% was observed in most of the 
cells, suggesting that the activity of EGFR was monitored at substrate saturation. The 
increasing population of EGFR in dimer-state added a new dimension of combinatorial 
complexity.  
Besides, as the SW-FCCS measurements can be easily focused at a certain position in the 
cell, the diffusion parameters obtained can be used to study the process near the 
membrane. The large clusters of EGFR were observed by different groups (Lambert, 
Vind-Kezunovic et al. 2006; Rappoport and Simon 2009; Abulrob, Lu et al. 2010; 
Sergeev, Swift et al. 2012) but the physical features such as the exact localization are 
easily ignored due to lack of physical information. The observation of diffusion-
difference between the membrane-located clusters added one more layer into the 
complexity of EGFR activation mechanism.  
It also provides the possibility to explore the participating parties during this process in a 
dynamic manner. Further study could investigate the interactions involved in the 
endocytosis process. As ligand-induced EGFR signalling should be aborted at the correct 
location, phosphatases capable of dephosphorylating ligand-activated EGFR are known 
to locate to endomembranes (Haigler, Ash et al. 1978). So the phenomena we observed 
could possibly be the accumulation in the vesicles waiting for endocytosis, possibly 
through a clathrin-mediated, caveolae-mediated, or a macropinocytosis route (Zwang and 
Yarden 2009). Clathrin is found to form coated pits to accumulate EGFRs before vesicle 
formation (Huang, Khvorova et al. 2004; Sigismund, Argenzio et al. 2008; Rappoport 
and Simon 2009) in low to middle EGFR expression cells. Internalization of EGFR is 
mediated by caveolae especially when cells are treated with high concentration of ligands 
(Sigismund, Woelk et al. 2005). This process is lipid raft-dependent and is possibly 
facilitated by the cargo clustering (Lundmark and Carlsson 2010). Besides, EGFR can 
also undertake endocytosis through tubular structures by macropinosomes, a kind of 
characterized large vesicles (Zwang and Yarden 2009), or by forming circular dorsal 
ruffles (CDRs) (Orth, Krueger et al. 2006). Our observation of EGFR aggregation may 
shed a light on the mechanism of clustering or vesicles in the endocytosis pathways. 
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Further  investigation can also be done by detecting the co-localization or interaction of 
Cbl and EGFR under such conditions, as in this process, the role of Cbl remains a subject 
for debate (Pennock and Wang 2008; Lill and Sever 2012). 
Furthermore, the mechanism causing the different responses of cells could be an 
interesting topic. EGFR is involved in many processes in different stages of the cell cycle, 
such as DNA synthesis, cell growth and metastasis. EGFR pathways were activated by 
radiation in quiescent cells and led to progression of cells from G1 to S, but such 
activation was not observed in proliferating cells, suggesting the cellular proliferation 
status affects EGFR activation (Lui and Grandis 2002; Ahsan, Hiniker et al. 2009). 
Therefore, the cell cycle could be one possible explanation for the receptors' different 
behaviours in our observation.  Further research can involve similar measurements after 
synchronizing the cells in the culture.  
Some more aspects should be taken account of for a better understanding of the 
mechanism. For example, confocal-FCS measurements capture information only on the 
mobile population of receptors whereas immobile EGFR are observed highly clustered in 
images. The immobile EGFR could affect the understanding of the extent of clustering.  
In summary, our results provide some new directions in the modelling for EGFR 
activation and internalization. As abnormality in EGFR regulation has been closely 
linked to severe disease progression of varies cancers, the better understanding of its 
states may present an opportunity for therapeutic intervention. For example, the changes 
of dimerization/oligomerization state of EGFR can be detected in cancer cells in different 




Chapter 5. Interaction of EGFR and PTB 
 
In this chapter we report for the first time the measurement of an activation and time 
dependent interaction between a cytosolic and a membrane bound protein by SW-FCCS 
in live cells. On the example of the epidermal growth factor (EGF) receptor (EGFR) we 
demonstrate that the activation of the receptor can be detected by the phosphorylation 
dependent binding of a phosphotyrosine binding (PTB) domain. SW-FCCS results 
indicate that in CHO cells there is low specific interaction between PTB and EGFR, 
possibly indicating a low level of EGFR phosphorylation even in the absence of EGF 
stimulation. After EGF stimulation the interaction between PTB and EGFR increases 
significantly in a time dependent manner. The elevated binding can be then depressed by 
an EGFR-specific inhibitor, AG1478, to a certain extent.  
 
5.1. Introduction of PTB 
The PTB (phosphotyrison-binding) domain is located at the amino-terminal of the human 
adaptor protein Shc. Two domains in Shc are capable of interacting with tyrosine-
phosphorylated receptors: the SH2 domain and the PTB domain. Shc is involved in Ras 
activation after stimulated by cell surface receptors including EGFR, antigen receptors on 
T and B cells and cytokine receptors. The tyrosine phosphorylated Shc binds to Grb2 and 
the interaction leads to Ras activation through interactions between Grb2 and Ras 
guanine nucleotide exchange factor, mSOS. The 3D NMR structure of PTB is shown in 




Figure 5. 1 The structure of PTB. 
The 3D NMR structure of the Shc PTB domain interacting with TrkA (green on the left) or ζ-chain 
of the T-cell antigen receptor(yellow on the right), viewed from different orientations. Source: 
Zhou's research article (Zhou, Ravichandran et al. 1995).  
 
The potential binding sites of EGFR to the PTB domain include Tyr1086, Tyr1148 and a 
non-major site Tyr1114 (Offterdinger, Georget et al. 2004). As Zhou et al. pointed out, the 
association rates of the PTB domain to EGFR are as high as 0.02-5.3 µM (Zhou, Harlan 
et al. 1996), making the dynamic equilibrium detectable in our FCCS set-up.  
 
5.2. Results 
5.2.1  z-scan  
The z-scan measurements can help understand the ACF shape changes in different focus 
for cytosolic and membrane proteins. To better understand the interaction between a 
cytosolic protein and a membrane protein, which has never been done in FCCS 
measurements before, the measurements were firstly performed in the z-direction across 
the upper plasma membrane of CHO cells (Benda, Benes et al. 2003; Dertinger, von der 
Hocht et al. 2006; Przybylo, Sykora et al. 2006), as demonstrated in Figure 5.2. Different 
points along the z-direction were chosen by moving the focus across the membrane with 




Figure 5. 2 Demonstration of the focal volume positioning in the z-scan measurements. 
 
The ACF curves suggested different diffusion behavior for the different constructs at 
different locations. All measurements outside the cell did not show any correlations as 
expected since proteins were expressed only on the membrane and in the cytoplasm. As 
the diffusion coefficients shown in Table 5.1: For PTB-EGFP, measurements in the 
cytoplasm showed the typical diffusion coefficient the same as cytoplasmic proteins (Shi, 
Foo et al. 2009), and the curves had another much slower component when focal volume 
was near to the membrane. For mRFP-EGFR, autocorrelations were seen in the 
cytoplasm, especially when no internalization inhibitors are applied. We attribute this to 
either internalized mRFP-EGFR or possibly mRFP-EGFR which is transported from the 
endoplasmic reticulum to the plasma membrane. On the contrary, for PMT-mRFP, the 
negative control, little correlation was detected in the cytoplasm.  
The ACFs and CCFs collected on the membrane, 0.4 µm and 1.4 µm below the 
membrane are shown in Figure 5.3. mRFP-EGFR exhibited a slow diffusion coefficient 
and only the amplitude of the ACF was influenced by the position. In contrast, for PTB-
EGFP measurements, the fast diffusion coefficient was at the range of one measured in 
the cytosol, and the slow diffusion coefficient was similar to the diffusion coefficient 
measured for the mRFP-EGFR on the plasma membrane. The closer to the membrane, 
the higher the slow component (i.e. the component with the EGFR-like diffusion 
coefficient) contributed to the ACF. Since the half-height of the focal volume is no larger 
than 1.4 µm, we measured the diffusion below the membrane (-1.4 µm) and found that 
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there was no slow diffusing component for PTB-EGFP, indicating that PTB-EGFP freely 
diffuses in the cytoplasm. PTB-EGFP close to the membrane shows some slow diffusing 
component with a fraction of 8 ± 2 % (mean ± standard error of the mean (SEM)) even 
for PTB-EGFP/PMT-mRFP. This indicates either some basic binding, which may not be 
EGFR-specific, of PTB-EGFP to membrane proteins (Yarden and Schlessinger 1987) or 
some FCS artifact as has been found before (Fradin, Abu-Arish et al. 2003).  
Table 5. 1 Diffusion coefficients in different proteins. 
D of the green and red autocorrelation function (ACFG and ACFR) and the cross-correlation function (CCF) 
measured for different combinations of proteins co-expressed in CHO cells. 
Proteins D [µm2/s] ACFG D [µm2/s] ACFR D [µm2/s] CCF N 
PMT-EGFP/PMT-mRFP  
(neg. ctrl) 
0.4 ± 0.2 0.3 ± 0.1 1.0±0.5 82 
EGFR-EGFP/mRFP-EGFR 0.3 ± 0.2 0.3 ± 0.2 0.5±0.3 65 
PTB-EGFP/mRFP-EGFR   
(- EGF) 
31 ± 16 (0.7 ± 0.4) 0.3 ± 0.2 22±12 (0.6±0.4) 24 
PTB-EGFP/mRFP-EGFR  
(+EGF 20min) 
26 ± 10 (0.9 ± 0.4) 0.3 ± 0.2 25±15 (0.7±0.5) 24 
PTB-EGFP/PMT-mRFP  
(-EGF) 
28 ± 10 (1.0±0.5) 0.8 ± 0.5 30±20 (0.7±0.5) 12 
PTB-EGFP/PMT-mRFP  
(+EGF 20min) 
31 ± 10 (0.8±0.7) 0.7 ± 0.3 27±14 (1.0±0.5) 10 
mRFP-EGFR-EGFP  
(pos.ctrl) 
0.8 ± 0.3 0.7 ± 0.3 0.3±0.2 25 
 
Values in parenthesis represent a second, slower diffusion coefficient if present. N represents the 
number of measurements performed for each case. The values have been calibrated against R6G 





Figure 5. 3 FCCS z-scans for PTB-EGFP/mRFP-EGFR co-transfected CHO cells around the 
upper membrane in the absence of stimulation.  
The z-scans were performed at 3 heights, on the membrane, 0.4 µm below the membrane and 1.4 
µm below the membrane, suggesting different diffusion behaviour for the different constructs at 
different locations. (A) ACF curves of PTB-EGFP: two diffusive components exist in the curves; 
one is on the order of cytosolic proteins and another is consistent with EGFR-FPs diffusion on the 
membrane. (B) ACF curves of mRFP-EGFR. The amplitude of the ACF is influenced by the focal 
position in relation to the membrane. (C), (D), and (E): ACF and CCF curves of PTB-
EGFP/mRFP-EGFR at different locations. 
 
5.2.2 Controls and brightness parameters  
To set the stage for the measurement of interactions, negative control measurements were 
taken between differently labelled plasma membrane targeting proteins (PMT) and the 
PTB domain. The complex percentage (cplx%) value was calculated using Eqs (2.16-
2.19). The negative controls give low cross-correlations with interaction percentages of 5 
± 2 % (average ± standard error of the mean (SEM)) for PTB-EGFP/PMT-mRFP. The 
positive control (mRFP-EGFR-EGFP) gave a much higher cross-correlation amplitude 
with a maximum interaction percentage of 48 ± 3 %.  The values of positive and negative 
control are slightly different from the previous chapter because to grant better 
comparisons, the controls' interaction percentages in this chapter were calculated using 
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the cplx% calculation Eqs (2.16-2.19) while the controls in Chapter 4 were treated as 
dimers and used the dimer% calculation Eqs (2.20-2.23).  
In my experiments, under 20 mW 514 nm illumination, the brightness (η, as mentioned in 
Chapter 2) of 𝜂𝑃𝑇𝐵−𝐸𝐺𝐹𝑃 = 1539 ±  845Hz. The rest brightness values were the same as 
those mentioned in Chapter 4. 
 
5.2.3  Interaction between EGFR and PTB stimulated by EGF 
Having set the bottom and upper limit for the EGFP and mRFP pair under the presented 
conditions, the interaction between proteins can be quantified. As mentioned in the 
previous chapters, for measurements with and without EGF stimulation we used 
internalization inhibitors to avoid the rapid internalization of EGFR which would make 
the interaction percentage measurements very difficult and imprecise. The cross-
correlation measurements were taken on a single cell before and after the addition of 100 
ng/ml EGF by focusing on a single position. For consistency, the peak intensity in the red 
channel as the membrane position was refocused on the membrane before every 
measurement to avoid artifacts of membrane movement. After EGF addition several 
measurements were taken at different times ranging from 3 minutes to about 30 minutes.  
The amplitudes of cross-correlation curves measured before stimulation from cells co-
expressing PTB-EGFP/mRFP-EGFR (11 ± 2 %, absolute values) were much higher than 
those expected for pure cross talk. In addition they were as well higher than the negative 
control (5 ± 2 %) (Table 5.2 and figure 5.4). This indicates that there is some basic 
binding of PTB-EGFP to mRFP-EGFR even in the absence of stimulation. This is 
probably due to a low basal amount of phosphorylated EGFR even when the cells are not 
stimulated (Yarden and Schlessinger 1987; Posner, Engel et al. 1992). The binding 
percentage increases after adding EGF to 14 ± 2 % at 3-5 minutes and 17 ± 3 % at 10 
minutes. After 20 minutes stimulation with EGF the interaction percentage increased to 
25 ± 4 %, showing a statistically significant increase in PTB-EGFP binding in a time-
dependent manner. It should be noted here that the somewhat larger SEM for the 
stimulation measurements is due to the fact that the values before and after stimulation 
can vary over a larger range than seen for the negative and positive controls. This is a 
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reflection of the biological variability between cells (Fig. 5.5) (Chung, Sciaky et al. 
1997).  







PTB-EGFP/PMT-mRFP (-EGF) 5±2 9±3 12 
PTB-EGFP/PMT-mRFP (+EGF 20 min) 5±2 9±3 10 
PTB-EGFP/mRFP-EGFR (-EGF) 11±2 22±4 24 
PTB-EGFP/mRFP-EGFR (+EGF 20 min) 25±4 51±9 24 
PTB-EGFP/ mRFP-EGFR (+EGF) 35±5 73±11 12 
PTB-EGFP/ mRFP-EGFR (+EGF+AG1478) 18±3 38±6 12 
mRFP-EGFR-EGFP (pos. ctrl) 48±3 100±6 25 
SE is the standard error of the mean and N the number of independent measurements performed. 




Figure 5. 4 Auto- and cross-correlation curves of controls and experiment.  
The colors of the FP labels are indicated by the colors of the curves. (A) PMT-EGFP/mRFP 
(negative control) shows the lowest level of cross-correlations. (B) mRFP-EGFR-EGFP (positive 
control) showing the highest level of cross-correlation for our system. (C, D) PTB-EGFP/mRFP-
EGFR before and after 20 min of stimulation, respectively, indicating not only the increase of the 
amplitude of the CCF but also an increase of the slow diffusing component of the PTB. (E, F) 
PTB-EGFP/PMT-mRFP before and after 20 min of stimulation (negative control) shows no 
significant increase in complex percentage. (G, H) PTB-EGFP/mRFP-EGFR stimulated by EGF 
and followed by AG1478 (100nM), respectively, showing a mild decrease of binding between PTB 
and EGFR. F2 stands for fraction of the slow component in PTB. Cplx % stands for the complex 
percentage as determined from the CCF amplitude (not normalized). 
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The cross-correlation of PTB and EGFR does not reach its possible maximum because 
the cytosolic concentration of PTB-EGFP exceeds the concentration of mRFP-EGFR on 
the membrane. In addition, this is not expected as EGFR will not interact with only one 
downstream protein and competition of endogenous proteins can play a role. However, 
the results of SW-FCCS are supported by changes in diffusion coefficients of PTB-EGFP 
upon binding and by a change in the ratio of the concentrations of fast cytosolic PTB-
EGFP versus slow membrane bound PTB-EGFP.  
The measurements indicate that only a small fraction of PTB-EGFP is bound on the 
membrane before stimulation but that binding increases shortly after stimulation with 
EGF and reach a maximum after about 20-30 minutes. In the negative control of PTB-
EGFP/PMT-mRFP in which we stimulated cells with the same concentration of EGF, the 
percentage showed no significant increase with time (5 ± 2 % at 20 min) and was 
markedly below the level when mRFP-EGFR was co-expressed.  
However, some cells (3 in 24) internalize mRFP-EGFR very rapidly even in the presence 
of internalization inhibitors. The complex percentage calculated from these cells 
exceeded the value of positive control, indicating the aggregation of EGFR. These cells 
were excluded from the evaluations since they showed clearly shorter diffusion times 
(distorted ACF curves), higher CCF (cross-correlation function) amplitudes, and 
increased cps possibly due to the presence of multiple EGFR/PTB pairs in vesicles below 




Figure 5. 5 Dynamic changes of PTB-EGFP/mRFP-EGFR interaction exhibit cell dependent 
patterns,  
The different changes  contributes to the large variability of the complex percentage measured. (A, 
B): before EGF stimulation. (C, D): after a short exposure of EGF. (E, F): PTB-EGFP/mRFP-
EGFR after a long exposure of EGF. (G, H): Comparison of CCF curves for two different cells 
showing different activation patterns. Although in both cases binding can be clearly detected by a 
rise in the second slower diffusing component (similar to EGFR-FP) in the CCF, the time of 
highest interaction is different for the two cells. The complex percentages are shown as a time-
course column chart: the colors of the column indicate the time coinciding with the CCF curves, 
and the Y-axis values present the complex percentage values (not normalized). 
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5.2.4 PTB domain translocation induced by EGF stimulation 
The autophosphorylation of EGFR, the first step of its signalling cascade, can be 
determined by measuring the interaction between signalling molecules and the receptors 
as well as the translocation of the signalling molecules. To further prove that the 
interaction between mRFP-EGFR and PTB-EGFP was driven by EGF stimulation we 
observed also the fraction of the slow diffusing component of PTB-EGFP in the ACF 
(auto-correlation function). This should rise when more PTB-EGFP binds to mRFP-
EGFR in the plasma membrane as is indeed found in the results (Figure 5.6). 
As we expected, same as the cplx% listed in table 5.2, the slow component% in ACF 
curves of PTB in PTB/EGFR co-expression system increased upon activation in a time-
depend manner (Figure 5.6 and table 5.3), while in the PTB/PMT co-expression system, 
the fraction didn't increase in the ACF curves of PTB. Before activation, the slow-
component% in PTB ACF curves in different systems are both around 8 %, suggesting 
the basal binding of PTB with some membrane proteins including ErbB family. The 
difference started from at least 10 min after stimulation, when the initial moderate 
increase in slow-component% of PTB in PTB/PMT system may be caused by other 
endogenous PTB-binding partners. At 20 min after stimulation, the difference is 
significant (16.7 % vs. 9.0 %). A similar trend was also observed in the slow-
component% in CCF curves in these experiments, but with a small drop at 20 min. The 
slight inconsistence may suggest at 20 min the interaction dynamic has changed. The 
increasing trend is in good agreement with the trend of complex% between PTB and 
EGFR, suggesting more PTB were translocated to the membrane when the receptors were 
activated. These data add some more solid evidence to prove the dynamic interaction 
between PTB and EGFR on the membrane after EGF stimulation as well as the capability 




Figure 5. 6 The increasing ratio of slow component% in PTB.  
Increasing ratio is calculated by dividing the after stimulation values by the before stimulation 
values from the same cell. (A) the trends are presented by absolute values of slow-component%. 
(B) the trends are presented by increased ratios. 'nd' is short for normalized. 'ab' is short for 




Table 5. 3 Slow-component% trends with time 
 
before 5min 10min 20min 
Absolute values of the slow-component% in PTB ACF curves 
PTB/EGFR average 8.5 % 13.2 % 12.7 % 16.7 % 
 
SE 1.6 % 2.6 % 2.6 % 2.0 % 
PTB/PMT average 8.3 % N.A. 10.1 % 9.0 % 
 
SE 2.0 % N.A. 2.2 % 1.7 % 
CCF average 19.6 % 28.0 % 30.9 % 29.5 % 
 
SE 2.5 % 3.7 % 4.1 % 3.3 % 
Relative values (increased ratios) of the slow-component% in PTB ACF 
curves 
PTB/EGFR average 1 1.55 1.88 1.62 
 
SE 0 0.30 0.70 0.37 
PTB/PMT average 1 N.A. 1.56 1.04 
 
SE 0 N.A. 0.36 0.14 
CCF average 1 1.93 2.32 2.10 
 
SE 0 0.36 0.69 0.49 
 
5.2.5 Inhibition of EGFR-PTB interaction by inhibiting phosphorylation 
After a clear elevated cross-correlation was observed, the EGFR-specific tyrosine kinase 
inhibitor AG1478 (100 nM) was added. The addition of AG1478, a specific 
phosphoralation inhibitor of EGFR (Levitzki and Gazit 1995; Offterdinger, Georget et al. 
2004), resulted in a decrease in the interaction within a short time (usually less than 3 
min) in most cases (12/15) but cannot completely reverse the binding (Table 5.2 and 
Figure 5.7). It was shown that EGF induced a 3-fold increase in binding, suggested by the 
elevation of complex%, whereas AG1478 reduced the interaction to ~50% from the 
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stimulated values, but is still somewhat higher than the initial values. The reasons may be 
that AG1478 cannot fully inhibit all the binding sites of EGFR to PTB, and more 
importantly, some of the reactions may have already passed a threshold when the 
interacting process irreversibly reaches the next step, such as aggregation or endocytosis. 
The average of the complex percentage of PTB-EGFP/mRFP-EGFR in the inhibition 
experiment before adding AG1478 was higher than that obtained from the 20 minute 
average because in this experiment the stimulation period was not fixed. Measurements 
followed cell’s own reaction case by case: when the complex percentage was already 
higher than that of before stimulation when AG1478 was applied. The overall decrease of 
the cplx% suggests that EGF-induced phosphorylation is reversible.  
 
Figure 5. 7 The reversibility of AG1478 to EGFR-PTB binding.  




We have presented here the quantitative measurement in space and time of the interaction 
of EGFR with a phosphotyrosine-binding domain (PTB) in live cells using SW-FCCS. 
This is, to our knowledge, the first time-dependent quantitative study of a cytosolic 
protein binding to a membrane receptor in an activation dependent manner by SW-FCCS. 
SW-FCCS was to date only used to study the interaction between membrane proteins or 
cytosolic proteins. The measurements presented here demonstrate that SW-FCCS can 
also be used to study the binding of cytosolic proteins to membrane proteins despite the 
fact that this type of experiment poses particular problems. Firstly, there is a mismatch in 
concentrations between the cytosolic and membrane proteins leading to a limited 
response in the cross-correlation amplitudes. Secondly, binding is activation dependent 
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and thus has to be observed over time, posing problems of membrane focusing while the 
membrane moves. And thirdly, because of the necessary EGF stimulation only one 
measurement can be performed per cell or even cell chamber. In combination with the 
variability of the biological response of different cells this makes measurements difficult. 
Our findings indicate that there is little non-specific binding of PTB-EGFP (<12 %, 
normalized percentage to positive control) to membranes lacking mRFP-EGFR 
independent of EGF stimulation. However, in the absence of stimulation, EGFR 
expressing cells showed a higher percentage of PTB-EGFP binding (~26 %) to the 
plasma membrane than cells which lacked EGFR (~5 %). This indicated that even in the 
non-stimulated state some PTB-EGFP is interacting with mRFP-EGFR, implying a low 
level of mRFP-EGFR phosphorylation. The basal phosphorylation for mRFP-EGFR has 
been observed by our group previously, see Fig. 2A in (8). Upon activation, PTB-EGFP 
is recruited to the membrane within minutes although the full binding is seen only at a 
later stage about 20-30 minutes in the presence of EGF (~45 %). This finding is 
supported also by the fact that the ACF of PTB as well as the CCF shows an increasing 
fraction of slowly diffusing, i.e. membrane bound, PTB-EGFP compared to the fast 
cytosolic fraction which diffuses almost a factor 50-70 faster.  
By subsequent treatment of cells with AG1478 after stimulation with EGF, we 
demonstrated the reversibility of EGF-induced binding of PTB domain to EGFR to a 
certain level (~50 % decrease) by inhibition of EGFR kinase activity. The reversion of 
the binding took more than 3 min and lasted no more than 15 min. 
It should be noted though that, as already reported in our earlier work, we sometimes 
recorded very big intensity fluctuations in combination with a smaller diffusion 
coefficient. We interpret this as receptor clustering on the membrane. The observed 
increase in the diffusion time implies very large receptor clusters since the diffusion 
coefficient is only weakly dependent on particle size in membranes (Saffman and 
Delbruck 1975). Although large clusters can be easily identified, smaller clusters may be 
difficult to detect especially if they constitute a small portion of a measurement. This 
might partly explain the variability in results between cells. It would be very interesting 
to use Photon Counting Histogram (Chen, Muller et al. 2002) and Fluorescence 
Distribution Analysis (Kask, Palo et al. 1999; Kask, Palo et al. 2000; Saffarian, Li et al. 
2007), or to determine distribution of brightness of these clusters in future measurements. 
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This study shows that EGFR activation, and indirectly phosphorylation, can be followed 
in time by SW-FCCS in live cell. However, the detectors in the conventional confocal 
FCCS setups allow only one spot to be detected each time. The different responses 
between periphery and peri-nuclear regions may result in missing of some interesting 
information (Offterdinger, Georget et al. 2004). Therefore, an instrument which can 
cover a wider area of the sample and can take measurements simultaneously would be of 
great help. We will address the use of imaging FCS, a method which can record 
thousands of pixels simultaneously, although still at the sacrifice of time resolution, in the 




Chapter 6. Study of proteins by imaging total internal 
reflection fluorescence correlation spectroscopy (ITIR-
FCS) 
 
Camera-based FCS provides an opportunity to understand the mobility of proteins of 
interest in a complex environment. However, due to intrinsic difference between camera-
based FCS and confocal-FCS, it is of great importance to design proper guidelines and 
experimental conditions for the new approach so that utilization of ITIR-FCS as a tool to 
study diffusion and partitioning of EGFR is consistent and comparable to the results of 
confocal-FCS. The test for the best measurement conditions, which will be presented in 
this chapter, include the determination of measurement parameters such as acquisition 
time, laser power used, number of frames recorded, and bleach correction applied. Next, 
mobility of PTB and EGFR measured by ITIR-FCS will be summarized, and EGFR 
clustering with and without EGF stimulation observed by ITIR-FCS measurements will 
be introduced.  
 
6.1 System testing 
6.1.1 Determination of measurement parameters  
Parameters such as acquisition time for each frame, the number of frames, and the laser 
power affect the error or even the results of ITIR-FCS experiments (Bag, Sankaran et al. 
2012). Hence, tests were done to find the best scenario for our settings to generate 
reliable ACFs, that is, to achieve relatively high signal-to-noise ratio before the main 
body of experiments. The ways to increase the signal-to-noise ratio include increasing 
acquisition time and laser power. All tests were repeated at least 10 times.  
The acquisition time is limited by both the frame rate of the camera and the signal-to-
noise ratio of the sample. To choose the best acquisition time, 0.5 ms, 1.0 ms, 2.0 ms and 
4.0 ms were tested. Figure 6.1 shows a comparison of the four acquisition times, which 
compares the averages of the standard deviation of the fitted Diffusion coefficients (D) 
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divided by the average D, also called the coefficient of variation. Figure 6.1.A and 6.1.B 
demonstrate that for the same position in the same cell, acquisition of 2.0 ms returns a 
much smoother curve than the acquisition time of 0.5 ms. As shown in Figure 6.1.C, the 
measurement with acquisition time of 2.0 ms and 4.0 ms returned a relatively small 
standard deviation on average. It was found that with acquisition time of 2.0 ms, a 
maximum of 3-4 repetitions can be achieved for one single cell before the fluorophores 
were significantly bleached. As the experiment plan was to track one single cell for its 
response to stimulation for at least 3 time spots, 2.0 ms was selected.  
Similar tests were done for laser power.  If the laser power is too weak, the ACF becomes 
too noisy. When the laser power is increased, the cps (count per particle per second) of 
the fluorophore increases and so does the signal-to-noise ratio. However, very high laser 
power causes photobleaching. The best laser power which yielded the smallest error was 
0.9 mW for the five laser powers tested. So the laser power used for the following 
experiments was kept at 0.8 to 1 mW. Taking account of the illuminated area this 
translates to a maximal intensity of 11-14 kW/cm2 (Bag, Sankaran et al. 2012), which is 
similar to the intensity used in confocal FCS. 
Another parameter to determine is the number of frames for the measurement. On one 
hand, to achieve the required accuracy and precision (within 20% difference between the 
simulated and the obtained values), a minimum of 10,000 frames should be recorded 
(Sankaran, Bag et al. 2013). On the other hand, the hardware storage capacity restricts the 
upper limit of the number of frames that can be recorded each time, especially for a larger 
region of interest such as ~2,000 pixels. To guarantee such accuracy and precision, 
20,000 was selected as the number of frames for the ACFs.  
In summary, a balanced scenario was determined as 2 ms acquisition time, 20000 frames, 





Figure 6. 1 Range of measurement parameters in ITIR-FCS.  
Data were obtained with the assistance of Muhammad Na'im Bin Sa'dollah, a previous honors 
student of our lab. (A) and (B) show the comparison of ACFs and their fitting under 0.5 ms and 
2.0 ms acquisition time conditions. (C) and (D) are the comparison of the relative ratio defined as 
average ± standard deviation of D  over the average of D. (C) compares the  different acquisition 
times while (D) compares the different laser powers.  
 
6.1.2. Bleach correction method determination 
As introduced in Chapter 2, currently there are mainly two methods of correcting the 
photobleach, exponential correction and sliding window correction. A comparison of the 
two methods is done to determine the more proper manner for our system. This section 
will introduce the reasons for selecting sliding window correction, due to its better 
correction capability.  
The results of both bleaching corrections are shown in figure 6.2, which compares a 
bleach-dominated curve and the corrected ones using the two different methods. The 
distortion of the ACF is largely avoided even when the bleaching is strong for both 
methods in most pixels. The average diffusion coefficient of mRFP-EGFR from 
106 
 
exponential correction was 0.25 ± 0.01 (Average ± SE, the same for D in this chapter) 
µm2/s for 38 cells, and the average from sliding window correction was 0.41 ± 0.02 µm2/s 
for the same set of data (Table 6.1). A similar difference was also found in DiI-C12 data 
with a certain level of photobleaching (~20-40% over the 40s). The reason for the 
difference may be related to the following issues: firstly, the intensity of the first few 
frames largely affects the exponential correction. Hence, if the first few frames show no 
clear decreasing trend, as shown in Figure 6.3, this correction method won't work. 
Secondly, the translocation of vesicles of the fluorophores and the membrane movements 
caused abnormal peaks in some of the intensity traces (Figure 6.3). Sliding window 
correction, due to its featured correction process, can correct such peaks as well as 
bleaching, while exponential correction cannot correct for transient peaks.  
This is the first reason that for further analysis, the sliding window correction is chosen. 
The second reason will be mentioned in the next section.  
 
Figure 6. 2 Correction for photobleaching.  
(A) and (B) are the intensity traces before and after exponential correction, respectively; (C), the 
ACF of the intensity trace shown in (A) suggesting dominated by photobleaching; (D)The 
measurement was corrected by exponential correction; (E) the same measurement corrected by 





Figure 6. 3 Correction for bleaching in intensity trace with transient peaks.  
(A) and (B) are the intensity traces before and after exponential correction, respectively; (C), the 
ACF of the intensity trace shown in (A) suggesting dominated by photobleaching; (D)The 
measurement was corrected by exponential correction; (E) the same measurement corrected by 
sliding window correction. The red lines in (D) and (E) show fits to the data. 
(Fig 6.2, pnt [33,10] and 6.3, pnt[35,20] from 20120301, p1c2) 
 
6.1.3. Comparison of the results from confocal FCS and ITIR-FCS 
To compare the measurement results from confocal FCS and ITIR-FCS, CHO cells 
stained with DiI or transfected by mRFP-EGFR were maintained in 1×PBS and the FCS 
measurements were performed at the position of the apical and basal membranes above 
and below the nucleus for each cell. Sankaran et al (Sankaran, Bag et al. 2013) has 
simulated that up to 2,000 particles/µm2 yield estimates within 10 % error, which 
corresponds to a number of particles per pixel of 115. All the experiments done in this 
thesis showed a concentration much lower than this, so the concentration of the particles 
of interest won't exceed the number that allows accurate fitting.  
To test whether the fluidity of the top membrane is comparable with the fluidity of the 
bottom membrane, we firstly compare the diffusion coefficients of 2 different fluorescent 
lipid probes, DiI-C12 and DiI-C18 using confocal FCS. After staining with 0.1 µM lipid 
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analogues for 10 min, the cell membrane was found to be uniformly labeled (Figure 6.4).  
We found that the autocorrelation function of DiI-C12 and DiI-C18 was similar for both 
top and bottom membranes as shown in table 6.1, allowing the comparison of the data 
from confocal and TIRF measurements (Vrljic, Nishimura et al. 2002). The similarity 
suggested that the fluidity of the bottom membrane is not affected by the physical 
adhesion to the cover-glass, suggesting the bottom membrane is not rigid and fixed to the 
glass surface (Gingell, Todd et al. 1985). Curtis showed the shortest distance between cell 
surface and substrate in its adhesions is typically around 100 Å, and much of the cell 
membrane lied farther away (Curtis 1964). This is different from artificial lipid 
membranes of GUVs (Giant unilamellar vesicles) in which the difference of the diffusion 
coefficients of supported membranes to freestanding membranes is about a factor of 1.8 
(Guo, Har et al. 2008).  
 
Figure 6. 4 Cell bottom membrane labeled by DiI-C12 recorded by TIRF-mode.  
(A) and DiI-C18 (B), respectively. The cells were labeled for 10 min at 37°C with a concentration 
of 0.1 µM Dil.  



















































The two lipids were shown to have slightly different preference of partitioning due to 
their tail length (Baumgart, Hunt et al. 2007). We also found a trend that the longer the 
tail, the slower the probe diffusion on average, but the difference is not significant 
between DiI-C12 and DiI-C18 (0.74±0.05 µm2/s of DiI-C12 vs 0.68±0.05 µm2/s of DiI-
C18 on the upper membrane, and 0.72±0.05 µm2/s of DiI-C12 vs 0.70±0.06 µm2/s of DiI-
C18 on the lower membrane).  
Next we compared the diffusion coefficients resulting from ImFCS measurements with 
those from confocal FCS. The parameters such as number of particles and diffusion 
coefficients, at each pixel location in the image were obtained from a home-made fitting 
program in IgorPro (Chapter 2).  
The exponential correction gave us similar result as our previous study on SLBs 
(supported lipid bilayers). In that work we showed that ITIR-FCS yielded a smaller 
diffusion coefficient on SLBs than confocal FCS (Guo, Har et al. 2008). On the contrary, 
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DiI diffusion coefficients obtained from data, which were corrected by the sliding 
window procedure, resulted in values very similar to confocal FCS, suggesting that 
bleach correction is better with the sliding window approach. This is the second reason 
for us to choose the sliding window correction to analyze our results.  
Interestingly, the sliding window correction yielded larger diffusion coefficients than 
confocal FCS in the case of EGFR. This may be due to the effect of strong 
photobleaching which may reduce the apparent diffusion time in the detection area, and 
the effect is enhanced by the fact that mRFP is less photostable than DiI and the reservoir 
of EGFR is limited. However, it should be noted that ITIR-FCS provides absolute 
diffusion coefficients (Bag, Sankaran et al. 2012; Sankaran, Bag et al. 2013) and does not 
require a calibration standard, such as a dye with known diffusion cofficient, which was 
until recently not available for confocal FCS measurements in membranes (Ries and 
Schwille 2006). In addition, confocal FCS requires proper focusing on the membrane 
(Milon, Hovius et al. 2003; Przybylo, Sykora et al. 2006; Heinemann and Schwille 2011), 
which is not trivial as the maximum intensity is not necessarily the same position at 
which a minimal diffusion coefficient is measured. This can lead to ambiguities in 
measurements and therefore confocal FCS is more likely to introduce artifacts compared 
to ITIR-FCS.  
 
6.2  The mobility of EGFR and PTB on the bottom membrane of CHO cells 
recorded and analyzed by ITIR-FCS 
6.2.1 The mobility of EGFR 
To better understand the diffusion and distribution of EGFR, we identify and quantify the 
motion pattern of EGFR using ITIR-FCS. One of the advantages of ITIR-FCS is that it 
can probe the diffusion on an entire cell membrane in a single measurement.  
We firstly found that the values of intensity and D vary largely in ImFCS measurements. 
The pixel-by-pixel variation presumably arose from the uneven distribution and the local 
environments of EGFR in each pixel on the cell's surface. Figure 6.5 presents the analysis 
by our self-written ImFCS program. The fitting can be done for the whole area recorded 
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in a few seconds. If the fitting cannot reach convergence, it returns a white pixel. The 
program returns the average of diffusion coefficients and number of particles. As 
mentioned above, the diffusion coefficient of EGFR is found to be 0.41±0.10 µm2/s. 
Next, to reflect the behaviour of EGFR under conditions closer to physiological ones, we 
carried out the experiments at 37 °C.  The mobility in 37 °C (0.58±0.04 µm2/s, 26 cells), 
as we expected, was found to be higher than that in room temperature given the increased 
fluidity of the membrane. Results of diffusion coefficients for the recorded probes from 
regions of interest on the surface of CHO cells are summarized in Table 6.2. 
 
Figure 6. 5 Membrane dynamics investigated by ITIR-FCS.  
(A) The pixel-by-pixel intensity of the observation area. The ACFs (black lines) are shown in (B) 
together with their fitting (red lines). The diffusion coefficients, D, and number of particles, N, are 
presented as heat maps in (C) and (D).  




6.2.2 The mobility of PTB 
As a cytosolic protein, the diffusion of PTB can still be captured by ITIR-FCS as some of 
the proteins diffuse near the membrane within the evanescent field. As PTB diffuses 
faster than the shortest time resolution that ITIR-FCS can achieve in our setting (0.5 ms), 
only the tail of the PTB's ACF curves can be captured (Figure 6.6). Potentially, that can 
bias diffusion coefficient measurements. After fitting, the D of PTB was found to be 
35.79±7.31 µm2/s, which is comparable with confocal FCS data (31 ± 3 µm2/s) as 
mentioned in Chapter 5, suggesting the precision of ITIR-FCS is still acceptable despite 
the worse time resolution compared to confocal-FCS. A slower component in the ACF 
(Figure 6.6.B) was found in the range typical for membrane proteins and similar to the 
one observed in our confocal-FCCS measurements. However, the slow component 
appears only in a small number of pixels, suggesting the interaction of PTB with 
membrane molecule is transient.  
 
Figure 6. 6 PTB diffusion probed by ITIR-FCS.  
(A) The image of PTB recorded by ImFCS measurements. (B) and (C) represent the ACFs of PTB. 
The slow component can be observed in (B), the curve is not fitted by 2-particle model but the 
fitting yielded a much smaller D.  




6.3. ITIR-FCS as a tool to study large cluster diffusion on cell membrane  
6.3.1 The cluster observed in resting cells 
Two types of clusters were observed in ITIR-FCS data: i) clusters diffusing within a 
certain area (Figure 6.7.A) and ii) clusters moving in a certain direction (Figure 6.7.B). 
Some large clusters of EGFR were observed to be trapped within a certain area. Among 
the 12 clusters analyzed, the relative brightness of the cluster compared with the non-
clustered position varies from 2 to 5, in line with results from different groups, such as 
the following references (Clayton, Walker et al. 2005; Nagy, Claus et al. 2010). The 
diffusion area varies from 6x6 pixels to 12x15 pixels, resulting an average of 5.91±2.55 
µm2 (average ± SD, same as below in this paragraph)  within the 40 seconds recorded. If 
this kind of cluster was recorded by confocal SW-FCCS, it would very possibly result in 
the above-positive dimer% described in Chapter 4. The transportation of EGFR clusters 
was also observed. The direction of the movements can vary from center-to-peripheral 
region, to peripheral-to-peripheral, or peripheral-to-center. The time of existence for a 
cluster from its appearance in the image to its vanishing was 4.66±3.82 s in 59 clusters 
analyzed. The average speed was 1.06±0.60 µm/s, and the average tracking distance was 
3.98±2.85 µm. The length of the polarized trafficking as well as the transport speed 
match well with the measured average length of microtubule and speed for microtubule-
dependent transport (Chernobelskaya, Grigoriev et al. 2001; Ha, Lo et al. 2008). EGFR-
loaded vesicles were known to be directed by microtubule-based transport system and the 
process was promoted by the acetylation of microtubules (Gao, Hubbert et al. 2010). The 
sorting pathways are closely related the endocytosis and cycling of EGFR. Hence, this 
observation may shed some light on the understanding of EGFR recycling in the absence 




Figure 6. 7 The movement of EGFR clusters.  
(A) the clusters are trapped within a smaller region. (B)the cluster is moving towards a certain 
direction. (data from A: 20100703, p2c7;B: 20100724, c9. ) 
 
6.3.2 EGFR cluster formation regulated by EGF  
ITIR-FCS was used to successfully demonstrate a significant increase of EGFR cluster 
formation following stimulation with EGF in a time-dependent manner. Images were 
taken randomly in plates of cells before any treatment, after adding 100 ng/mL EGF and 
after adding 100 nM AG1478, a selective EGFR tyrosine kinase inhibitor. Statistical 
analysis was done by calculating the percentage of clustered and un-clustered cells' 
numbers in a consequent time period.  
Cluster formation occurred in response to receptor activation by EGF. As shown in 
Figure 6.8, clustering existed in 24 % of untreated cells. When the living EGF-treated 
cells were observed, we noted that the percentage increased steadily after EGF 
stimulation to at least 30 min. To detect whether the cluster formation is related to its 
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receptor tyrosine kinase activity, we used AG1478 to treat the activated cells and found 
that the portion of clustered cells decreased upon adding the inhibitor. A similar trend 
was found in 37 °C. But compared to room temperature, there were slightly more 
clustered cells before stimulation at 37 °C, and the percentage of clustered cells increased 
more quickly, suggesting a higher reaction rate. The percentage of clustered cells reached 
the limit in about 10-20 min, and the inhibition of AG1478 was weaker than at room 
temperature. In concordance with our previous data mentioned in Chapter 5, where we 
found that the elevated dimer% could not be decreased to the initial value by AG1478, 
the inhibitor was not able to reverse the clustering back to non-treated conditions. No 
such clustering was observed in DiI-stained cells. It should be noted that for the analysis 
of the majority, the measurements in the next chapter are taken in cells without clusters 




Figure 6. 8 Statistical analysis for EGFR clustering upon stimulation and inhibition.  
Illustration for (A) un-clustered cell without EGF treatment, (B) clustered cell without treatment, 
(C) un-clustered cell after adding EGF, and (D) clustered cell after adding EGF. (E) shows 
changes of  the percentages of clustered and un-clustered cells upon treatments.  
 
6.4. Discussion 
In this chapter, we have tested and determined suitable parameters for ITIR-FCS in our 
setting. The acquisition time of 2 ms, laser power of 0.8-1 mW, number of frames of 
20,000 was selected for the measurements, and sliding window correction was chosen to 
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correct the effect of photobleaching. Applying the measurements with determined 
standards returned comparable results with Confocal-FCS in terms of diffusion 
coefficients for membrane molecules as well as cytosolic proteins.  
Furthermore, it is of great interest to study the fast transport or trapped EGFR clusters 
mentioned in section 5. The record of trapped clusters by ITIR-FCS can shed light on 
abnormal measurements seen with confocal FCCS mentioned in Chapter 4. In that 
chapter, we reported the observation of very high correlation with relatively small τD in 
both ACFs and CCFs. We suspected that these phenomena were caused by some 
clustering. Interestingly, this type of clusters observed in ITIR-FCS may possibly explain 
the extremely high cross correlations, although we haven't proved the linkage between 
the two. The fast moving type of clusters may be closely related to membrane transport 
processes. Membrane trafficking is known to be able to influence the signalling 
transduction and may lead to receptor ubiquitination. In the process, many proteins may 
play a role in the regulation, such as Rab5 (a small GTPase regulating the mobility of 
early endosomes), Hrs (Hepatocyte growth factor regulated tyrosine kinase substrate, a 
prominent target for phophorylated receptors localised in endosome) and Cbl (a 
ubiquitin ligase family) (Clague and Urbe 2001). One possible structure that can transfer 
the proteins in such a direction is the components of the cytoskeleton as evidence of their 
regulatory role in trafficking EGFR was found (Fiori, Zhu et al. 2009). Experiments 
showed that the formation of EGFR clusters could facilitate the activation of unliganded 
receptors during an amplification process (Ichinose, Murata et al. 2004), whereas the 
quantitation in different regions demonstrated that the activation of EGFR were more 
pronounced at the periphery than in the perinuclear regions of the cells (Offterdinger, 
Georget et al. 2004). Hence, the translocation of EGFR could possibly facilitate the signal 
transduction. Further investigation could identify the relationship between EGFR 
trafficking and its activation status as well as the cytoskeleton network as previous 
studies were more focusing on the regulation of the cytoskeleton and its role on EGFR's 
endocytic trafficking (Burke, Schooler et al. 2001; Nie, Hirsch et al. 2006; Fiori, Zhu et 
al. 2009; Rappoport and Simon 2009; Gao, Hubbert et al. 2010).  
Nevertheless, the direct fitting of ACFs may not yet be accurate enough to discriminate 
between complex diffusions and a somewhat higher time resolution, higher signal-to-
noise ration and better fitting procedures would help tremendously in elucidating EGFR 
membrane dynamics. Modulation of the diffusion of the inactivated and activated 
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receptor could provide novel insights of its activation and distribution mechanism. 
Hence, it is therefore important to develop methods that allow the quantitative assessment 
of the receptor's heterogeneity in intact cells and stimulated cells so that the role of the 
receptor in the resting and activated cells can be accurately determined. Further 
quantitation methods, diffusion law studies, are needed to detect and characterize the 





Chapter 7. The study of factors affecting the diffusion of 
EGFR 
 
Many approaches have been used over the last few decades to characterize the diffusion 
of molecules on the cell membranes. However, direct fitting of ACFs sometimes was 
inaccurate to discriminate between complex diffusion scenarios, so the FCS diffusion law 
was invented to provide a quantitative standard to detect the diffusion modes 
(Wawrezinieck, Rigneault et al. 2005). In this chapter, the combination of diffusion 
coefficient analysis and FCS diffusion law study will provide a better view on the 
mobility and the constraints of EGFR on the membrane, such as lipid rafts and the 
cytoskeleton. We found that the restriction of lipid rafts on EGFR diffusion is cholesterol 
concentration dependent. When a small amount of cholesterol was removed, the diffusion 
of EGFR on the membrane became more 'free', but when a large amount of cholesterol is 
removed, the diffusion of EGFR became more restricted, probably a result of large 
cluster formation. On the contrary, cytoskeleton disruption had no significant effect on 
the diffusion of EGFR. 
 
7.1. Diffusion law plots in ITIR-FCS 
As mentioned in Chapter 2, FCS diffusion law plots several diffusion times over the 
square of the corresponding waists of the focal volume, and the y-axis intercept of FCS 
diffusion law plot is an indicator of the molecule's diffusion mode. An intercept of 0 
suggests free diffusion, while above 0 and below 0 suggest microdomain-restricted and 
meshwork-restricted diffusion, respectively. The different observation volumes were 
obtained by varying the size of the confocal volume, conventionally. However, this 
method requires a series of measurements at different observation volumes, which take at 
least several minutes to realize. The time span may cause the miss-out of some dynamic 
process. ITIR-FCS perfectly solves this problem as in this setup, the diffusion law 
calculation is conducted through varying the binning of the pixels post-acquisition. 
Therefore, one single measurement is enough to create a diffusion law plot, and repeating 
exposure of the sample to the excitation light is avoided. 
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There are several differences between the FCS diffusion law plot in ITIR-FCS system 
and confocal systems (Wenger, Conchonaud et al. 2007; Eggeling, Ringemann et al. 
2009; Favard, Wenger et al. 2011). A typical FCS diffusion law plot is depicted in Figure 
7.1. In ITIR-FCS, the diffusion law was visualized by plotting 𝐴𝑒𝑓𝑓/𝐷 vs 𝐴𝑒𝑓𝑓, in which 
𝐴𝑒𝑓𝑓/𝐷 is the average time a particle needs to diffuse though the effective observation 
area, 𝐴𝑒𝑓𝑓. From the simulation done in our lab, for samples with slow mobility (D=0.1 
µm2/s) measured using an acquisition time of 2 ms, it was shown that free diffusion is 
consistent with FCS diffusion law intercepts smaller than 0.3 s, whereas for fast diffusing 
molecules (D=1 µm2/s), the threshold is 0.1 s (Sankaran, Bag et al. 2013). However, the 
intercepts deviate from zero depending on the experimental conditions used, so internal 
controls, such as DiIs, should be applied for EGFR in living CHO cells. Besides, to 
decrease the effect of the intrinsic large standard deviation in ITIR-FCS measurements, 
the fitting of the diffusion law is weighted using the standard error of the mean 
(Sankaran, Bag et al. 2013).  
Nevertheless, the comparison of diffusion coefficients in different binning (Figure 7.1.B) 
suggests the binning does not significantly affect the accuracy of the fitting despite the 
increase of the total number of fluorophores in the area.  
 
Figure 7. 1 Illustration of experimental FCS diffusion law plot analysis obtained by plotting 
𝐴𝑒𝑓𝑓/𝐷 vs 𝐴𝑒𝑓𝑓.  
(data from 20120629, p1c1) 
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7. 2. ITIR-FCS diffusion law study on EGFR 
7.2.1. The heterogeneity of EGFR diffusion revealed by ITIR-FCS diffusion 
law 
Free diffusion, diffusion in domains and meshwork-hindered diffusion were 
demonstrated in our system by using artificial lipid bilayers (unpublished data). However, 
considering that the live cell membrane system is more complicated and the parameters 
affecting the intercepts (such as probability of EGFR to get in to/out of the domain and 
domain size) were undetermined, internal controls are done by measuring the diffusion of 
DiI-C12 and DiI-C18 in CHO cells. It was found that even long-chain DiIs such as DiI-
C16 and DiI-C18 acted as non-raft markers in artificial bilayers (Bacia, Scherfeld et al. 
2004; Sankaran, Manna et al. 2009; Tian and Baumgart 2009). 
The intercepts of DiI-C12 and DiI-C18 (D=~0.74 µm2/s and ~0.64 µm2/s in room 
temperature and ~1.30 µm2/s and ~1.10 µm2/s in 37°C, respectively) were 0.32 ± 0.05 s 
(Average ± SE, same for intercepts below) and 0.28 ± 0.06 s on average in room 
temperature and 0.19 ± 0.02 s and 0.22 ± 0.04 s in 37 °C, respectively. Hence, using the 
95 % confidence interval and using the larger value between DiI-C12 and DiI-C18, 
positive intersections of 0.42 s in room temperature and 0.30 s in 37 °C set the upper 
limit for a free diffusion in this experiment setting (Figure 7.2). That the values are 
positive could be explained from simulation study from our lab, which suggested that in 
the case of free diffusion, the threshold of the intercept on the y-axis for free diffusion is 
dependent on the diffusion coefficient, acquisition time, measurement time and the 
relative ratio of acquisition time over diffusion time (Sankaran, Bag et al. 2013).  
Partitioning of the EGFR into domains could give rise to intercepts of 1.06 ± 0.09 s in 
room temperature and 0.56 ± 0.05 s in 37°C, which are significantly above the limits set 
by DiIs. The high value of intercepts suggests the receptor's preference to rafts. Previous 
studies have shown the relationship between EGFR localization on the membrane and its 
signalling (Irwin, Mueller et al. 2011), so it is of great importance to explore the factors 




7.2.2. The effect of cholesterol depletion by mβCD on the mobility of EGFR 
7.2.2.1 The cholesterol depletion is mβCD-concentration dependent and 
temperature dependent 
In order to understand the effect of cholesterol depletion on EGFR, we first determined 
the cholesterol content on CHO cells after treatment with different concentration of 
mβCD by Amplex® Red Cholesterol Assay Kit, which uses the fluorescence intensity of 
the Amplex® Red reagent as an indicator of the cholesterol concentration.  
The cholesterol concentration detection was done in different scenarios. The ITIR-FCS 
measurements for mβCD treatment were conducted either in room temperature (RT) or 
37 °C after incubation with a certain concentrations of mβCD in 37 °C, 5 % CO2 for 0.5 
hr. The drug was left in the plates during measurements, which lasted at most 1 hr for one 
plate. Hence, to mimic the measurement conditions, the cholesterol concentration 
detection scenario is as follows: cells were seeded into 6-well chambers after cell 
counting to guarantee the numbers of cells are the same in each well (~2x105) a day 
before the experiment; three different concentrations of mβCD and three different 
incubation conditions were tested, and for each condition the test was repeated at least 3 
times. The concentration of the cholesterol is indicated by cholesterol%, which is the 
ratio of the fluorescence intensity of cells after mβCD treatment divided by that of the 
cells without treatments. Figure 7.2 shows that mβCD depleted the cholesterol on the 
CHO cell membrane in a dose-dependent manner. 37 °C, 0.5 hr treatment removed 16 ± 7 
% (average ± SD, same for cholesterol% in this chapter) cholesterol with 0.5 mM, 26 ± 9 
% cholesterol with 1.5 mM, and 34 ± 15 % cholesterol with 5.0 mM. Treatment of 
another 0.5 hr in 37°C removed 33 ± 5 % cholesterol with 0.5 mM, 50 ± 14 % cholesterol 
with 1.5 mM, and 67 ± 7 % cholesterol with 5.0 mM, almost double of the results of 0.5 
hrs (1.97 times on average), suggesting a linear reaction rate. The negative control data 
were obtained from measurements in wells filled up with the same culture medium but 
without seeding cells.  
We also found that after incubation for 0.5 hrs at 37°C, a further incubation of 0.5 hrs at 
RT did not remove any further cholesterol (see the similar levels of the blue and red bars 
in Figure 7.2.A). This result indicates that if the measurements were conducted at room 
temperature, the cholesterol% should not change during the 1 hr measurement period, 
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whereas for measurements conducted under 37 °C, the cholesterol% was still decreasing 
during the measurements.  
 
7.2.2.2 The diffusion coefficients of EGFR change differently under low and 
high concentration of mβCD 
To understand the effect of different cholesterol% on EGFR's diffusion, we plot the 
relative D, which is derived by dividing the average D after mβCD treatment by D before 
mβCD treatment at the same temperature, with the cholesterol%. D was found to be 0.41 
± 0.02 µm2/s at RT and 0.58 ± 0.04 µm2/s at 37 °C. As shown in Figure 7.2.B, the 
diffusion coefficients changes differently depending on the remaining cholesterol%. An 
increased D,  0.48 ± 0.04 µm2/s, after the addition of 0.5 mM to the CHO cells, has been 
observed in the RT group (P<0.05), the rest two treatments didn't result in significant 
differences in diffusion coefficients. On the contrary, in the 37 °C group, 5 mM mβCD 
treatment led to a decrease of 36 % in the diffusion coefficient (P<0.01) to 0.37 ± 0.04 
µm2/s. Correspondingly, the distribution was shifted to a higher D in 0.5 mM/RT group, 
and to a lower D with a narrower width of distribution in the 5 mM/37 °C group (Figure 
7.3, the total numbers of data points were normalized to the same value in both figures). 






Figure 7. 2 The relative concentration of cholesterol in different scenarios and its effect on the 
diffusion coefficients (average ± SE).  
(A) Relative cholesterol% under different conditions. The relative concentration is calculated as 
the value of after treatment cells divided by the value of the cells without treatment. (B) Relative 





































Figure 7. 3 Normalized histogram of diffusion coefficients of mRFP-EGFR in different conditions.  
(A) At RT, the diffusion is faster in the cells after 16% of the cholesterol was removed from the 
membrane (blue) than in the untreated cells (green). On the contrary, (B) at 37°C, the diffusion is 





Similar measurements were conducted for DiI-C12 and Dil-C18, and an increase in 
diffusion coefficients was observed. However, the thresholds for the two lipids were 
slightly different: The increase started mainly after 33 % cholesterol is removed for DiI-
C12 (from 0.74 ± 0.09 to 0.83 ± 0.04 µm2/s) and after 16 % cholesterol is removed for 
DiI-C18 (from0.64 ± 0.07 to 1.01 ± 0.06 µm2/s). The values of diffusion coefficients are 
summarized in table 7.1. 
 
7.2.2.3 The effect of cholesterol depletion on EGFR diffusion mode is 
concentration dependent 
To understand the change of EGFR's distribution in different membrane organization 
condition, we examined the effect of cholesterol depletion on EGFR partitioning. As 
shown in figure 7.4, cholesterol depletion led to a significant decrease in intercept when 
~16 % of the cholesterol was removed (1.06 ± 0.54 s without treatment versus 0.61 ± 
0.24 s with 84 % cholesterol, P<0.01), but still significant higher than those of DiI-C12 
and DiI-C18 in the same temperature, indicating that the physical barriers confining the 
receptors were lowered. The intermediate value illustrated that the net effect of 
cholesterol depletion at the level of 16 % was the partial abolishment of the lipid-
mediated microdomain organization. As suggested by the diffusion coefficient histogram 
in Figure 7.3, The peak value of the diffusion coefficients was almost doubled after the 
cells were treated with 0.5 mM mβCD, consistent with the experimental results which 
concluded that the D in domain is about 3 times of the D out of domain (Dietrich, 
Bagatolli et al. 2001; Dietrich, Yang et al. 2002; Filippov, Oradd et al. 2003; Filippov, 
Oradd et al. 2004; Elson, Fried et al. 2010). Cholesterol extraction by mβCD affected the 
diffusion of EGFR to a different extent when the extraction reached a high level. The 
intercept increased by a factor of 1.4 when the cell cholesterol was reduced to ~33 % of 
normal. On the contrary, the intercept of DiI-C12 and DiI-C18 was decreased, which 
could be caused by the different partitioning and the change of the fluidity and viscosity 
of the plasma membrane. The relative changes of intercepts were summarized in figure 
7.4, and the values of intercepts are summarized in table 7.2. 
The changes of the intercepts of EGFR upon changes of cholesterol% could indicate 
several aspects of the receptor's diffusing environment.  Studies showed that depletion of 
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cellular cholesterol to different levels could have different effects in sorting of proteins 
(Mays, Siemers et al. 1995; Brown and London 1998; Keller and Simons 1998). We 
hypothesis that these results may be caused by the mechanism of the way the lipid rafts 
are destroyed when cholesterol is depleted.  
The diffusion law simulations from Wawrezinieck et al suggested: when the 
microdomains were partially abolished, both the confinement strength (reflected by an 
increase of the probability of exiting the domain, a decrease of the probability of entering 
the domain, or a combination) and the size and density of the domain were decreased. 
The effect led to a decrease in the intercept. Whereas the increased of the intercept of 
EGFR by the removal of large amount of cholesterol corresponded to the increase of 
confinement strength, increase of the domain size or both (Wawrezinieck, Rigneault et al. 
2005; Humpolickova, Gielen et al. 2006; Lenne, Wawrezinieck et al. 2006; Favard, 
Wenger et al. 2011).  
The change of intercepts after 16 % cholesterol was removed was similar to the effect of 
0.1 U COase on GPI, a well-recognized raft-marker, in COS-7 cells (Lenne, 
Wawrezinieck et al. 2006). Although 0.1 U COase converted only 8 % of the total 
cholesterol into cholestenone, the combined effect of decreased cholesterol and increased 
cholestenone was able to abolish the microdomain to this level. Whereas for the result 
after 67 % cholesterol was removed, and cytoskeleton may also be affected, one 
explanation could be the formation of a smaller number of larger and more rigid domains 
on the plasma membrane containing more concentrated EGFR, compared with untreated 
cells (Saffarian, Li et al. 2007). In summary, it is possible that when rafts were disrupted 
by high concentration of mβCD, EGFR rearranged into other types of domains. Hence, 
we hypothesize that cholesterol depletion firstly lead to the release of EGFR from the 
disintegrating rafts into a more homogenous membrane environment, and as more 




Figure 7. 4 The summary of relative intercepts in different cholesterol% for EGFR, DiI-C12 and 
DiI-C18 (average ±SE).  




Figure 7. 5 Summary of the effect of mβCD on diffusion coefficients and intercepts.  




7.2.3. Cytoskeletal effects are negligible on EGFR partitioning and diffusion 
Besides rafts, another major constraint of molecule diffusion on the membrane is caused 
by cytoskeleton. On the membrane, cytoskeleton forms fences and pickets that restrict 
diffusion and partitioning of many membrane molecules. The relationship of EGFR and 
cytoskeleton on the plasma membrane was found different in different cells and 
conditions. In this section, the influence of CHO cells' cytoskeleton on EGFR diffusion 
was tested with LatA, a drug that can disrupt microfilament organization in living cells. 
After incubation for 20 min at RT, we found that the diffusion coefficient of EGFR was 
not changed (from 0.41 ± 0.02 µm2/s to 0.42 ± 0.03 µm2/s), although the cell morphology 
was clearly altered as shown in Figure 7.6, suggesting that the diffusion of EGFR is 
cytoskeleton independent. Not only the diffusion of EGFR was not affected, but also the 
nanocluster formation was not affected by LatA either, in line with the results mentioned 
in the reference (Ariotti, Liang et al. 2010). Actin disruption by adding LatA did not 
appear to have an effect on the confinement observed with EGFR since no significant 
changes of intercept values were observed in either room temperature or 37°C.  
Similarly, DiI probes treated with LatA didn't show significant changes in diffusion 
coefficients (from 0.77 ± 0.08 µm2/s to 0.82 ± 0.09 µm2/s for DiI-C12, and from 0.64 ± 
0.06 µm2/s to 0.69 ± 0.05 µm2/s for DiI-C18). But one exception for intercept is that of 
DiI-C12 after adding LatA in room temperature. At best DiI-C12 showed a small change 
at RT after adding LatA, and further investigations into this might be needed. However, 
at 37°C this effect was not reproducible. The diffusion coefficients and intercepts of 






Figure 7. 6 The effect of 3µM LatA on CHO cells and the membrane molecules.  
(A) LatA changes the morphology of a CHO cell in RT within 5 min. (B) Summary of the effect of 
LatA on diffusion coefficients and intercepts under room temperature.  (C) Summary of the effect 




It has been shown that ITIR-FCS can detect the meshwork as long as the size of the 
meshwork is in the same order of the smallest binning (unpublished data). Hence, the 
addition of LatA may cause the disruption of cytoskeleton at a range beyond the size of 
the observation area.  
 
7.2.4. EGF stimulation caused the reorganization of EGFR-contained rafts in 
certain cells  
It is of great importance to figure out the influence of EGF stimulation on the EGFR's 
localization because the special effect is involved in the functions and pathway 
triggering. Till now, opposing effects of the ligand-binding on EGFR partitioning were 
observed in different setting of experiments. In our setting, diffusion coefficient of EGFR 
was not significantly affected by EGF stimulation, but the intercepts were increased if 
large and non-moving EGFR clusters formed.  
Diffusion coefficient analysis suggests that the average mobility did not change by EGF 
stimulation (D from 0.41 ± 0.02 µm2/s to 0.39 ± 0.03 µm2/s). However, as some clusters 
were observed in some cells, we analyzed the cells with clusters separately and found that 
the largest difference between the clusters after stimulation with the clusters observed in 
untreated cells was that these clusters do not move significantly. In other words, they 
were located at certain spots, as shown in figure 7.7). In the 9 cells with clusters 





Figure 7. 7 The clusters induced by EGF stimulation.  
 
The intercept for a certain cell expressing mRFP-EGFR changed correspondingly to other 
changes such as diffusion coefficients and formation of clusters. Since the cells presented 
two different responses, EGFR clustering and no EGFR clustering, we analyzed the two 
groups separately. If no clustering of EGFR was observed in the cells, the diffusion 
coefficient and intercepts were 0.37 ± 0.02 µm2/s and 1.09 ± 0.07s (35 cells), showing no 
significant difference from the untreated cells. On the contrary, if EGFR formed clusters, 
the diffusion coefficient and intercepts were changed to 0.48 ± 0.07 µm2/s and 1.68 ± 
0.33 s, both higher than the untreated values, suggesting the FCS diffusion law study 
successfully reflect the formation of EGFR big clusters. Meanwhile, the responses of DiI-
C12 and DiI-C18 could reflect the changes in the plasma membrane as a whole. DiI-C12 
showed a significant decrease in intercept and a significant increase in diffusion 
coefficients (from 0.32 ± 0.05 s to 0.19 ± 0.03 s and from 0.74 ± 0.09 µm2/s to 0.88 ± 
0.06 µm2/s). On the contrary, DiI-C18 showed no significant difference in either 
parameters (from 0.28 ± 0.06 s to 0.29 ± 0.05 s and from 0.64 ± 0.07 µm2/s to 0.72 ± 0.05 
µm2/s). The different response between the two lipids may be caused by the different 
length of their tails. It is known that the thickness of the CHO cell's plasma membrane is 
comparable to the tails of DiI-C16. Therefore, the partitioning and diffusion of the two 
lipids may be affected to a certain level, especially when the plasma membrane 
undergoes stimulations and raft coalescence (Hofman, Ruonala et al. 2008).  
Regions of interest from 9 cells were tracked before and after EGF addition to understand 
the individual response of EGFR to stimulation. On average, the diffusion coefficients 
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increased with time (Figure 7.8), suggesting that EGF may facilitate EGFR to move out 
of its initial raft partitioning to enter into either other types of rafts or non-raft regions. 
 
Figure 7. 8 Summary of the effect of EGF on diffusion coefficients and intercepts.  
(A) results under room temperature. (B) results under 37°C. (C) Relative D in single cell tracking 





Table 7. 1 Summary of diffusion coefficients. 
D (µm2/s) 
 (Avr±SE) 
EGFR DiI-C12 DiI-C18 
RT 37°C RT 37°C RT 37°C 
No treatment 














mβCD 0.5 mM 
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LatA 3 µM 

















Table 7. 2 Summary of intercepts. 
D (µm2/s) 
 (Avr±SE) 
EGFR DiI-C12 DiI-C18 
RT 37°C RT 37°C RT 37°C 
No treatment 














mβCD 0.5 mM 
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EGF 100 ng/mL 














LatA 3 µM 


















Our data demonstrated that EGFR exists in cholesterol-dependent, actin-independent rafts 
in serum-starved CHO cells, confirmed by the reference (Ariotti, Liang et al. 2010). 
Using the FCS diffusion law in ITIR-FCS, we identified the concentration of cholesterol 
as an important component responsible for driving EGFR's localization in lipid rafts.  
The quantitative measurements presented here were the first application of ITIR-FCS in 
studying the diffusion and distribution of a membrane protein in living cells. Our finding 
indicates that the mobility of EGFR was affected differently by different drugs including 
mβCD, LatA and EGF, or by different concentrations of the same drug like mβCD. The 
diffusion coefficients of EGFR increased when a small amount of cholesterol (~16 %) 
was removed by low concentration of mβCD from ~0.41 µm2/s to ~0.48 µm2/s in room 
temperature measurements. On the contrary, when a large amount of cholesterol (~67 %) 
was removed, the diffusion coefficient of EGFR decreased from ~0.58 µm2/s to ~0.37 
µm2/s in 37°C measurements. Under the same conditions, the mobility of two lipids, the 
mobility of DiI-C12 and Dil-C18 both increased, although the thresholds of the extracted 
amount of cholesterol for a significant increase to be detected where slightly different. 
We hypothesize that the change of D is related to the mechanism of how the disruption of 
lipid rafts is caused by cholesterol removal. The increase of D could be caused by a 
disruption of rafts and a more homogenous membrane after 16 % cholesterol was 
removed, while the decrease of D was due to a formation of larger nanodomains after 
about 67 % cholesterol was removed. On the contrary, the treatment with LatA for a time 
long enough to change the cell's morphology did not change the diffusion coefficients or 
the intercepts of either EGFR or the lipids, DiI-C12 or DiI-C18 significantly.  
The importance of cholesterol on EGFR localization was reported in different groups 
(Lambert, Vind-Kezunovic et al. 2006; Saffarian, Li et al. 2007; Irwin, Mueller et al. 
2011). Our finding that EGFR is organized in rafts on the cell membrane is consistent 
with previous studies using other high-resolution imaging techniques, such as high-
resolution spatial mapping (Ariotti, Liang et al. 2010), and fluorescence intensity 
observations (Ichinose, Murata et al. 2004). However, we extend these studies and show 
for the first time that the localization of EGFR differs driven by different concentrations 
of cholesterol. This is a particularly intriguing observation, since the localization is 
critically linked to the regulation of EGFR activity. The intercept of EGFR decreased 
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when small amount of cholesterol was depleted while it increased when a larger amount 
of cholesterol was removed from the cells. The results provided a level of detail that has 
not been achieved previously. Based on these observations, the traditional model of 
EGFR partitioning may need to be reformulated to include the effect of cholesterol level 
on the existence of more complex equilibrium.  
The relationship between cholesterol and EGFR may shed new light on the pathogenesis 
of EGFR-involved diseases such as some cancers (Oh, Leem et al. 2010; Irwin, Mueller 
et al. 2011), given the regulatory function of the rafts on EGFR related pathways.  
Actin disruption has been reported to have some effect on the diffusion of different 
membrane molecules (Kwik, Boyle et al. 2003; Treanor, Depoil et al. 2010; Jaumouille 
and Grinstein 2011). However, in our setting, we found that the disruption of the 
cytoskeleton by LatA did not change the diffusion mode of EGFR, suggesting a limited 
effect of cytoskeleton on its diffusion (Ariotti, Liang et al. 2010).  
EGF stimulation resulted in EGFR clustering in cells, and this clustering can be 
suppressed by the EGFR-specific inhibitor AG1478 to a certain level. The diffusion 
coefficients in cells with clustering increased to ~0.49 µm2/s, but did not change if the 
cells without clusters observed were counted in. For single cell tracking, we found that 
the diffusion coefficients of EGFR increased with time after EGF was added in 8 of the 9 
cells recorded, and the increase could be suppressed by AG1478 in 3 out of 5 cells 
recorded. The different responses again suggest the existence of a sub-population 
mentioned in the previous chapters, so sometimes the distribution of parameters rather 
than the average could provide more information (Goulian and Simon 2000; Vrljic, 
Nishimura et al. 2005; Haggie, Kim et al. 2006).  
The FCS diffusion law intercepts obtained in cells with clustered EGFR after EGF 
stimulation showed its ability to reflect the formation of these large clusters. As a result, 
our ImFCS-diffusion-law provided explicit information on the distribution of fluorescent 




Chapter 8. Conclusion and Outlook 
8.1 Conclusion 
The objective of this work was to quantitate protein interactions and mobility in a living 
cell system. For this purpose, we applied SW-FCCS and ITIR-FCS as our biophysical 
techniques. The quantitation methods employed in this work present a more fully 
complexity of the biological phenomena observed.  
The development of advanced fluorescence-based microscopy techniques has provided 
powerful tools to probe biomolecular dynamics and interactions. Among the widely used 
techniques, i.e. FRET, FRAP, FLIM and FCS/FCCS, confocal FCS/FCCS is particularly 
useful in quantitating protein-protein interactions in a low-to-middle protein expression 
level in living systems, while ITIR-FCS provides multiplexing for the molecules of 
interest. This thesis started from confirming the pre-formed dimer of EGFR in resting 
cells, and further studied the change of dimer% upon EGF stimulation. Then it extended 
the quantitation of biomolecule-interactions into a dynamic process, and studied the 
interaction between EGFR and PTB along with their interaction after EGFR is being 
activated by EGF. Next, the study extended from single point measurement to  
multiplexing methods. To understand the behaviour of EGFR in a membrane system, 
ITIR-FCS was first calibrated, and was then applied in combination with the FCS-
diffusion-law to understand the factors influencing EGFR mobility.  
The observation of pre-formed dimers of EGFR with and without activation provided 
information about the EGFR clustering upon stimulation. More than 10 min was required 
before maximal dimer% was observed in most cells, suggesting the observation was at 
substrate saturation conditions. The precise positioning of SW-FCCS made the study of 
the process near the membrane possible. All these observations added new dimensions of 
the complexity of the activation mechanism, which is no longer simple about the 
transition from monomer to dimer or oligomer but about the increase of dimer% in the 
population.   
We provided quantitative information about the interaction between a membrane protein, 
EGFR, and its downstream cytoplasmic interaction partner, PTB, in living cells in an 
activation dependent manner by SW-FCCS for the first time. This type of experiments 
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posed several problems, such as concentrations between the cytosolic and membrane 
proteins may mismatch (which leads to a limited response in the cross-correlation 
amplitudes), membrane focusing along the time needs to be paid special attention (as 
membrane movement may distort the ACF and CCF curves), and limited number of cells 
can observed each time. Despite the difficulties, our findings indicated that the interaction 
between EGFR and PTB was elevated significantly before the receptors were activated 
by its ligand, although a low level of binding was observed, suggesting basal 
phosphorylation of EGFR. Upon activation, PTB was recruited to the membrane and the 
full binding was seen mostly at about 20-30 minutes. The binding was reversed and 
lowered to a certain level by applying AG1478, an EGFR-specific tyrosine kinase 
inhibitor, suggesting the importance of the phosphorylation of EGFR for their interaction. 
In these experiments, we interpret that very big intensity fluctuations recorded 
sometimes, were due to receptor clustering. This clustering and the movements of the 
clusters were observed again in ITIR-FCS measurements.  
Before ITIR-FCS was applied to study the mobility mode and distribution of EGFR, the 
optimal operational parameters of ITIR-FCS were determined. 2 ms, 20,000 frames and 
laser power of 0.8-1.0 mW were used for our ITIR-FCS measurements, and the 
photobleaching in the intensity was corrected using the sliding window correction 
method. Our data suggested, not only the membrane molecules can be properly recorded 
by ITIR-FCS, the information of cytosolic components can also be extracted, although 
only a small part of the curves was captured due to a limitation of the acquisition time. 
Besides, two types of EGFR clusters were observed. One type only diffuses within a 
certain small regions, probably being constrained by particular membrane structures. 
Another one type was active transport, possibly facilitated by cortical microtubules on the 
plasma membrane. However, when the cells were stimulated by EGF, more cells 
presented clusters and the localization of clusters was almost immobile during the 40 s 
measurement period.  
Next, the mobility and distribution of EGFR was analyzed in combination of diffusion 
coefficients analysis and diffusion law studies. The membrane structure disruption by 
cholesterol depletion was found to exert influence on EGFR in a concentration dependent 
manner. When a small amount of cholesterol (~16 %) was removed, the diffusion 
coefficients of EGFR were increased and the intercept of its diffusion law plotting was 
decreased, suggesting the lipid rafts structures were partially destroyed. However, when a 
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large amount of cholesterol (~67 %) was depleted, the effect was different. The diffusion 
coefficients were decreased while the intercepts were decreased, possibly suggesting the 
reorganization of the microdomains. EGF stimulation resulted in two different responses 
of the cells. Some of them obtained non-moving clusters, which returns a higher 
intercept, compared with cells without stimulation. The rest of them didn't show the 
formation of clusters, and the intercepts were not changed for them. Actin-cytoskeleton 
was found not to affect the diffusion and localization of EGFR.  
Based on my experimental results I would like to propose a speculative model of EGFR 
function as far as that is possible. The receptor seems to exist in an equilibrium of dimers, 
possibly other oligomers, and monomers. Although most of these are inactive, there 
seems to be some basal phosphorylation and possibly some basal activity. 
Phosphorylation and activity (including internalization) is dramatically enhanced by EGF 
stimulation. Nevertheless, the results from ITIR-FCS may suggest the apparent 
monomer-dimer-oligomer distribution is caused by the raft localization of the receptor. 
With the stimulation of EGF, the rafts coalescence and reorganize, which lead to the new 
balance of the distribution. The new equilibrium provides the platform for a various of 
downstream interactions and activate the related pathways.  
 
8.2 Outlook 
As abnormality in EGFR regulation has been closely linked to severe disease 
progression, it is of great importance to better understand the states, mobility, and 
regulation for future therapeutic intervention. The real-time participations of many 
proteins were still lacking, not to mention their interaction strengths or processes. This 
thesis reveals the advantages as well as limitations of SW-FCCS and ITIR-FCS as a 
biophysical fluorescence technique for the interaction and mobility of proteins in living 
cells. The major limitations are cause by the photostability of the fluorescent probes and 
the competition effect of endogenous proteins. Also, the accessibility of these techniques 
for most biological laboratories is still limited, hence many studies still employ 
microscopy systems that are prevalent but do not provide quantitative information such as 
that from SW-FCCS and ITIR-FCS .  
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Imaging FCCS, which cross correlates the signals between each corresponding pixel, 
could be a very promising direction for further development. It will capture more spatial 
information in one single measurement and establish a map using interaction strength 
data as the contrast. Trials have been done by using DiI-C18 as a calibration dye and 
PMT-EGFP/PMT-mRFP as a negative control (Figure 8.1). The emission light was splitt 
by a 560 nm dichroic mirror, and the two sides of light pass through the corresponding 
filters (545AF35 and 615DF45, exactly the same as confocal SW-FCCS setting) before 
reach the camera to decrease cross talks as much as possible. The whole light splitter was 
implemented in a tube and the tube was able to easily attach onto the camera, but 
adjustment is required each time. Even a micrometer ruler is used to adjust the two 
image, as shown in Figure 8.1.C, there is no physical way to precisely measure how well 
they coincide. So the cplx% calculated from DiI is used as a calibration procedure and 






Figure 8. 1 Illustration for camera-base SW-FCCS measurements.  
(A) The Dual-View tube added for Dual-View SW-FCCS measurements, (B) the image for the 
ruler used to adjust the two images, (C) ACFs and CCFs of DiI-C18 almost coincide with each 
other, and (D) the CCFs of PMTs are near flat. 
 
Unfortunately, due to the limitation in terms of the quantum yield and photostability of 
the current red fluorescent proteins (FPs), the current sensitivity of the available camera, 
and the emission filter set with the dichoic mirror, in the measurements of cells 
expressing mRFP-EGFR-EGFP, recognizable ACF curves exist in only a small fraction 
of pixels. Hence, developing new fluorescent probes with better quantum yield and long-
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term photostability as well as improving the performance of the camera could improve 
the signal to noise ratio and result a less-noisy result. In addition, the new fluorescent 
probes for proteins in living cells, to be excited by a single wavelength, must also be 
well-separated in emission spectra, which requires a large Stocks shift for one of the FP 
pairs. Some easily adoptable organic dyes could be another choice, if they have strong 
affinity to structures that can be genetically tagged to target proteins. The sensitivity as 
well as acquisition time of the camera needs to improve to increase the signal-to-noise 
ratio to a level that is high enough for FCCS analysis. In all, the camera-based SW-FCCS 
leads to an exciting area to quantitate spatial and temporal information for biomolecules.  
In general, more quantitative results could help us understand the mechanism differences 
between normal and disease responses of essential pathways more clearly, draw more 
attention in the different responses for the same treatments (which may be based on a cell 
level), and could provide numerical information to improve computational simulations 
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